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Abstract 
Enteroaggregative Escherichia coli (EAEC) is a genetically diverse enteric pathogen that causes 
growth faltering among children, acute and chronic diarrhoea among children and adults living 
in both industrialised and low income countries. The German outbreak of EAEC-Shiga-toxin-E. 
coli in 2011 resulted in over 4000 confirmed cases of diarrhoea with over 54 fatalities in 14 
European countries as well as United State of America and Canada. Several studies conducted in 
sub-Sahara Africa (SSA), Latin America and Asia countries have identified EAEC more 
frequently than any other bacterial pathogens. In SSA, case fatality due to EAEC is not well 
documented but the morbidity rate particularly among younger children is huge.  Studies 
conducted in Senegal, Central-Africa-Republic and Tanzania showed that EAEC were endemic 
among HIV-positive patients with diarrhoea. Few studies from SSA have reported distribution 
of antimicrobial resistance pattern of EAEC.   
The Global Enteric Multisite Study (GEMS), a three-year case-control study conducted in seven 
African and Asia countries, showed that the prevalence of EAEC was higher among children 
with no diarrhoea (463/741, 62.5%) compared to children with diarrhoea (278/741, 37.5%).  
The aim of this retrospective analytical study nested to GEMS is to explore other molecular 
approaches that identify infectious EAEC and to show the genetic diversity and antimicrobial 
resistant pattern of EAEC. Study design of the first approach involves unmatched case-control 
428 (157 cases and 271 controls) EAEC isolates that were examined by polymerase chain 
reaction (PCR) for the presence of 21 common EAEC virulence genes. This investigation 
implicated plasmid-encoded toxin (pet), AAF/1 fimbrial subunit (aggA) and hexosyltransferase 
homolog (capU) to be associated with diarrhoea in infants. In addition, two other virulence 
genes; Shigella exracellular protease A (sepA) and EAEC-heat-stable enterotoxin 1 (EAST1) 
were implicated in the EAEC that cause diarrhoea among children under 5 years old.  
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The second approach utilised qualitative PCR (TaqMan-qPCR) method to assess the use of 
bacterial load diagnostic tool to diagnose infectious EAEC on selected matched case-control 160 
(80 cases and 80 controls) EAEC isolates. Two biomarker genes, aatA and aaiC were the target 
in this study and both resulted in higher rate of higher bacterial load in controls (58/80 [72.5%]) 
compared to cases 48/80 [60%]), p – value 0.096.  
The third approach explored bacterial biofilm formation to diagnose infectious EAEC on 400 
unmatched cases (150) and controls (250) EAEC isolates. Infectious EAEC produces biofilm to 
consolidate its colonisation in the host and damage to the tissue. The result of this study showed 
higher proportion of biofilm-producing EAEC in controls (61%) compared to cases (39%). 
However, biofilm-producing EAEC isolates that has aggR gene combined with one or all of the 
following virulence genes aatA, Aap, Orf3 and Orf61 revealed strong association with diarrhoea  
Investigation into the antimicrobial resistant EAEC on the same 400 unmatched EAEC isolates 
revealed multi-drug resistant (MDR) EAEC infection as a significant problem among infants in 
the Gambia. MDR EAEC strains are almost equally distributed among cases and controls, and 
high (>71%) rate of resistant to Ampicillin, Sulphamethoxazole-trimethoprim and Tetracycline, 
and moderate (25%) rate of resistant to Chloramphenicol among study children. However, over 
ninety-four percent of the Gambia EAEC strains are susceptible to Cefotaxime, Ceftazidime, 
Ceftriaxone, Ciprofloxacin, Gentamicin and Amoxicillin-clavulanic acid.  
Additionally, result of whole genome sequencing (WGS) on 50 randomly selected EAEC 
isolates showed average 94% concordance of resistance genes with phenotypic disc diffusion 
method.  
This thesis provides detailed initial description and exploration of virulence genes associated 
with EAEC strains circulating in the rural Gambia and has revealed the likely biomarker genes 
to target in the diagnosis of infectious EAEC that cause diarrhoea in infant.  
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Chapter 1: Literature Review 
  
1.1 Introduction 
This study was nested to a three year case-control diarrhoea project tagged Global 
Enteric Multisite Study (GEMS) jointly sponsored by Bill and Melinda Gates foundation 
of USA and Medical Research Council Unit, The Gambia, West Africa. The samples used 
were obtained in a population of children with moderate-to-severe diarrhoea (MSD) cases 
and non-moderate-to-severe diarrhoea (non-MSD) controls and were 0-59 months of age. 
Case definition of MSD is a child with diarrhoea (≥3 abnormal loose stools) within the 
previous 24 hours with onset within the previous 7 days, following at least 7 days without 
diarrhoea, and accompanied by evidence of clinically significant dehydration (loss of skin 
turgor, sunken eyes, or a decision by the clinician to administer intravenous fluids), 
dysentery (blood in the stool), or clinical decision to hospitalize the child (Farag, Nasrin 
et al. 2012).   
The pathogenesis of Enteroaggregative Escherichia coli (EAEC) diarrhoea comprises 
colonisation of the intestinal mucosa, elaboration of enterotoxins and release of 
proinflamatory cytokines from the infected epithelial cells. Characteristically, EAEC 
strains enhance mucus secretion from the mucosa, with trapping of the bacterium in a 
bacterium-mucus biofilm. The clinical presentation of EAEC is characterized by watery, 
mucoid, secretory diarrhoea with low-grade fever and occasional vomiting. 
 
This retrospective analytical study aimed at providing the first case-control data to 
evaluate role of Enteroaggregative E. coli (EAEC) in diarrhoeal disease and assessment 
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of molecular approaches to the diagnosis of diarrhoea caused by EAEC in children in The 
Gambia.  
 
The benefit of this study will influence policy regarding treatment and recommending an 
uncomplicated, affordable and accessible diagnostic tool that decreases the prevalence of 
diarrhoea caused by EAEC among children in the Gambia.  
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 1.2 The Gambia and Upper River Region Gambia 
The Gambia is a country in West-Africa that is mostly surrounded by Senegal. It is the 
smallest country on mainland Africa that has become a centre for tropical medical 
research, largely due to the over 70 years presence of Medical Research Council Unit The 
Gambia at London School of Hygiene and Tropical Medicine (MRCG@LSHTM) 
providing required scientific and clinical facilities to The Gambia and to the west-African 
regions.  
 
The Gambia is situated 12° north of the equator. The country is bordered to the north, east 
and south by Senegal. The western side of the country borders the North Atlantic Ocean 
with 50 miles of the coastline. The country is narrow and its border mirrors the 
meandering Gambia River which empties into the Atlantic Ocean.  The country is less 
than 30 miles wide with a total area of 11,300 km
2
, 1,300 km
2 of Gambia‟s area is 
covered by water. Its size is about 10, 500km
2
. Currently, the country is divided into five 
administrative regions that include West Coast, North Bank, Lower River, Central River 
(CRR) and Upper River regions (URR) with two municipal areas which are Banjul and 
Kanifing (figure 1.1). The MRC Unit The Gambia operates in all the regions but has field 
stations in two regions (West Coast – Keneba and Basse-URR) with headquarter at Fajara 
in Kanifing municipality. 
 
The climate of The Gambia is tropical. From June to October is the rainy season period 
with intermittent warm weather. The annual average rainfall is 800-1200 mm. From 
November to May there are cool temperatures and is part of a dry season. The 
temperature during hot season (February to May) at CRR and URR can go as high as 
47
o
C.  The commonest fruit in the Gambia is Mango of various species.  
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The Gambia population is estimated at 2 million, and about 90% of the population are 
Muslims and 63 % live in rural villages. The official language is English however; the 
country has a wide variety of ethnic groups, each preserving its own language and 
tradition. The Mandinka tribe is largest, followed by the Fula, Wolof, Jola, Sarahule, 
Serers, Karoninka, Manjago and Bianukas [https://en.wikipedia.org/wiki/The_Gambia]. 
The Krio known as Aku and the Hausa are the smallest ethnic minorities in The Gambia. 
About 1% of the Gambia population are non-African descendants that include Europeans 
and Lebanese origin (Gambia 2015) [Central Statistics Department, The Gambia 2015]  
 
 
Figure 1.1: Map of The Gambia 
 
 
 
 
 
 
 
 
(Maps 2015)https://www.ezilon.com/maps/africa/gambia-maps.html 
 
The economy of the Gambia is dominated by farming, fishing and largely tourism. About 
a third of the population lives below the international poverty line of US$1.25 a day 
(Gambia 2016) https://en.wikipedia.org/wiki/Economy_of_the_Gambia  
 
North Bank Region West Bank Region Lower River Region Central River Region Upper River Region 
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Currently, Gambia life expectancy for females is 57 years and for males is 54 years with 
mortality rate of 39.1 per 1000 for children less than 5 years of age 
[https://data.unicef.org/topic/child-survival/under-five-mortality/]. 
The report in 2010 showed maternal mortality rate per 100,000 births as 400, and the 
under-5 mortality rate per 1000 births, was 106 and the neonatal mortality, as a 
percentage of under-5 mortality, is 31. It was estimated that the number of midwives per 
1,000 live births is five and the lifetime risk of death for pregnant women is one in 49  
[https://en.wikipedia.org/wiki/The_Gambia].  
 
In October 2010, a report showed that Gambia had made significant improvements in 
polio, measles immunisation and the PCV-7 vaccine (Roca, Hill et al. 2011; Scott, 
Odutola et al. 2014). Additionally, in August 2013, a nationwide coverage rotavirus 
vaccine was introduced (Unicef 2013)[https://www.unicef.org/gambia/media_8418.html]. 
A regional representative of the WHO (Thomas Sukwa) commended Gambia “The 
Gambia Expanded Programme on Immunization (EPI) program is one of the best in the 
World Health Organisation African Region” [https://en.wikipedia.org/wiki/The_Gambia] 
  
 
 
 
 
 
 
 
 
 
32 
 
1.3 An overview of diarrhoeal disease 
Infectious diarrhoea is one of the principal causes of morbidity and mortality particularly 
in young children globally. Diarrhoeal illnesses account for 22% of the 10 million annual 
worldwide deaths of children under 5 years of age (Black, Morris et al. 2003). More than 
half of these cases occur in Africa and South Asia. In emergency conditions, 90% of 
deaths are due to diarrhoea (Toole and Waldman 1997). A study conducted in 2000 
estimates that diarrhoea accounts for only 13% of all childhood deaths, amounting to 1.4 
million deaths per year (Murray 2001). Since then the incidence of diarrhoea reported 
varies hugely with the seasons and a child‟s age, the incidence is high in the first two 
years of life and declines as a child grows older. In 2004, a study recorded a decline in 
mortality caused by diarrhoea among children under five years from an estimated 5 
million deaths to 1.5 million deaths over the last 20 years (Pinto 2009). Despite this 
decline, WHO recorded in 2017 maintains diarrhoea was the second most common cause 
of death among children under five years old globally and the disease kills about 525000 
children under five (WHO 2017) (http://www.who.int/mediacentre/factsheets/fs330/en/). 
Globally, there are about 1.7 billion cases of childhood diarrhoeal illness annually and it 
is regarded as the leading cause of malnutrition in children under five years old hence, 
risk of life-threatening diarrhoea is mostly associated to this age group (WHO 2017) 
(http://www.who.int/mediacentre/factsheets/fs330/en/).  
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1.3.1 Definition of diarrhoea 
Diarrhoea is defined in epidemiological studies as the passage of three or more loose or 
watery stools in 24-hour period. Infectious diarrhoea is caused by a bacterial, viral or 
parasitic infection mostly in the small intestine. Under normal conditions, there is a 
balance in absorptive and secretory functions of intestinal water and electrolytes. The 
inner surface of the small intestine lined with specialised cells known as enterocytes are 
responsible for secretion and adsorption during the process of digestion (Cuting 1998). 
When the intestine fails to absorb water or when there is an increase in fluid secreted into 
the intestine, the amount of water in stool increases and the individual has diarrhoea 
 
1.3.2 Clinical syndrome of diarrhoea 
The three known clinical syndromes of diarrhoea are acute watery diarrhoea, dysentery and 
persistent diarrhoea. Each of these reflects a different pathogenesis and requiring different 
approaches to treatment.  
1.3.2.1 Acute watery diarrhoea involves the passage of frequent loose or watery stools 
without visible blood. This symptom can last up to 14 days but most episodes often last less 
than seven days. Vomiting may occur and fever may be present. The severity loss of water 
and salt from the body leads to dehydration and ultimately results into death due to 
breakdown in vital organs function. Several previous studies have shown that about 60% of 
stool samples from children with acute diarrhoea yielded enteric pathogens, which include 
rotavirus and diarrhoeagenic-E. coli as the most common (Kang, Ramakrishna et al. 2001; 
Reither, Ignatius et al. 2007). Others are Campylobacter species, Shigella species, Salmonella 
species, Vibrio cholera, Norovirus and Cryptosporidium species (Kotloff, Nataro et al. 2013). 
All these play an important role in many different geographic areas.    
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1.3.2.2 Dysentery diarrhoea involves visible blood in the faeces. The effect includes rapid 
anorexia, weight loss, and damage to the intestinal mucosa by the invasive pathogen such as 
Shigella, Enteroinvasive E. coli, C. jejuni and occasionally salmonella (WHO-document 
1992). 
 1.3.2.3 Persistent diarrhoea is of unusually long duration, at least 14 days. The episode 
may begin either as watery diarrhoea or as dysentery. Diarrhoeal stool volume may be huge, 
with risk of dehydration and frequency of severe weight loss. There is no specific microbial 
cause for persistent diarrhoea. However, Enteroaggregative E. coli (EAEC) and 
Cryptosporidium were fund to play a greater role compared to other diarrhoeagenic agents 
(WHO-document 1992) (Jensen HB 2016; Molloy FS 2010). It should be noted that 
persistent diarrhoea must not be confused with chronic diarrhoea, which refers to recurrent or 
long-lasting diarrhoea due to non-infectious causes, such as sensitivity to gluten or inherited 
metabolic disorders. 
1.3.3 Transmission and Spread of Diarrhoea 
The infectious agents that cause diarrhoea are usually transmitted by the faecal-oral route 
which includes ingestion of faecal contaminated water or food, person-to-person 
transmission, and direct contact with infected faeces (Baker 2011). A number of behaviours 
that help spread diarrhoeal pathogens include preparing food with hands that have been 
contaminated during defecation and not properly washed, allowing an infant to crawl, or a 
child to play in an area where human or animal faeces are present (Baker 2011).    
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1.3.4 Pathogenesis of Microbial agents of Diarrhoea 
Infection by a diarrhoeal causing pathogen following ingestion is by adhesion and 
colonisation to a receptor on the enterocyte cells of the small intestine. Secretory diarrhoea 
therefore occurs when pathogens stimulates infected enterocytes to secrete water and salts 
into the small intestines. If the cells are hugely affected, the intestine cannot reabsorb all of 
the fluid secreted and the infected individual develops diarrhoea (Cuting 1998). Invasive 
diarrhoea occurs when pathogens kills enterocytes, reducing the surface area available for 
adsorption of water and in turn reducing the ability of the intestine to absorb water and 
causing diarrhoea (Cuting 1998).  However, all of these are induced by different mechanisms 
of action of different enteric pathogens.            
1.3.5 Risk factors 
There are four major risk factors that make younger children highly susceptible to diarrhoea. 
These are behavioural, host immune response, age and seasonality factors.   
1.3.5.1 Behavioural risk factors – These include failure of the mother to breast-feed 
exclusively for the first 4-6 months of life or failure to continue breast-feeding for at least 1 
year, using infant feeding bottles that easily become contaminated with faecal bacteria, 
storing cooked food at room temperature, drinking water that is contaminated with faecal 
bacteria, failing to wash hands before handling food and failing to dispose of faeces 
hygienically (Barrell and Rowland 1979; Feachem 1984).  
1.3.5.2 Host Immune factors – These includes undernutrition, recent measles infection and 
immunosuppression. In undernourished children there is increase in frequency, severity, 
duration and risk of death from diarrhoea. Also, diarrhoea and dysentery tend to occur more 
frequently and or severely in children with measles and those children who had measles in 
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the previous four weeks. This speculated to have resulted from immunological impairment 
caused by measles (WHO 1992) (http://rehydrate.org/diarrhoea/tmsdd/1med.htm). Diarrhoea 
due to immunosuppression resulting from viral infection can be brief or can be longer in 
individuals infected with acquired immunodeficiency syndrome (AIDS) and in this condition 
diarrhoea can also be caused by unusual microbial agents.     
1.3.5.3 Age factor – In the case of age factor, most diarrhoeal episodes occur during the first 
two years of life. Incidence is highest in the group 6-11 months, when weaning often occurs. 
This pattern reflects the combined effects of declining levels of maternally-acquired 
antibodies, the lack of active immunity in the infant, the introduction of food that may be 
contaminated with faecal bacteria and direct contact with human or animal faeces when the 
infant starts to crawl. Most enteric pathogens stimulate at least partial immunity against 
repeated infection or illness, which helps to explain the declining incidence of disease in 
older children and adults (WHO 1992) (http://rehydrate.org/diarrhoea/tmsdd/1med.htm).  
1.3.5.4 Seasonality - In the case of seasonality factor, distinct seasonal patterns of diarrhoeal 
occur in many geographical locations. For example, in temperate climates bacterial 
diarrhoeas tend to occur more frequently during the warm season, whereas viral diarrhoeas, 
particularly disease caused by rotavirus, peak during the winter. In tropical areas, rotavirus 
diarrhoeas tends to occur throughout the year, increasing in frequency during the drier, cool 
months, whereas bacterial diarrhoeas tend to peak during the warmer, rainy season. The 
incidence of persistent diarrhoea follows the same seasonal pattern as that of acute watery 
diarrhoea(WHO 1992) (http://rehydrate.org/diarrhoea/tmsdd/1med.htm). 
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1.3.6 Interrelationship between diarrhoea and malnutrition 
The intimate relationship between diarrhoeal illness and undernutrition among children from 
developing countries is well documented (Lima and Guerrant 1992). Diarrhoeal injury to the 
gut can impede children growth which can results in extreme forms of chronic malnutrition 
that predispose young children to diarrhoeal related mortality like in the case of moderate and 
severe stunting (Guerrant, Oria et al. 2008; Roche, Cabel et al. 2010). Diarrhoea is a 
recognised cause of malnutrition because demands for nutrients are high during diarrhoea, as 
during other infectious diseases, consequently, nutrient intake and absorption are often 
declined. Each episode of diarrhoea often lead to weight loss and growth faltering, and if 
occurs frequently, there may be too little to “catch up” on growth which means unable to 
make up for the growth that failed to occur between episodes. Children who experience 
frequent episodes of acute diarrhoea, or have persistent diarrhoea, are more likely to become 
malnourished than children who experience fewer or shorter episodes of diarrhoea. In 
summary, the impact of diarrhoea on nutritional status is proportional to the number of days a 
child spends with diarrhoea each year. Malnutrition also contributes to the problem of 
diarrhoea. Malnourished children due to inadequate feeding, severe and more frequent acute 
and persistent diarrhoeal episodes as well as frequent dysentery stand high risk of dying from 
this complication (WHO-document 1992). Hence, diarrhoea and malnutrition combine to 
form a vicious circle (figure 1.2) which, if it is not broken may eventually lead to death 
(WHO-document 1992). 
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Figure 1.2: Interaction of 
Diarrhoea and Malnutrition 
(Adapted from WHO 
document of library 
cataloguing data 1992 of 
student manual) WHO 91816 
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1.3.7 Management of acute-diarrhoea 
The most common risk with acute diarrhoeal illnesses particularly in children is dehydration 
and loss of electrolytes and in the developing countries malnutrition has been implicated. So 
the first step in managing acute diarrhoea is to correct dehydration and electrolyte imbalance 
(Warren 1983) which can be accomplished with an oral glucose or starch-containing 
electrolyte solution in the vast majority of cases. Oral Rehydration Therapy (ORT), one of the 
greatest medical innovations of the 20
th
 century (Santosham, Keenan et al. 1997) has proven 
to be highly effective. Oral Rehydration Solution was formulated base on the observation that 
glucose-sodium co-transport was unaffected in cholera and that the recognition of secretory 
and absorptive processes in the intestine are quite separate. ORT solutions contain specific 
concentration of sodium, glucose, potassium, chloride and alkali (bicarbonate or citrate) in 
clean water (Guerrant, Van Gilder et al. 2001). These constituents of ORTs help to restore the 
electrolyte balance and hydration.  
In some cases treatment with an antibiotic may be necessary (Estrada-Garcia, Perez-Martinez 
et al. 2014). However, antimicrobial therapy must be carefully weighed before commencing 
treatment. This is due to the fact, that the harmful consequences of non-prudent use of 
antibiotic increase risk of complications and conditions such as  antimicrobial resistant-
enteric pathogens, side effects of antibiotic treatment, superinfections when normal flora are 
eradicated by antibiotics and likelihood induction of disease-producing phage by antibiotics 
(such as Shiga-toxin phage induced by quinolone antibiotics) which might outweighed the 
benefit of the antimicrobial therapy (Nguyen 2005).  
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1.3.8 Timely recognition 
Early recognition and treatment of infectious diarrhoea is paramount. So the detection of 
clinical symptoms, particularly the danger signs such as vomiting, convulsions, lethargy or 
unconsciousness, lost of appetite and blood in stool are very important. A thorough history 
must include both clinical and epidemiological features in evaluating patient who present 
with diarrhoeal illnesses (Nguyen 2005). The clinical information includes the duration and 
frequency of diarrhoea, stool characteristics (appearance, colour, watery, bloody, mucous, 
purulent and formed or unformed), quantity of stool produced, presence of dysenteric 
symptoms (fever, tenesmus, blood and/or pus in stool), symptom of volume deletion (thirst, 
tachycardia, decreased urination, lethargy, decreased skin turgor), and associated symptoms 
and their frequency and intensity (nausea, vomiting, abdominal pain, cramp, headache, 
myalgias, altered sensorium).  
The epidemiological information that is very useful to public health professionals in decision 
making includes identification and sub-typing of the causative agent, prompt notification of 
pathogens-specific diagnoses and other epidemiological factors that can reduce the rate of 
transmission and lead to timely detection and control of diarrhoea outbreaks.  
Investigation: In this thesis, “Molecular approaches in the diagnosis of diarrhoeal 
disease in children from a developing country” (Gambia), we investigate the role of 
Enteropatogenic E. coli (EPEC), Enterotoxigenic E. coli (ETEC) and Enteroaggregative E. 
coli (EAEC) in diarrhoea by analysing the GEMS Gambia site specific data that showed high 
prevalence of EAEC among MSD and non-MSD children but with no association with 
diarrhoea. These three diarrhoegenic E. coli (DEC) strains are known to be of global health 
importance, specifically afflicting humans, particularly, children under five years old in 
developing countries. Additionally, we utilized molecular diagnostic approaches that involve 
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group multiplex-PCR and PCR to detect EAEC-virulence factors, measured bacterial load for 
EAEC using qPCR TaqMan assay and screened the isolates for biofilm and biofilm-
producing-genes in order to establish EAEC pivotal role in childhood diarrhoeal disease. 
Furthermore, we investigated antimicrobial resistant patterns of EAEC isolates in order to 
know the prevalence of the set of antibiotic resistant-EAEC strains that are in circulation in 
this region, discover the transmission pattern of resistant strains and ultimately establish 
mechanisms to reduce or eliminate the spread of the antimicrobial resistant agents.   
In addition, whole genome sequencing (WGS) regarded as the hallmark of microbial 
diagnosis was used on some randomly selected EAEC strains in order to better understand 
and interrogate the genetic components of the EAEC from Gambian children.   
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1.4 Diarrhoeagenic Escherichia coli (DEC) strains at a glance  
Diarrhoeagenic E. coli (DEC) strains which are sometimes referred to as E. coli 
pathotypes are E. coli strains that cause diarrhoea in the infected host when genetic 
element that encodes for virulence factors is acquired.  
E. coli was first discovered in the gut in 1885 by the German bacteriologist-paediatrician 
Theodore von Escherichia, who called the organism Bacterium coli commune (Mora, 
Lopez et al. 2012). E. coli remain the commonest facultative anaerobe of the member of 
Enterobacteriaceae family of human colonic flora. The organism typically colonises 
infant gastrointestinal tract within hours of life, and, thereafter, E. coli and the host 
derived mutual benefit (Nataro and Kaper 1998). Most E. coli strains are normal flora of 
the intestinal microbiota of humans and other animals, however, a good number of the 
strains have acquired virulence factors that enable them to cause important intestinal and 
extraintestinal disease that includes diarrhoea, haemolytic uremic syndrome (HUS), 
haemorrhagic colitis (HC), urinary tract infection (UTI), septicaemia and neonatal 
meningitis. Diarrhoeagenic E. coli pathotypes represent a leading cause of paediatric 
diarrhoea in developing countries (Nataro and Kaper 1998; Estrada-Garcia, Lopez-
Saucedo et al. 2009) and also an emerging cause of diarrhoea in developed countries 
(Robins-Browne and Hartland 2002; Cohen, Nataro et al. 2005). A wide range of 
bacteria, viruses and parasites cause diarrhoea (Kotloff, Nataro et al. 2013). Among the 
bacterial agents that are purported to possess the ability to cause severe and fatal 
diarrhoeal disease in younger children, DEC is the most implicated and represents a major 
public health problem in the developing countries (Nataro and Kaper 1998). In addition, 
DEC constitute a reservoir of latent diarrhoeal infection which may hinder control and 
future elimination. The contribution of DEC diarrhoea to malnutrition and growth 
impairment is likely more detrimental than even rotavirus infections (Mondal, Haque et 
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al. 2009; Okeke 2009). DEC strains have been classified into 7 groups, based on 
epidemiological, clinical and molecular characteristics: Enteropathogenic E. coli 
(EPEC), Enteroaggregative E. coli (EAEC), Enterohaemorrhagic E. coli (EHEC), 
EnteroInvasive E. coli (EIEC), Diffusely adherent E. coli (DAEC) and Cell-detaching 
E. coli (CDEC)  (Nataro and Kaper 1998; Guion, Ochoa et al. 2008). DEC strains that are 
responsible for about 40% of all diarrhoeal episodes in developing countries include 
ETEC, EPEC and EAEC (Clarke 2001; O'Ryan, Prado et al. 2005; Dutta, Guin et al. 
2013). This explains why GEMS has chosen these three DEC strains as the target 
microbial agents of diarrhoea. Generally, E. coli remain as a commensal provided genetic 
elements encoding for virulent factor are not acquired (Kaper, Nataro et al. 2004). 
Identification of DEC requires ability to differentiate these strains from non-pathogenic E. 
coli that constitute normal intestinal flora. Thus, molecular identification and 
classification of DEC is based on the presence of different chromosomal or plasmid-
encoded virulence genes, which are absent in the commensal E. coli. ETEC is defined by 
the elaboration of the heat labile (LT) and/or heat stable (ST) enterotoxins. EPEC is 
characterised by attaching and effacing (AE) lesions that harbour eae gene that encodes 
structural gene for outer membrane protein Intimin. EPEC is classified into typical and 
atypical EPEC. Typical-EPEC (tEPEC) strains are those harbouring the chromosomal 
attaching and effacing (eae) and the EPEC adherence factor (EAF) virulence plasmid 
encoding bundle-forming pili (Kaper, Nataro et al. 2004), whereas atypical-EPEC 
(aEPEC) strains harbour the eae gene only (Nataro, Mai et al. 2006). Enteroaggregative 
E. coli, a well-recognised diarrhoeal pathogen mostly among children in developing 
world has been traditionally defined as an aggregating cell adherence phenotype. The 
ability of EAEC to adhere to HEp2 cell line in a stacked brick manner confers the term 
aggregative adherence (AA). The AA phenotype is associated with specific fimbriae 
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(AAFs) which are encoded by plasmids (pAAs), and an EAEC molecular marker Center 
for Vaccine Development 432 (CVD432) has been shown in the pAA (Dutta, Guin et al. 
2013). Also, EAEC strains harbouring virulence factors under the control of AggR 
regulator are designated typical EAEC and strongly associated as a diarrhoeal pathogen 
(Nataro 2005; Nataro, Mai et al. 2006). Diffusely adherent E. coli (DAEC) is never 
associated with any outbreaks and volunteer studies did not result in disease (Nataro, Mai 
et al. 2006) so its pathogenicity status is unclear.  A recently discovered additional 
putative pathotype, known as Cell-detaching E. coli (CDEC) harbours the E. coli 
haemolysin gene and also secretes cytotoxic necrotizing factors (CNF1) (Kaper, Nataro et 
al. 2004). Studies have described pathogenic mechanisms of the six DEC in detail (Nataro 
and Kaper 1998; Nataro and Martinez 1998; Kaper, Nataro et al. 2004; Croxen and Finlay 
2010). The schematic diagram of molecular mechanisms of EPEC, EHEC, ETEC, EAEC 
and DAEC pathogenicity is illustrated in figures 1.3 and 1.4 below (Croxen and Finlay 
2010).   
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Figure 1.3: Pathogenic mechanisms of enteropathogenic and enterohaemorrhagic E. 
coli. (Adapted from Croxen and Finlay 2010) 
EPEC and EHEC are attaching and effacing (A/E) pathogens that efface the microvilli and 
subvert host cell actin to form pedestals beneath the attachment site. The pedestal formation 
mechanisms shown for EPEC and EHEC are based on studies of the prototypical strains 
EPEC E2348/69 and EHEC O157:H7. Effectors secreted by the type III secretion system can 
affect Cl
––OH– and Na+–H+ exchanger activity, mislocalize aquaporins and inhibit sodium-d-
glucose co-transporter 1 (SGLT1) (Croxen and Finlay 2010).  
EPEC attaches to the small bowel through the bundle-forming pilus (BFP), forming localized 
adhesions (LA). Intimate attachment is mediated by the interaction between intimin and the 
translocated intimin receptor (Tir). Tir is phosphorylated by host tyrosine kinases, and 
phosphorylated Tir recruits Nck, which activates neural Wiskott–Aldrich syndrome protein 
(N-WASP) and the actinrelated protein 2/3 (ARP2/3) complex to mediate actin 
rearrangements and pedestal formation. Using the locus of the enterocyte effacement-
encoded type III secretion system, a large repertoire of effector proteins is injected into the 
host cell, subverting host cell pathways ) (Croxen and Finlay 2010).  
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EHEC mechanism of pedestal formation is slightly different from that used by EPEC. Tir is 
not phosphorylated, and pedestal formation is Nck-independent. The actin rearrangements 
that are necessary for pedestal formation are mediated by Tir cytoskeleton-coupling protein 
(TccP; also known as EspFU), which is linked to Tir through the host protein insulin receptor 
tyrosine kinase substrate (IRTKS; also known as BAIAP2L1) and interacts with N-WASP to 
activate the ARP2/3 complex. In addition to this intimate attachment, EHEC attaches to the 
large bowel through the E. coli common pilus (ECP) and the haemorrhagic coli pilus (HCP). 
EHEC injects many of the same effectors as EPEC into the host cell to manipulate host 
processes(Croxen and Finlay 2010). 
Shiga toxin (Stx); also known as verocytotoxin is released following phage-mediated lysis 
in response to stress, further contributing to disease. Globotriaosylceramides (Gb3s) on 
Paneth cells in the human intestinal mucosa act as receptors for Stx.(Croxen and Finlay 
2010). 
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Figure 1.4: Pathogenic mechanisms of enterotoxigenic E. coli, enteroagreggative E. coli 
and diffusely adherent E. coli (Adapted from Croxen and Finlay 2010) 
ETEC becomes anchored to enterocytes of the small bowel through colonization factors 
(CFs) and an adhesin that is found at the tip of the flagella (EtpA). Tighter adherence is 
mediated through Tia and TibA. Two toxins, heat-labile enterotoxin (LT) and heat-stable 
enterotoxin (ST), are secreted and cause diarrhoea through cyclic AMP (cAMP)- and cyclic 
GMP (cGMP)-mediated activation of cystic fibrosis transmembrane conductance regulator 
(CFTR) (Croxen and Finlay 2010) 
EAEC attaches to enterocytes in both the small and large bowels through aggregative 
adherence fimbriae (AAF) that stimulate a strong interleukin-8 (IL-8) response, allowing 
biofilms to form on the surface of cells. Plasmid-encoded toxin (Pet) is a serine protease 
autotransporter of the Enterobacteriaceae (SPATE) that targets α-fodrin (also known as 
SPTAN1), which disrupts the actin cytoskeleton and induces exfoliation (Croxen and Finlay 
2010).     
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DAEC forms a diffuse attaching pattern on enterocytes of the small bowel, which is mediated 
through afimbrial (Afa) and fimbrial adhesins, which are collectively known as Afa–Dr 
fimbriae. Most Afa–Dr fimbriae bind to complement decay-accelerating factor (DAF); a 
subset of Afa–Dr fimbriae bind to receptors in the carcinoembryonicantigen- related cell-
adhesion molecule (CEACAM) family. The autotransported toxin Sat has been implicated in 
lesions of tight junctions (TJs) in Afa–Dr-expressing DAEC, as well as in increased 
permeability. Polymorphonuclear leukocyte (PMN) infiltration increases surface localization 
of DAF (Croxen and Finlay 2010).                     
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1.5 Review of Enteroaggregative Escherichia coli (EAEC) 
1.5.1 Discovery 
The six categories of E. coli (ETEC, EPEC, EIEC, EHEC, EAEC and DAEC) have virulence 
attributes that help the bacteria to cause diseases by different mechanisms (Weintraub 2007). 
Three (ETEC, EIEC and EHEC) of the six categories are known to possess specific virulence 
attributes that include toxins, invasins and colonisation factors. Over a century ago a study 
confirmed set of E. coli serotypes later referred to EPEC that were associated with diarrhoea 
outbreaks (Ewing 1963). In 1979, this set of serotypes regarded as EPEC was investigated for 
in vitro adhesion assay and were found to bind to the Hep-2 cells in a localized pattern 
(Cravioto and Arrieta 1979). A few years later studies showed adherent non-EPEC strains 
that were associated with diarrhoea, the strains were named „enteroadherent E. coli‟ (Cravioto 
and Arrieta 1979; Mathewson, Johnson et al. 1985; Mathewson, Oberhelman et al. 1987).  
Round about the same time, Nataro and colleagues observed in their experiment two different 
phenotypes among the enteroadherent strains which are diffuse and aggregative adherent 
strains (Nataro, Kaper et al. 1987). The finding of the aggregative adherent strains was the 
first description of EAEC by James Nataro. Thus, the aggregative adherence patterns signify 
a new strain with distinct class of diarrhoeagenic E. coli called Enteroadherent-aggregative E. 
coli (Nataro, Kaper et al. 1987) now known as Enteroaggregative E. coli (EAEC). In 
summary, a study comparing adherence patterns of 516 E. coli isolates from faecal samples 
of children with and without diarrhoea. The study used DNA probes to examine three 
adherence patterns to HEp-2 cells and were distinguished and described as (1.) Localised, (2.) 
True diffuse and (3.) Aggregative. Localised adherence was attributed to EPEC, True diffuse 
adherence had no association with diarrhoea whilst Aggregative adherence was associated 
with diarrhoea in 84 of the 253 probe negative strains from children with diarrhoea. The 
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aggregative adherence is characterised by a stacked-brick formation of bacterial cells 
attached to the Hep-2 cells (Nataro and Kaper 1998).  
Heterogeneity of EAEC virulence in a volunteer study: Four EAEC reference strains used in 
the study include EAEC 042, 17-2, 34b and JM221 isolated from a child with diarrhoea in 
Lima Peru, Chile, India and an adult wit diarrhoea in Mexico respectively (Nataro et al. 
1995). Twenty volunteer study participarnts were allocated into 4 groups of 5 each and each 
group received a different EAEC strain. It is important to mention that the 20 volunteers were 
screened for serologic evidence of antibodies to te 14-kDa protein encoaded by the 17-2 
plasmid by Western immunoblot of which 17 were seronegative and 3 seropositive. The 3 
seropositive volunteers were distributed into different groups. Study participants were given a 
single dose of 10
10
 colony forming unit (cfu) of bacteria.  
Of the 20 study participants, only 4 experienced loose stool and the 4 are those inoculated 
with the dose of EAEC 042 strain and 3 of them met the case definition of diarrhoea. All the 
20 study participants secreted their organism by 24 hour after inoculation and 17 continued to 
shed at 96 hour, at which time antibiotic therapy commenced.    
The absence of disease in EAEC 042 infected individual who was seropositive for 14-kDa 
protein encoded by 17-2 plasmid showed that EAEC 17-2 strain is protective. A possible 
explanation of the EAEC 042 virulence is dependence on host age and genetic factors. For 
example,  infants who are naturally known to possess poor adaptive immune system will 
easily develop diahrroea if infected by EAEC 042 strain. 
Despite the fact that this experiment was hailed by most scientific community but there was 
no strong evidence that EAEC 042 cause disease in children and adults who are not 
immunocompromised. Also, the suitability of the EAEC 042 as a reference strain is doubtful 
because the challenged experiment showed that the strain lacks AAF/I which is an important 
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variant among the five aggregative adherence fimbriae variants that enhance the the strain to 
colonise host mucosal epithelial cells or enterocytes (Nataro, Yikang et al. 1994 and Jonson, 
Struve et al. 2015). Additionally, a reference strain suppose to be consistence in its virulence 
characteristics and features.  
1.5.2 Classification 
EAEC is classified into typical and atypical based on the presence and absence of a virulent 
factor aggR. Following the discovery of EAEC, a method to identify the new pathotype was 
developed using a probe that hybridised with an ATP-binding cassette transporter apparatus 
that translocates dispersin across the bacterial cell membrane (Nataro, Mai et al. 2006). The 
majority of the samples that were probe positive carries aggR factor but not all 
diarrhoeagenic strains were positive for aggR hence a general classification of EAEC into 
typical (having aggR) and atypical (not having aggR) groups was recognised (Harrington, 
Dudley et al. 2006; Croxen, Law et al. 2013). Further classification can be based on 
difference adherence patterns of some strains affinity to infect the small bowel and others 
infect both the small bowel and the colon (Okhuysen and Dupont 2010; Croxen, Law et al. 
2013). Another recent classification was the Shiga-toxin-EAEC and non-Shiga-toxin-EAEC. 
Shiga-toxin-EAEC was implicated in the German outbreak EAEC in 2011 causing 
haemolytic uremic syndrome (HUS). This outbreak resulted in over 4,000 confirmed cases 
with over 54 fatalities in 14 European countries, the USA and Canada (Buchholz, Bernard et 
al. 2011; Karch, Denamur et al. 2012). The identified strain included features of EAEC with 
capacity to produce Stx 2a (Frank, Werber et al. 2011). Reports from countries such as 
France (Morabito, Karch et al. 1998), Japan (Iyoda, Tamura et al. 2000), Central Africa 
Republic (Mossoro, Glaziou et al. 2002) and Northern Ireland (Dallman, Smith et al. 2012) 
have established EAEC acquiring Shiga toxins among patient with HUS.                                                                                                        
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Additionally, using serology means to serogroup/serotype EAEC is enormous challenge due 
majorly to autoagglutination and cross reactivity of many strains that share serotypes 
differentially adhere to HEp-2 cells, a gold standard method use to detect and to classify E. 
coli pathotypes (Jenkins, Tembo et al. 2006; Estrada-Garcia and Navarro-Garcia 2012).                                                                                       
Furthermore, the use of Multilocus Sequense Typing (MLST) investigation in a Nigeria study 
has not only shown the complexity of EAEC sequence types but also the multiplicity of 
EAEC pathogenic lineages that strengthens the global heterogeneity of EAEC (Okeke, 
Wallace-Gadsden et al. 2010; Croxen, Law et al. 2013).  Many studies have shown that 
EAEC was found scattered among the 6 major E. coli phylogenetic groups (A, B1, B2, C, D 
and E) (Czeczulin, Whittam et al. 1999). An epidemiological study also investigated the 
potential clustering of EAEC strains into different phylogenetic groups found strains in 
phylogroups A, B1, B2 and D. This emphasise the multiple linages of EAEC origin and 
enhance phylogenetic diversity of the strains (Okeke, Wallace-Gadsden et al. 2010). 
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1.5.3 Epidemiology                          
1.5.3.1 Developing Countries 
Many studies from developing countries have shown the association of EAEC with persistent 
and acute diarrhoea (Bhan, Khoshoo et al. 1989; Lima, Fang et al. 1992; Paul, Tsukamoto et 
al. 1994; Pai, Kang et al. 1997; Araujo, Tabarelli et al. 2007). Most diarrhoeal investigations 
in children have shown a significant presence in the prevalence of EAEC compared to the 
controls (Gonzalez, Diaz et al. 1997; Okeke 2009; Opintan, Newman et al. 2010). A case- 
control diarrhoeal investigation in Mongolian children showed that EAEC strains with the 
aggR gene were found to be associated with diarrhoea (Sarantuya, Nishi et al. 2004). 
Similarly, a study performed in Kolkata, India implicated the EAEC strains detected using 
gold standard technique (HeLa cell assay) and PCR amplification to be associated with 
diarrhoea in children <36 month of age (Dutta, Pal et al. 1999) and the study further reported 
more frequent cases of watery diarrhoea than cases of mucoid diarrhoeal children (72% 
versus 28%) (Hebbelstrup Jensen, Olsen et al. 2014). A study in Vietnam revealed frequency 
of EAEC associated with diarrhoea in children less than 2 years of age (Nguyen, Le Van et 
al. 2005). Multiple investigations revealed the association of EAEC with diarrhoea 
particularly in populations in low-income countries (Moyo, Maselle et al. 2007), prominently 
in association with persistent diarrhoea (≥14 days). Recent studies in Iran and Egypt 
demonstrated the implication of EAEC in paediatric diarrhoea (Ali, Ahmed et al. 2014; 
Bafandeh, Haghi et al. 2015). However, a high rate of carriage of EAEC in children has been 
reported by several other studies that include case-control study conducted 2003 and 2006 in 
South India (Rajendran, Ajjampur et al. 2010). Similar report was shown from other case-
control studies conducted in north-eastern Brazil (Scalesky 2001), Mali (Boisen, Scheutz et 
al. 2012) and Gambia (Ikumapayi, Boisen et al. 2017).  
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1.5.3.2 Developed Countries                              
An earlier investigation in 1985 has implicated EAEC responsible for 14.9% of diarrhoea in a 
US student population visiting Guadalajara (Mathewson, Johnson et al. 1985). Again, report 
from Adachi‟s diarrhoeal investigation detected EAEC in 33% overseas travellers who are 
citizen of Americans, Canadians and Europeans from three different regions that include 
Guadalajara in Mexico, Ocho-Rios in Jamaica and Goa in India (Adachi, Jiang et al. 2001). A 
Scandinavian case-control study also revealed the association of EAEC with diarrhoea 
(Bhatnagar, Bhan et al. 1993). Likewise, East London investigation unmasked the recovery of 
EAEC from children suffering from acute and persistent diarrhoea (Chan, Phillips et al. 
1994). Additional evidence of association of EAEC with diarrhoea in Europe and Eastern 
Europe was demonstrated in another case-control investigation in Germany were 2% of 
diarrhoeal cases revealed presence of EAEC but none fund among the healthy control 
(Huppertz, Rutkowski et al. 1997). Similar evidences EAEC diarrhoea were shown in 
cohort/case series (Presterl, Nadrchal et al. 1999; Knutton, Shaw et al. 2001) and a one year 
cohort investigation in Denmark where EAEC was detected in 25 (14%) among Danish 
children attending day-care facilities and diarrhoea was reported in 6 (24%) of the EAEC 
infected children (Hebbelstrup Jensen, Stensvold et al. 2016). The more confirmatory 
evidences were the outbreaks that occurred in Serbian neonatal ward in which some children 
died (Cobeljic, Miljkovic-Selimovic et al. 1996) and Japan in which school children who ate 
contaminated lunch were infected and developed severe diarrhoea and EAEC was detected in 
10% of cases (Itoh, Nagano et al. 1997). Other outbreaks involving children and adults have 
been reported in United Kingdom (Smith, Cheasty et al. 1997; Spencer, Smith et al. 1999) as 
well as France (Boudailliez, Berquin et al. 1997). 
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1.5.4 Transmission and Reservoir                                 
Transmission of EAEC is recognised as faecal-oral route (Jiang, Greenberg et al. 2002) and 
mostly occurs through either drinking contaminated water or consumption of contaminated 
food such as salads and other food deserts as reported in England case control study 
(Tompkins, Hudson et al. 1999) and investigation of contaminated vegetables from a popular 
restaurant at Guadalajara, Mexico (Koo, Jiang et al. 2008). The France outbreak of EAEC 
was speculated to be person-to-person transmission (Boudailliez, Berquin et al. 1997). A 
more current and major outbreak of Shiga-toxin (Stx) producing EAEC in northern Germany 
in May 2011 was epidemiologically associated with the consumption of fenugreek sprout as 
the most likely source of infection (Buchholz, Bernard et al. 2011). It was reported that the 
seeds were imported as a lot in late 2009 from Egypt, and it is still unknown if the point of 
contamination occurred at the site where seeds were produced, during transportation, or at the 
importer (Buchholz, Bernard et al. 2011). A community wide outbreak in the India village 
was epidemiologically associated with the consumption of water from open well (Pai, Kang 
et al. 1997). A study investigated the growth of EAEC in drinking water revealed that 
viability of EAEC strains can be up to 60 days at normal storage temperature and the strain 
survival in mineral water compared to spring water (Vasudevan, Annamalai et al. 2003). In 
Australia, EAEC was identified in water samples obtained from surface water of source of 
drinking water by PCR targeting aggR gene. A study in Bangladesh investigated water during 
both winter and summer detected EAEC in 17% and 4% of the water samples tested in the 
two seasons respectively (Akter, Islam et al. 2013).                                                               
Food handling has been speculated in the transmission of EAEC. For example, study 
conducted in Sao-Paulo Brazil showed presence of EAEC in 3% of milk samples investigated 
from infant feeding bottles that were handled by mothers (Morais, Morais et al. 1998). Food 
handlers, particularly those working in tourist hotels have identified primary carriers of 
56 
 
EAEC. An investigation of two successive foodborne outbreaks of gastroenteritis that 
occurred in Italy farm-holiday resort implicated a pecorino cheese prepared with 
unpasteurised milk as the source of the outbreaks (Scavia, Staffolani et al. 2008) suggesting 
the source as animal origin. The Burkina-Faso investigation on faecal samples from cattle, 
chicken and pigs yielded EAEC positive at 7%, 6% and 32% respectively, reiterate animals 
as possible reservoirs. Also, a study conducted in Brazil detected EAEC in 7.4% of dogs with 
diarrhoea and 3.9% of dogs without diarrhoea (Puno-Sarmiento, Medeiros et al. 2013). 
Again, a Gambia epidemiological study associated animal that includes Cow, fowl and 
ruminant with EAEC high bacterial load among diarrhoeal children (Ikumapayi 2016). 
However, other thorough studies have reported absence of EAEC in animals. For example, in 
Great Britain, 1,227 E. coli isolates from 401 cows, 406 sheep and 400 pigs were investigated 
for EAEC, interestingly, no EAEC strain was detected (Cassar, Ottaway et al. 2004). 
Similarly, in a French study, EAEC was not detected in wastewater or effluents in an 
investigation that wanted to establish source of EAEC in rivers (Bibbal, Kerouredan et al. 
2014) and the target genes for this particular study are aggR, aap and aatA. A very recent 
study conducted in Spanish 46 farms (20 cattle farms, 17 sheep farms and 9 goat farms) 
located in Eastern and southern Spain investigated to help establish whether ruminants are a 
potential source of EAEC transmission to humans (Orden A. Jose 2017). Interestingly again, 
the result of the investigation showed EAEC negative by revealing absence of the target 
(aggR, aap and aatA) genes for E. coli isolates from faecal cultured samples from the 920 
ruminants (Orden A. Jose 2017). Despite overwhelming evidences that exonerate animals 
such as cattle, sheep and goat from being reservoirs of typical EAEC pathogenic strains to 
humans, it is not absolute that EAEC cannot transiently colonise ruminants. Therefore, there 
is likelihood that ruminants can be a reservoir of EAEC and a potential source of 
transmission to humans. Further investigations that elucidate risk factors and the reservoir for 
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EAEC is needed. However, poor sanitation and crowded living conditions increase the 
propensity for EAEC to spread.   
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1.5.5 Pathogenesis 
1.5.5.1 Brief explanation 
Generally, understanding the complexity of interactions between host and bacteria is crucial 
for unmasking pathogenesis of infectious disease. In the case of enteric disease Philipson‟s 
review provides detail explanation on host-pathogen interactions (Philipson, Bassaganya-
Riera et al. 2013). The intestinal epithelium is continuously exposed to trillions of 
microorganisms and confronts the challenge to peacefully coexist with harmless bacteria, at 
the same time responding to pathogens (Vossenkamper A. 2011; Philipson, Bassaganya-Riera 
et al. 2013). The ability for a host to resist colonisation or make infection impossible is 
determined by well structured cellular and molecular interactions between the host and 
pathogen at the mucosal interface. A single layer of epithelial cells which is the epithelial 
barrier provides the first line of defence against pathogenic microorganisms. The epithelial 
barrier integrity is formed by “tight-junctions” between cells and protective mucus-gel that 
coats the cells (Gouyer, Gottrand et al. 2011). In the Philipson‟s review we learnt that if an 
enteric pathogen passes through the mucus layers, group of established evolutionarily 
conserved pathogen-associated molecular patterns (PAMPs) expressed on the microbial 
surfaces are recognized by a set of receptors called pattern recognition receptors (PRRs) 
which expressed on epithelial cell surfaces such as toll-like receptors (TLRs). TLRs activate 
potent innate responses by triggering signalling pathways that regulate gene transcription, 
such as NFκB and mitogen-activated protein kinases (MAPK) and activate the production of 
a large repertoire of pro-inflammatory mediators to orchestrate the influx of leukocytes (Eddy 
and Storey 2007). More specifically, secretion of Interleukin 8 (IL-8) and Chemokine C-X-C 
motif Ligand1 (CXCL1) by enterocytes generates a chemotactic gradient promoting the 
recruitment of neutrophils to facilitate clearance of bacteria through phagocytosis (Eckmann 
and Kagnoff 2005). Epithelial cells also secrete Chemokine C-C motif Ligand 20 (CCL20) in 
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response to enteric pathogens to enhance infiltration of cells expressing Chemokine Receptor 
6 (CCR6). Dendritic cells expressing CCR6 are brought to the underlying lamina propria to 
hasten antigen presentation and activation of the adaptive immune system (Wells, Rossi et al. 
2011). Th17 cells are CCR6+ and implicated as primary contributors to defence against 
extracellular bacterial infections. In addition to the secretion of cytokines to mediate cellular 
trafficking, epithelial cells produce potent antimicrobial proteins such as β-defensins, 
cathelicidins and calprotectin in response to stimulation from enteric pathogens or 
proinflammatory cytokines for further defence against infection (Eckmann and Kagnoff 
2005). Importantly, a great amount of attention has recently shifted away from the host 
response and toward understanding the protective barricade created by commensal microbiota 
during infection (Littman and Pamer 2011). The combined efforts of innate and adaptive 
immune responses with the beneficial influence of the gastrointestinal microbiome generally 
contribute to successful eradication of disease in healthy individuals. 
Multidrug resistance efflux pumps including the AcrAB-TolC system have been reported to 
be associated with the colonization and persistence of bacteria in the host and to have roles in 
bacterial pathogenicity (Piddock 2006). One study suggested that EAEC strains possessing 
CVD432 and EAEC heat-stable enterotoxin-1 (EAST-1) virulence markers are most 
commonly associated with chronic diarrhoea in children (Pereira, Ferraz et al. 2007); whereas 
another study suggested that EAEC strains possessing aggR, aap, and astA that encodes for 
EAST-1 protein are most commonly associated with acute diarrhoea in adults (Huang, 
Mohamed et al. 2007).  
The pathogenesis of EAEC is complex. It may be interesting to know that despite numerous 
outbreaks and several high level pathogenesis investigations conducted the understanding of 
EAEC and its pathogenesis is still not definite, partly due to the paucity of suitable animal 
models and heterogeneity of its virulence factors. Pathogenic bacteria such as EAEC have 
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developed strategic mechanisms to conceal recognition and consequently enhance 
survivability during interaction with its host; these strategies are mostly driven by genetically 
encoded virulence factors. EAEC strains harbour a 60- to 65-MDa virulence plasmid (pAA) 
that encodes many of the known virulence factors including the aggregative adherence 
fimbriae (AAF), Pet toxin, the transcriptional regulator AggR and the secretory protein 
dispersin. A key virulence factor harboured by pAA is the transcriptional activator AggR 
which is considered the master regulator of virulence due to its capability to activate a large 
cluster of virulence genes in EAEC permitting adherence while also promoting the 
production of cytotoxins and enterotoxins (Aslani, Alikhani et al. 2011). A study has proven 
that AggR activates the expression of at least 44 genes in the EAEC prototype strains 042 
(Morin, Santiago et al. 2013). Additionally, in order to mediate secretion of protein, EAEC 
possess a type VI secretion system (T6SS) that is chromosomally encoded on the 
pathogenicity island pheU and transcriptionally regulated by AggR. Two gene clusters known 
as Sci-1 and Sci-2 are present on pheU are responsible for encoding T6S machines (Dudley, 
Thomson et al. 2006). Also, the identification EET2 gene cluster in the EAEC 042 genome 
sequence showed evidence for T3SS prevalence (Ren, Chaudhuri et al. 2004). As it is 
speculated that these secretion systems play a key role in EAEC virulence due to expulsion of 
toxic proteins and association with biofilm formation (Aschtgen, Bernard et al. 2008) yet 
their fundamental roles in mechanisms of pathogenesis is unknown (Philipson, Bassaganya-
Riera et al. 2013). Therefore, heterogeneity among EAEC strains remains a major factor that 
complicates our understanding of pathogenic mechanisms underlying infection; an 
accomplice too is the limited rigorous studies to show definite immunoregulatory responses 
by the host that potentiate EAEC clearance. Nonetheless, many studies have suggested that 
infection can be summarised in three general stages that are; (1) adherence and colonisation, 
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(2) increase mucus or biofilm production and (3) toxin release and host response (Estrada-
Garcia and Navarro-Garcia 2012). 
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1.5.5.2 Adherence and Colonisation 
As custom for pathogenic enteric bacteria, attachment to the intestinal mucosa is the first step 
in colonisation and production of disease by EAEC. The defining feature of pathogenic 
EAEC strains is their ability to produce the staked-brick-pattern adherence termed 
aggregative adherence (AA) that consolidate firmness and abundance adherence of these 
bacteria to the intestinal mucosa. The plasmid-borne aggR gene is an important gene for the 
pathogenesis and adherence properties of EAEC, where strains possessing the aggR gene are 
known as “typical EAEC strains” (Morin, Santiago et al. 2013). The best studied virulence 
factor is aggR, a well-recognised transcriptional activator that promotes the expression of 
both chromosomal and plasmid-encoded virulence factors, including AAF and dispersin 
(aap). The adhesion is facilitated by fimbriae termed aggregative adherence fimbriae or factor 
(AAF). Although three fimbriae (AAFs) encoded by the pAA plasmid are responsible for 
EAEC adherence which are aggA (AAF/I), aafA (AAF/II), agg-3 (AAF/III). Each EAEC 
isolate carries only one AAF subtype at a time. aggA is responsible for aggregative phenotype 
and human erythrocyte haemagglutination of EAEC (Nataro 2005), aafA allows EAEC to 
adhere to the intestinal mucosa (Czeczulin, Balepur et al. 1997), aag-3 function as an 
adhesion (Bernier, Gounon et al. 2002). Earlier studies have showed stacked-brick 
aggregative adherence with Hep-2 cells, likewise biopsies from paediatric intestinal mucosa 
cultured with EAEC strains 17-2 and 221 demonstrate EAEC ability to adhere to jejuna, ileal 
and colonic mucosa (Hicks, Candy et al. 1996). Furthermore, three membrane-associated 
proteins (MAP), of 18, 20 and 80kDa, are believed to play an important role in EAEC 
adherence to and haemagglutination of animal cells (Monteiro-Neto, Bando et al. 2003). A 
study conducted in Sao Paulo Brazil characterised OMP profiles of EAEC strain from 
children with diarrhoea observed heterogeneity in OMP profiles (Monteiro-Neto, Bando et al. 
2003). Hence, the binding of EAEC fimbriae to components of the extracellular matrix 
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proteins of intestinal epithelial cells, such as laminin, type-IV collagen, cytokeratin 8, and 
fibronectin is an initial step in adherence to intestinal mucosa (Farfan, Inman et al. 2008; 
Izquierdo, Navarro-Garcia et al. 2014).                                                                                                                    
The characteristics of four recognised AAFs vary between EAEC strains both in morphology 
and genetic code nonetheless all mediate key function of bacterial attachment to epithelial 
cells. The five major variants of AAF, with distinct structure of pilin subunits aggA (AAF/I), 
aaFA (AAF/II), agg-3 (AAF/III) and AAF/IV have been found in prototype strains EAEC17-
2, 042, 55989 and C1010-00 respectively and the four strains develop the aggregative 
adherence (AA) phenotype (Bernier, Gounon et al. 2002; Harrington, Dudley et al. 2006; 
Boisen, Struve et al. 2008). The fimbriae often splay out from the bacteria due to the surface 
protein dispersin encoded by aap (Sheikh, Czeczulin et al. 2002; Harrington, Dudley et al. 
2006). Dispersin is known to induce changes in the electrostatic surface of the 
lipopolysaccharide layer of the bacteria which is a demonstration of key role for the 
adherence properties of EAEC (Harrington, Dudley et al. 2006).                                                                                                 
In a more clear term, AafA, the major pilin protein of AAF fimbria, is directly linked to 
diminished transepithelial resistance (Strauman, Harper et al. 2010). The expression of 
AAF/I, AAF/II and AAF/IV is sufficient for the induction of polymorphonuclear cell 
transmigration in vitro (Philipson, Bassaganya-Riera et al. 2013). AAFs are highly 
hydrophobic thus enhancing agglutination in an aqueous environment. In order to propagate 
the spreading of EAEC for effective attachment and colonisation EAEC secretes a low 
molecular weight protein Dispersin (aap), a positively charged hydrophobic surface protein 
that maintains electrostatic interactions with the outer lipopolysaccharide layer of the bacteria 
preventing the positively charged AAF from clinging to bacterial membrane (Sheikh, 
Czeczulin et al. 2002; Mortensen, Fowlkes et al. 2011). Dispersin is responsible for 
mediating an antiaggregation phenotype by inducing changes in the outer membrane 
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polarisation of the bacterial cell which requires an ABC transporter system encoded by att 
(Velarde, Varney et al. 2007). Also, another transporter located in the outer membrane 
protein (OMP) called TolC, which is encoded by the aatA has been associated with the 
secretion of a yet to be characterised factor that contribute to aggregation (Imuta, Nishi et al. 
2008). In a volunteer challenge study, dispersin was shown to be highly immunogenic, 
suggesting that it is a potential vaccine candidate (Nataro, Deng et al. 1995). Factually, AAF 
fimbriae collapse in the absence of dispersin and lack functionality critical for adherence 
(Harrington, Sheikh et al. 2009). In addition to these AAF variants, some EAEC strains can 
encode alternative fimbrial structures, such as type IV pili in EAEC strain C1096 (Cobeljic, 
Miljkovic-Selimovic et al. 1996; Dudley, Abe et al. 2006). However, some EAEC strains lack 
AAFs, and their aggregative adherence has been linked to the hral gene on the genome (also 
known as hek) or to possession of alternate adhesions such as HdaA (Bhargava, Johnson et 
al. 2009) regulated by aggR regulon but distantly related to the Dr family of adhesions. 
Undeniably, other unravels AAF and adherence factors exist that need unravelling.                                                                                                                                                                                                                                                                                                                        
Other molecules associated with EAEC colonisation include Pic – a member of serine 
protease autotransporter (SPATE) that encodes on the chromosome of EAEC strain 042 and 
thought to play a role in EAEC colonisation and growth. Pic possesses hemagglutinin and 
mucinolytic activity that enable it to penetrate the intestinal mucus layer and enhance the use 
of nutrients from mucin for possible development of EAEC (Harrington, Sheikh et al. 2009; 
Philipson, Bassaganya-Riera et al. 2013). The importance of Pic protein in the pathogenicity 
of EAEC cannot be underestimated as the protein has been detected as an important virulent 
factor in other enteropathogens such S. flexneri and uropathogenic E. coli. Additionally, 
human neutrophils challenged with purified Pic protein resulted in impaired chemotaxis and 
transmigration but increased activation of the neutrophil oxidative burst while activated T 
cells experience Pic-induced apoptosis (Ruiz-Perez, Wahid et al. 2011). 
65 
 
1.5.5.3 Increase Mucus or Biofilm production 
Following the successful adherence of epithelial cells by EAEC, the epithelial cells are 
stimulated to produce a thick mucus layer above the enterocytes forming a biofilm (figure 
1.5). Formation of biofilm is an important pathogenicity trait of EAEC and the formation is 
mainly in the colon although report has implicated small intestine too (Hicks, Candy et al. 
1996). The formation of biofilm play a key role in persistent infection by allowing bacteria to 
evade the local immune system and by restricting the transport of antibacterial factors that 
include antibiotics (Tokuda, Nishi et al. 2010). Colonisation is consolidated by EAEC 
encased themselves with biofilm and recruit cells forming micro-colonies that are 
interspersed within fluid-filled channels (Mohamed, Huang et al. 2007; Garnett and 
Matthews 2012). The biofilm then protects the colonies restricting antimicrobial penetration. 
Animal and in vitro culture studies demonstrate that EAEC survives within the mucus layer, 
elucidating our understanding why individuals infected, especially children in developing 
countries with pre-existent malnutrition, may develop mucoid stools, malnutrition, and 
persistent colonization with prolonged diarrhoea. However, the mucus layer and biofilm 
possibly do not explain malnutrition in affected children. This is because, for the biofilm to 
impair nutrient absorption, it would have to cover most of the small intestinal mucosa, but 
there is no evidence that this actually occurs. It is more likely that inflammatory responses or 
altered intestinal microbiota are primarily responsible (Kaur, Chakraborti et al. 2010). Many 
studies have shown the importance of expression of AAF for biofilm formation by EAEC 
(Sheikh, Hicks et al. 2001; Sheikh, Czeczulin et al. 2002; Boisen, Struve et al. 2008). Other 
factors involved in the formation of biofilm include shf gene shown to be important for solid 
biofilm production in EAEC strain 042 (Fujiyama, Nishi et al. 2008). The ShF gene codes for 
the 32.8-kDa Shf protein has been localized in one of the three open reading frames between 
aafC and aatA, and has also been implicated in biofilm formation (Fujiyama, Nishi et al. 
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2008), and it is predicted to be similar to IcaB, a mediator of biofilm formation in 
Staphylococcus epidermidis (Heilmann, Schweitzer et al. 1996). Also important are the 
implication of yafK that codes for a 28-kDa protein and fis gene, which codes for a DNA-
binding protein involved in growth regulation likely due to their involvement in the 
regulation of AAF gene expression (Sheikh, Hicks et al. 2001). Other registered genes 
associated with biofilm formation are plasmid-borne aatA gene (Mohamed, Huang et al. 
2007) encoding the dispersin transporter; the set1 gene (Wani, Hussain et al. 2012); and the 
aggR gene (Mendez-Arancibia, Vargas et al. 2008). EilA, a HilA-like regulator, and air, 
encoding the predicted OMP in EAEC chromosome, are associated with biofilm formation 
(Sheikh, Dudley et al. 2006). Interestingly, loss of biofilm formation and diffuse adherence 
pattern was observed in EAEC at pH 4.0 whereas at pH 7.4, typical aggregative adherence 
pattern was observed (Figure 1.4) (Kaur, Chakraborti et al. 2010).  
 
 
(1) Agglutination of planktonic EAEC bacteria.  
(2) Adherence to the intestinal epithelium and colonisation of the gut.  
(3) Formation of biofilm.  
(4) Release of bacterial toxins, inducing damage to the epithelium and increased secretion.  
(5) Establishment of biofilm. (Hebbelstrup Jensen, Olsen et al. 2014).  
(Adapted from Betina Hebblstrup Jensen 2014. Epidemiology and Clinical Manifestations of 
Enteroaggregative Escherichia coli. Clinical Microbiology Reviews P.614-630). 
 
 
Figure 1.5: Stages of pathogenesis 
of EAEC Numbers circle guide to 
show the progression of EAEC 
pathogenesis 
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 1.5.5.4 Release of Toxins 
Once the biofilm formation is established, more damage to the intestinal epithelium is 
required to consolidate the release of bacterial toxins (Hebbelstrup Jensen, Olsen et al. 2014). 
The secretion of toxins is thought to play an important role in secretory diarrhoea which is a 
clinical manifestation of EAEC infection (Harrington, Dudley et al. 2006; Arenas-Hernandez, 
Martinez-Laguna et al. 2012). The putative enterotoxins and cytotoxins that EAEC secretes in 
this EAEC stage of pathogenesis elicit a host inflammatory response that resulted in mucosal 
toxicity causing morphological changes in the structure of the mucosa characterised by 
microvillus vesiculation, enlarged crypt openings and increased epithelial cell extrusion 
(Harrington, Dudley et al. 2006). Three main enterotoxins have been identified which are 
EAEC heat-stable enterotoxin-1 (EAST1), plasmid-encoded enterotoxin (Pet) and Shigella-
enterotoxin-1(ShET1).                                                                                                          
EAST1 is a 4.1 kDa toxin first detected in EAEC strain 17–2 that has now been associated 
with other diarrhoeagenic strains of E. coli providing evidence for its relationship to 
enteropathogenic induced diarrhoea (Menard and Dubreuil 2002). The role of EAST1 in the 
molecular pathogenesis is not clearly understood, although it has been hypothesized that the 
toxin enhances the initial phase of watery diarrhoea seen in many patients (Savarino, 
McVeigh et al. 1996). EAST1 binds to the extracellular domain of guanylate cyclase (GC) on 
the apical membrane of enterocytes and then induces high production levels of cGMP inside 
cells inhibiting the Na/Cl transport system. This significantly reduces the absorption of 
electrolytes and water from the intestine at the villus tips resulting in elevated secretion of 
water in crypt cells (Telli, Guiral et al. 2010).  
Pet a serine protease autotransporter enterotoxin generates high toxicity in human epithelial 
cells resulting in structural damage to the cell. After internalization via receptor-mediated 
endocytosis, Pet is delivered to the cytoplasm by means of retrograde trafficking 
68 
 
accompanied by cleavage of spectrin, also known as the actin-binding protein fodrin (Fig. 
1.4) within microvilli cytoskeleton leading to cell elongation, exfoliation, rounding and 
ultimately the release of cells from the substratum (Croxen and Finlay 2010; Navarro-Garcia 
2010).  
ShET1 enterotoxin encoded by the set gene was first identified in S. flexneri and may be 
associated with increased fluid secretion (Fasano, Noriega et al. 1995). The toxin-induced 
damage observed in the intestinal epithelium, associated with EAEC infection, other 
complication includes haemorrhagic necrosis and shortening of villi, enlarged crypt openings, 
and formation of crypt abscesses (Nataro, Hicks et al. 1996; Navarro-Garcia, Sears et al. 
1999). ShET1 appears to induce intestinal secretion via cAMP and cGMP however much of 
the biochemistry and mechanism of action surrounding this toxin remain elusive (Navarro-
Garcia and Elias 2011).  
The SPATEs constitute a large family of extracellular proteases secreted by 
Enterobacteriaceae via the type-V secretion system (Dudley, Thomson et al. 2006). The 
SPATE genes can be either chromosomal or plasmid borne, organized into 2 phylogenetically 
different classes: class I SPATEs are cytotoxic to epithelial cells and include proteins 
encoded by the pet, sigA, and sat genes, whereas non-cytotoxic class II SPATEs have more 
diverse effects and include proteins encoded by the pic and Shigella extracellular protease 
(sepA) genes (Boisen, Scheutz et al. 2012). Pet (plasmid-encoded toxin) cleaves spectrin in 
the epithelial cytoskeleton (Navarro-Garcia, Sears et al. 1999) resulting in the deformation 
and exfoliation of the cell, and is associated with mucoid stools (Eslava, Navarro-Garcia et al. 
1998). Sat (secreted autotransporter toxin) originally discovered in uropathogenic and 
diffusely adhering E. coli, has been described as the most commonly detected SPATE among 
EAEC strains it cleaves the intracellular protein spectrin and cause cytoskeletal damage to 
tight junctions between intestinal epithelial cells (Guignot, Chaplais et al. 2007). Also, sat has 
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been shown to cause loosening of cellular tight junctions in kidney cells and vacuolation in 
both kidney cells and bladder cells (Guyer, Radulovic et al. 2002). SigA, a SPATE largely 
associated with S. flexneri pathogenesis, is capable of inducing fodrin degradation causing 
catastrophic morphological changes in cells (Al-Hasani, Navarro-Garcia et al. 2009). Pic 
(protein involved in intestinal colonization) is a mucinase that interferes with the integrity of 
the mucus membrane and induces serum resistance and hemagglutination (Henderson, 
Czeczulin et al. 1999; Navarro-Garcia 2010). SepA is the SPATE most strongly associated 
with severe diarrheal illness (Boisen, Ruiz-Perez et al. 2009) but only moderately prevalent in 
EAEC strains and its key role in EAEC pathogenesis remain largely uncharacterised 
(Philipson, Bassaganya-Riera et al. 2013).  
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1.5.5.5 Immunologic / Inflammatory response 
Almost simultaneous to adherence, EAEC induces a host inflammatory response. The initial 
inflammatory response to EAEC infection is dependent on the host innate immune system 
and the type of EAEC strain causing the infection. EAEC carrying “virulence” genes are not 
always associated with disease; however, virulence factors such as flagellin, AggR, AAF 
fimbria and dispersin are associated with increased levels of faecal cytokines and 
inflammatory markers, such as interleukin (IL)-1ra, IL-1β, IL-8, interferon (INF)-γ, and 
inflammatory markers that include lactoferrin, faecal leukocytes, and occult blood 
(Greenberg, Jiang et al. 2002). IL-8 is an important proinflammatory chemokine involved in 
EAEC pathogenesis and is responsible for recruiting neutrophils to the epithelial mucosa 
without mucosal injury, and facilitates intestinal fluid secretion (Kucharzik, Hudson et al. 
2005). Other than IL-8 production by EAEC strain, EAEC strain 042 has been shown to 
induce production of other proinflammatory cytokines that include IL-1β, IL-6, IL-12, and 
TNF, as well as IL-10 a regulatory cytokine (Estrada-Garcia, Perez-Martinez et al. 2014). In 
addition, in vitro studies have shown that EAEC induces the activation of mitogen-activated 
protein kinases (MAPK) on intestinal cells, that in turn activates the transcriptional factor 
NF-κB leading to the secretion of IL-8 and potentially other cytokines (Goyal, Konar et al. 
2010; Khan, Konar et al. 2010). EAEC also activates the production of eicosanoid-based 
PMNs, including neutrophils, chemoattractant, which in turn, leads to the recruitment and 
transmigration of neutrophils to the gut mucosa, causing intestinal damage that may promote 
EAEC colonization (Boll, Struve et al. 2012). Both cytokine production and PMN 
transmigration contribute to EAEC pathogenesis and are a hallmark of inflammatory 
infectious diarrhoea. 
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1.5.5.6 Host genetic / susceptibility factor 
Clinical manifestations of EAEC diarrhoea vary from individual to individual, depending 
upon the genetic composition of the host (Kaur, Chakraborti et al. 2010). Thus, genetics plays 
an important role in determining the host's susceptibility to diarrheal illness. Many studies of 
genetic susceptibility to infection with enteric pathogens have been carried out in adult 
subjects who developed traveller‟s diarrhoea (Flores and Okhuysen 2009; Mohamed, DuPont 
et al. 2011). IL-8 a proinflammatory chemokine that functions as a neutrophil 
chemoattractant by involve in the recruitment and the transmigration of neutrophils into the 
intestinal mucosa and then disrupts epithelial tight-junctions, ultimately induce colitis. This 
mechanism of action is common among diarrhoea-inducing pathogens (Philipson, 
Bassaganya-Riera et al. 2013). The presence of an AA genotype at the−251 position in the 
IL-8 promoter region homozygous for a single nucleotide polymorphism (SNP) produces 
higher levels of faecal IL-8 and more frequently develops symptomatic EAEC diarrhoea than 
those heterozygous for the gene after exposure to EAEC (Jiang, Okhuysen et al. 2003). In 
addition to IL-8, intestinal epithelial cells infected with EAEC 042, the prototype strain, 
upregulate the expression of IL-6, tumour necrosis factor (TNF)-α, growth-related gene 
product (GRO)-α, GRO γ, intercellular adhesion molecule (ICAM)-1, granulocyte 
macrophage colony-stimulating factor (GM-CSF), and IL-1α. These cellular responses are 
primarily mediated by flagellin (fliC), a major bacterial surface protein of EAEC (Harrington, 
Strauman et al. 2005), which causes IL-8 release by binding to Toll-like receptor 5 (TLR5). 
TLR5 signals through P38 mitogen-activating protein kinase (MAPK) and nuclear factor-
kappa B (NF-κB) induce transcription of pro inflammatory cytokines from monocytic cells 
(Kaur, Chakraborti et al. 2010).  
Polymorphisms in the promoter genes of lactoferrin – an iron-binding antimicrobial 
glycoprotein, osteoprotegerin, and Cluster of Differentiation 14 (CD14) are important 
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elements of the intestinal immune system, have been associated with increased susceptibility 
to diarrhoea in US travellers to Mexico. Thus, small variations in the genome can determine 
the susceptibility to a particular pathogen and/or influence disease severity. As the 
contribution of variations in a single gene on disease susceptibility or severity is at most 
modest, work is still needed to identify other host genetic factors that are important in 
determining susceptibility to EAEC infection. 
 
 
1.5.5.7 Pathogenicity Islands 
Different pathogenicity islands have been identified in EAEC strains. Study of a genomic 
island at the tRNA pheU locus, encodes the aaiC-associated type VI secretion system, which 
is regulated by the aggR gene (Dudley, Thomson et al. 2006; Hebbelstrup Jensen, Olsen et al. 
2014). The Shigella species she pathogenicity island found in some EAEC strains encodes the 
SPATEs Pic and ShET1 enterotoxin, thereby conferring toxic and mucinolytic activities 
(Henderson, Czeczulin et al. 1999). Furthermore, two pathogenicity islands associated with 
extraintestinal E. coli strains, the Yersinia high-pathogenicity island, encoding the 
yersiniabactin siderophore, and the hly pathogenicity island, encoding hemolysin and P-
fimbriae, have also been found in EAEC isolates (Schubert, Rakin et al. 1998).  
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1.5.5.8 Malnutrition   
From public health perspective, the most significant outcome of EAEC infection and EAEC 
persistent diarrhoea is on malnourished children living in developing countries, because it has 
been linked with growth shortfalls and decreased intellectual development of these children 
(Lima and Guerrant 1992; Steiner, Lima et al. 1998). EAEC persistence in human intestine 
subclinically induces chronic inflammation in the absence of diarrheal disease (Steiner, Lima 
et al. 1998; Opintan, Newman et al. 2010). The strains exert a complex pathogen-host 
immune interaction where the host inflammatory response to EAEC infection is dependent on 
the host innate immune system and the EAEC strain. Pathogenically, EAEC infection is 
characterized by release of cytokines from the intestinal mucosa and lactoferrin (Steiner, 
Lima et al. 1998; Greenberg, Jiang et al. 2002). These observed inflammatory potentials of 
the EAEC strains resulted in damaging the intestinal epithelium and reducing its absorptive 
function, leading to nutrient depletion and malnutrition. In turn, malnutrition further 
facilitates the infection and perpetuates the cycle of infection (Guerrant, Oria et al. 2008). 
Growth retardation due to EAEC infection was observed in a mouse model (Roche, Cabel et 
al. 2010). The growth impairment was found to be dependent on the dose of bacteria used for 
challenge. It was observed that malnourished EAEC-inoculated mice had reduced growth 
velocity and increased shedding of EAEC in stools compared to nourished mice (Philipson, 
Bassaganya-Riera et al. 2013). 
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1.5.6 Clinical Manifestation (Symptoms)  
1.5.6.1 Brief description 
The clinical features of EAEC illness have been described in volunteer studies, outbreaks and 
sporadic cases. The characteristic clinical picture includes watery secretory diarrhoea, often 
with mucus, with or without blood, low-grade fever, abdominal pain, nausea and vomiting 
(Nataro, Deng et al. 1995; Adachi, Ericsson et al. 2002). Although bloody diarrhoea is not a 
distinctive feature of EAEC illness, a study reported that one-third of affected infants less 
than two years of age had grossly bloody stools (Cravioto, Tello et al. 1991). In a recent study 
we conducted among children that were hospitalized for diarrhoea EAEC was identified 
in~7%. In those 20 patients in whom EAEC was the only etiological agent identified, 55% 
had mucus in faeces, 50% had more than six stool movements per day and 10% had bloody 
stools (Estrada-Garcia, Perez-Martinez et al. 2014). Overall, EAEC diarrhoeal episodes have 
been frequently associated with the presence of mucus, PMNs and lactoferrin in stools 
(Adachi, Ericsson et al. 2002; Cennimo, Abbas et al. 2009; Opintan, Newman et al. 2010). 
The site of colonization is believed to include the colon and the terminal ileum (Hicks, Candy 
et al. 1996; Andrade, Freymuller et al. 2011). The incubation time ranges from 8 h to 52 h 
(Huang, Koo et al. 2004; Scavia, Staffolani et al. 2008). A study by Steiner et al. in 1998 
found that children in developing countries who were diagnosed with EAEC infection 
suffered from growth retardation regardless of the presence of diarrhoea (Steiner, Lima et al. 
1998). Bloody diarrhoea has been reported only rarely and involves mostly small children 
(Sarantuya, Nishi et al. 2004; Denno, Shaikh et al. 2012). However, the German O104:H4 
EAEC Shiga toxin-expressing outbreak strain caused haemorrhagic colitis and haemolytic 
uremic syndrome (HUS), leading to considerable morbidity and casualties (Rasko, Webster et 
al. 2011; Scheutz, Nielsen et al. 2011). The outbreak strain contained the EAEC genes aggR, 
aggA, set1, pic, and aap and a prophage encoding the stx2 gene (Bielaszewska, Mellmann et 
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al. 2011). Urinary tract infections (UTIs) associated with EAEC (Guyer, Radulovic et al. 
2002; Olesen, Scheutz et al. 2012) and one case of urosepsis in an immunosuppressed female 
(Herzog, Engeler Dusel et al. 2014) have also been described recently. An outbreak of UTIs 
associated with EAEC in 1991 was reported in a Danish study (Olesen, Scheutz et al. 2012), 
where the UTI outbreak strain contained the following combination of EAEC genes: sat, pic, 
aatA, aggR, aap, aaiC, and aggA.  
 
 
1.5.6.2 Shigatoxin producing EAEC strain 
Genetic variability in both host and EAEC strains can significantly impact the susceptibility 
and outcome of EAEC infection. For example, the capacity for specific EAEC strains to 
produce Stx2 and cause HUS-induced mortality demonstrates enhanced virulence (Boisen, 
Melton-Celsa et al. 2015). Likewise, host age dictates disease severity which explains why 
infected children are more susceptible to persistent EAEC diarrhoea compared with healthy 
adults.  
The German outbreak in 2011 was caused by EAEC strain that has adopted the ability to 
produce Shiga-toxin (Stx2) strain serotype O104:H4. The strain is chromosomally encoded 
cytotoxic verotoxic that targets globotriaosylceramide (Gb3) receptors located on host 
intestinal and kidney cells. Death from infection with Stx2-producing EAEC strains is 
strongly linked to the development of haemolytic uremic syndrome (HUS), a life-threatening 
disease induced by Stx2 shortly after the onset of diarrhoea. Stx2 undergoes retrograde 
transport to induce endothelial cell apoptosis causing significant gastrointestinal damage 
(Philipson, Bassaganya-Riera et al. 2013). Additionally, Stx2 is able to enter systemic 
circulation and induce glomerular occlusion as blood is filtered through the capillary 
arrangement in the kidney. The resulting haemolytic anaemia and acute renal failure are 
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complications that most commonly affect children and contribute to increased mortality rates 
(Lingwood, Binnington et al. 2010; Pacheco and Sperandio 2012). Interestingly, in the 
German outbreak, death occurred in patients who had not developed HUS; these cases most 
commonly occurred in elderly females (Frank, Werber et al. 2011). Acquisition of a Stx2 
bacteriophage is the leading factor for hypervirulence, phenomenon that may have occurred 
in mammalian intestines or an environment where both human and ruminant faeces were 
present (Laing, Zhang et al. 2012; Philipson, Bassaganya-Riera et al. 2013). Survivability and 
Shiga toxin production alone are not likely the sole causes of HUS in EAEC infected patients. 
EAEC O104:H4 adherence to the intestinal mucosa is mediated by AAF/I and potentially 
more aggressive than EHEC LEE mediated adherence (Philipson, Bassaganya-Riera et al. 
2013). Additionally, EAEC infections induce proinflammatory responses and epithelial 
barrier disruption possibly enhancing systemic dissemination of shiga-toxin and HUS 
induction providing an explanation for the strain‟s hypervirulent activity. In addition to Stx2 
gaining systemic accessibility, severe epithelial damage induced by the toxin could have 
allowed bacterial components to enter peripheral blood exaggerating inflammation 
systemically leading to death by sepsis in non-HUS patients (Philipson, Bassaganya-Riera et 
al. 2013).  
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1.5.6.3 Outbreak of EAEC 
Prior the German outbreak of Stx2 producing EAEC strain, there were other reported 
outbreaks of gastroenteritis linked to EAEC. For example, the largest reported outbreak of 
EAEC, occurred in 1993 in Gifu prefecture, Tajimi, Japan where 2,697 children developed 
food poisoning symptoms following consumption of school lunches (Itoh, Nagano et al. 
1997). Twelve of the 30 faecal samples collected from 30 children with severe protracted 
diarrhoea tested positive for EAEC by the Hep-2 cell assay and the astA gene by PCR, 
interestingly the strains were untypable:H10. Another outbreak was the Serbian nursery 
outbreak in 1995, where EAEC was detected by the HEp-2 cell assay and were belonging to 
serotype O4 in 12 of 19 babies who had fever, diarrhoea and weight loss (Cobeljic, 
Miljkovic-Selimovic et al. 1996). Another outbreak implicating EAEC occurred in a police 
institute in Japan in 2005, staff experienced gastroenteritis following consumption of food 
suspected of being contaminated with EAEC. Investigation revealed four staff member and 
one food handler tested positive for EAEC in stool samples and the identified strains have an 
identical serotype O126:H27 (Harada, Hiroi et al. 2007). Another EAEC outbreak took place 
in 2008 in Italy at a farm holiday resort, where the guests developed gastroenteritis after 
having consumed unpasteurized cheese (Scavia, Staffolani et al. 2008). EAEC was isolated in 
stool samples from six restaurant guests and one staff member; the strains were identified by 
the HEp-2 cell assay and the EAEC strains identified belong to serotype O92:H33, and were 
tested positive for the virulence genes aggR, aat, aap, and set1A by PCR. Testing for 
norovirus, but not rotavirus, was performed in the study. The number and devastating effect 
of EAEC outbreaks reported showed a considerable potential for food-borne transmission of 
EAEC. So, lack of community, national and international surveillance of EAEC can lead to 
missed cases of diarrhoea outbreaks caused by EAEC.  
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Figure 1.6: Showing countries with EAEC outbreaks, case series and cohort studies   
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1.5.7 Laboratory Diagnosis  
1.5.7.1 Aggregation adherence assay 
The gold standard method to identify EAEC is to sub-culture confirmed five colonies of E. 
coli per patient in static Luria Bertani broth at 37
o
C overnight and then infect semiconfluent 
Hep-2 cells for three hours and look for the aggregation adherence (AA) pattern. A positive 
EAEC strain aggregates to produce a hallmark “stacked-brick” appearance, where the bacilli 
are elongated and sometimes line up in a single layer on the surface of the cell (Nataro, Kaper 
et al. 1987; Cobeljic, Miljkovic-Selimovic et al. 1996; Dudley, Thomson et al. 2006). 
However, this method neither distinguishes between pathogenic and non-pathogenic strains 
nor differentiates typical-EAEC from atypical EAEC and is unsuitable for EAEC outbreaks 
and limited to research settings, as it requires specialised equipment and labour intensive and 
experienced personnel (Croxen, Law et al. 2013). A study has shown majority of the HEp-2 
positive strains also been positive for antiaggregation protein transporter gene by PCR 
(Schmidt, Knop et al. 1995). Although in another study, 10% of the EAEC strains verified by 
HEp-2 assay were negative in the PCR assay which clearly shows difficulty of providing a 
genotypic definition for EAEC and design specific molecular biological assays for detection 
(Jenkins, Chart et al. 2006; Weintraub 2007). A cryptic DNA fragment sequence known as 
“CVD432,” or aggregative adherence (AA), from the pAA has been used as an EAEC 
molecular marker in epidemiological studies and comprises the locus aat that encodes an 
ABC transporter system (Baudry, Savarino et al. 1990; Okeke, Lamikanra et al. 2000). A 
transcription activator known as “AggR,” the gene of which lies on pAAs, has been described 
as the major EAEC virulence regulator for diverse virulence genes (Nataro 2005). Multiple 
PCR-based assays have been developed to identify the aggR gene, and detection of additional 
virulence genes, such as aap, astA, and set1A, significantly increases the detection of strains 
associated with causing diarrhoea in U.S. and European patients (Vila, Gene et al. 1998; 
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Cennimo, Abbas et al. 2009). However, strains that do not carry the aggR gene have also 
been isolated from gastrointestinal outbreaks (Cobeljic, Miljkovic-Selimovic et al. 1996).  
 
1.5.7.2 Polymerase Chain Reaction (PCR) assay to detect virulence (Marker) genes 
Recently, amplification by multiplex PCR of either the plasmid-carried gene aatA (CVD432) 
or the chromosomally carried aaiC locus is considered sufficient to confirm EAEC in the 
recently released GEMS, an initiative to comprehensively identify major enteric pathogens 
rapidly at sites where the diarrheal burden is high (Panchalingam, Antonio et al. 2012).  
 
1.5.7.3 Biofilm assay 
Biofilm formation is found useful in screening diagnostic tool when a large number of strains 
are examined in clinical and epidemiologic studies. All EAEC strains in a study demonstrated 
an OD570 > 0.2 in the assay, and the incidence of EAEC among the strains with an OD570 > 
0.2 was 89.2% (Iwanaga, Song et al. 2002; Wakimoto, Nishi et al. 2004). Furthermore, the 
test may be available without a spectrophotometer, since a biofilm demonstrating an OD570 
> 0.2 is clearly visible. In addition, this assay may contribute to demonstrating of the true 
incidence of EAEC with and without AggR among clinically isolated E. coli strains. Of the 28 
PCR-positive (AggR and EAST) strains screened for biofilm, 25 (89.2%) demonstrated 
positive results by microtiter plate method (Kaur, Chakraborti et al. 2010).  
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1.5.7.4 Serologic-Serotyping assay 
Serologic screening was adopted in a study where sera from children (control group) living in 
an endemic area show no antibody response to Pet but sera from children with diarrhoea 
caused by EAEC showed high titres of antibody against this toxin (Bellini, Elias et al. 2005). 
In addition, rabbit anti-Pet sera recognized 50% of the EAEC strains recovered from stools 
after culture supernatant concentration by immunoblotting (Bellini, Elias et al. 2005). The 
emergence of EAEC infection in Brazil (Zamboni, Fabbricotti et al. 2004) and the detection 
complexity of Pet expressing EAEC isolates led to the development of a methodology for Pet 
detection directly from supernatants of bacterial isolates using a slot blot immunoassay 
(Taddei, Fasano et al. 2005).  
Serotyping - of EAEC is a problem due to their aggregative phenotype, many of the strains 
auto-agglutinate and is often described in the literature as nontypable or as O-rough. EAEC 
from German children demonstrated 14 typable isolates and all belonged to different 
serotypes (Huppertz, Rutkowski et al. 1997). In another study in UK, 97 EAEC strains were 
serotyped to 40 different O-types. In one of the studies, 93 out of 143 EAEC strains could be 
serotyped and belonged to as many as 47 different serotypes (Jenkins, Tembo et al. 2006). 
Serotyping is no longer reliable in the diagnosis of diarrhoeagenic E. coli infections.  
 
1.5.7. 5 Newly proposed assay 
These diagnostic tests include an enzyme-linked immunosorbent assay (ELISA) for 
quantitative detection of secretory immunoglobulin A to EAEC (Sutjita, Bouckenooghe et al. 
2000) and cytokine response patterns to enteropathogens in which a specific pattern may 
become a distinguishing pathogen signature (Greenberg, Jiang et al. 2002). More studies and 
better diagnostic tools are needed to allow for a better understanding of the true epidemiology 
of EAEC in children. 
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1.5.7.6 Genome sequencing 
The first complete genomic sequence of E. coli 042, the prototypical member of the EAEC 
was performed and then published in 2010 (Chaudhuri, Sebaihia et al. 2010). The study 
showed the genome of EAEC 042 consisting of a circular chromosome of 5,241,977 bp, one 
plasmid pAA of 113,346 bp and other major features of the EAEC 042 genome that are serve 
as template for future diagnostic and intervention strategies for the EAEC pathotypes.    
In the detection of Stx2 EAEC strain whole genome-phylogenesis confirmed strain O104:H4 
as an EAEC strain. Alignment of an EAEC O104:H4 isolate TY2482 against the prototype 
EAEC strain 55989 chromosome ultimately revealed the presence of the large conjugative 
plasmid pAA which resembled the AAF gene-coding cluster from strain 55989 (Philipson, 
Bassaganya-Riera et al. 2013). Interestingly, pAA TY2482 encoded for AAF/I rather than the 
more common AAF/III. The isolate lacked the locus of enterocyte effacement (LEE; 
responsible for bacterial adherence), intimin adherence factor and a type-III secretion system 
normally identified in enterohaemmorhagic E. coli (EHEC) strains (Rohde, Qin et al. 2011). 
Since EAEC virulence factors are encoded on plasmids, bacteriophages and genetic 
pathogenicity islands, the traits are easily transferred to new emerging strains 
(Brzuszkiewicz, Thurmer et al. 2011; Philipson, Bassaganya-Riera et al. 2013). The 
phenomenon of genome sequence of TY2492 reveals the ability for Shiga toxin-producing E. 
coli to produce various adhesion mechanisms portraying the ability for pathotypes to overlap 
and evolve into more virulent strains. Therefore, rapid responses in sequencing efforts during 
the EAEC O104:H4 outbreak suggests that genomic epidemiology will become a standard 
molecular strategy to elucidate infectious disease outbreaks (Grad, Lipsitch et al. 2012).  
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1.5.8 Treatment and Drug Resistance  
1.5.8.1 Brief explanation 
In children, treatment of bacterial gastroenteritis including EAEC is primarily supportive and 
directed toward maintaining hydration and electrolyte balance. Antibiotic therapy is rarely 
indicated and should be deferred until culture results are available. Oral rehydration therapy 
(ORT) is the preferred treatment for fluid and electrolyte losses caused by diarrhoea in 
children with mild-to-moderate dehydration. Intravenous hydration is often administered for 
severe dehydration or when vomiting prevents ORT.  Antimicrobial therapy should be used 
in cases of severe diarrheal disease to reduce the duration of illness, particularly because of 
its association with persistent diarrhoea in children.                                                                      
 In the case of traveller‟s diarrhoea (TD) antibiotics are usually recommended but experts in 
travel medicine discourage the use of absorbable antimicrobial agents for TD prophylaxis, 
rifaximin, a poorly absorbed antibiotic, has been proposed for prevention of TD (de la 
Cabada Bauche and Dupont 2011; Estrada-Garcia, Perez-Martinez et al. 2014). However, 
EAEC infections are often successfully treated with ciprofloxacin and other fluoroquinolones 
as well as azithromycin, rifaximin, amoxicillin/clavulanic acid and nalidixic acid (Glandt, 
Adachi et al. 1999; Infante, Ericsson et al. 2004), but there are multiple antibiotic-resistant 
strains (Okeke and Nataro 2001; Mortensen, Fowlkes et al. 2011). For example, in southern 
India, EAEC is increasingly resistant to quinolones (Raju and Ballal 2009). In adult patients 
in the United States, EAEC is susceptible to rifaximin or a single dose of azithromycin with 
or without loperamide (DuPont 2007; Ericsson, DuPont et al. 2007).  
The progressive increase in antibiotic resistance among EAEC strains in developing countries 
is cause for concern (Estrada-Garcia, Cerna et al. 2005). Several investigators have suggested 
that lactoferrin may protect infants from gastrointestinal infections, including EAEC, and 
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might be an alternative treatment for antibiotic resistant EAEC strains (Ochoa and Cleary 
2009).  
 
1.5.8.2 Complication of Antibiotics in the Treatment of infections caused by Stx-
containing EAEC strains 
The detailed explanation provided in Croxen review (Croxen, Law et al. 2013) is as follows. 
Prior to the 2011 outbreak in northern Germany, there was no standardized treatment for Stx-
containing EAEC. During the 2011 German outbreak, 3 children with Stx-associated HUS 
showed rapid clinical improvement with eculizumab, but result from a subsequent 
nonrandomised trial with 298 patients were unclear and unreliable (Menne, Kielstein et al. 
2012; Hauswaldt, Nitschke et al. 2013). Patients who had no clinical improvement during 
plasmapheresis and/or were suffering from severe neurological complications were 
preferentially selected for the trial, leading to a selection bias that complicates the results 
(Hauswaldt, Nitschke et al. 2013). As eculizumab disrupts the complement cascade, 
clinicians at the time were required to treat with a prophylactic antibiotic to prevent 
meningitis (Croxen, Law et al. 2013). In general, antibiotics are normally not recommended 
for STEC, as they increased the risk for development of HUS by stimulating Stx production. 
Because of this risk, clinicians treating stx-expressing EAEC strain O104:H4 selected 
azithromycin, which in vitro represses the expression of stx (Bielaszewska, Idelevich et al. 
2012). Monitoring of STEC shedding in patients receiving azithromycin showed that these 
patients were rapidly decolonized (Nitschke, Sayk et al. 2012). Because of this, long-term 
(>28 days) carriers of STEC O104:H4 were treated with azithromycin, and after a 3-day 
course of treatment, all 15 were negative for shedding as well as HUS-related symptoms 
(Nitschke, Sayk et al. 2012). Further studies have since shown that sub-inhibitory 
concentrations of ciprofloxacin increase Stx production in STEC O104:H4 but that 
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meropenem, rifaximin, tigecycline, and azithromycin do not (Hauswaldt, Nitschke et al. 
2013). Stx production by STEC O157:H7 responds differently to these same antibiotics 
(Hauswaldt, Nitschke et al. 2013). Nonetheless, the use of azithromycin to eliminate Shiga 
toxin-containing strains such as O104:H4 from patients is still considered a controversial 
treatment; if used early in treatment, it is still unclear if it plays a role in the development of 
HUS and or if used later in treatment, it may actually increase the risk of sudden cardiac 
death (Seifert and Tarr 2012).  
 
 
1.5.8.3 Vaccine and other preventive therapy  
As EAEC proteins are antigenic, it remains possible that a vaccine could be developed, but as 
of yet, there is none. However, report from a vaccine study that uses ETEC heat-labile toxin, 
showed a decreased in the rate of infection and severity of disease caused by ETEC, and 
despite the presence of EAEC in the placebo groups, the vaccine-treated group had no EAEC 
detected, suggesting that the vaccine may also exert protection against EAEC (Frech, Dupont 
et al. 2008). In addition, an in vitro study demonstrates treatment with lactoferrin inhibits 
EAEC enteroadhesion and biofilm formation, however, it is not yet clear whether lactoferrin 
as a nonantibiotic approach is effective for the treatment and prophylaxis of EAEC but it is a 
potential though untested nonantibiotic treatment for the prevention of EAEC (Ochoa and 
Cleary 2009). In addition, IL-8 genotypes may define populations likely to benefit from 
therapeutic intervention such as prophylactic antibiotics and vaccines (Kaur, Chakraborti et 
al. 2010).  
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1.6 Summary of Gambian site specific GEMS study in which this study is nested 
The ultimate goal of the Global Enteric Multicentre Study (GEMS) was to conduct an 
investigation that provides data needed to guide development and implementation of enteric 
vaccines and other public health interventions that can decrease Paediatric morbidity and 
mortality from diarrhoeal disease. One of the strategies adopted to achieve the goal was to 
use common standard techniques across the selected seven sites (Mali, The Gambia, Kenya, 
Mozambique, Bangladesh, India and Pakistan) to identify microbiologic aetiology of 
diarrhoeal disease. Another important strategy was to characterize the phenotype and 
genotype distribution of major enteric pathogens. The overall results from this large study 
were detailed and helpful in developing policies required to achieve the study objectives 
(Kotloff, Nataro et al. 2013).  
The Gambia site specific results were comprehensive and revealing. Following standard and 
rigorous laboratory methods that included culture, immunologic and molecular techniques  
(Panchalingam, Antonio et al. 2012) five enteric pathogens were showed to be significantly 
associated with moderate-to-severe diarrhoea (MSD) among children less than 5 years old in 
The Gambia, these pathogens include Rotavirus, Shigella, Norovirus, Cryptosporidium and 
Enterotoxigenic E. coli (ETEC-ST) (Kotloff, Nataro et al. 2013). Additional other targeted 
pathogens were detected but were not significantly associated with moderate-to-severe 
diarrhoea include Aeromonas, Campylobacter, Salmonella, Typical EPEC, ETEC-LT, EAEC, 
EHEC, V. parahaemolyticus, Giardia, Entamoeba histolytica, Adenovirus, Astrovirus and 
Sapovirus.             
The Gambia GEMS results in relation to the three Commonest DEC (EPEC, ETEC and 
EAEC) showed that only ETEC was significantly associated with MSD whilst EPEC and 
EAEC were found not to be significantly associated with diarrhoea (table 1.1 & 1.2). 
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Surprisingly, EAEC, the most frequently detected bacterial pathogens in GEMS study was 
not significantly associated with diarrhoea among Gambian children. This finding contradicts 
report from previous studies that have implicated EAEC as a cause of diarrhoea mostly in 
children from developing countries (Okeke 2009). Furthermore, of the 42 deaths recorded 
among GEMS study participants, four death occured among diarrhoeal children with sole 
EAEC infection (figure 1.7).  Therefore, we were obligated to do further 
investigations/characterisations on the EAEC strains in order to reveal virulence factors 
harboured by the EAEC responsible for diarrhoeal disease among children from rural Gambia 
using molecular approaches. Also, we explored quantitation of bacterial load and expression 
of biofilm and characterisation of biofilm producing genes.    
 
 
Table 1.1: Distribution of Diarrhoeagenic Escherichia coli pathotypes from Diarrhoeal and 
Non-Diarrhoeal Children enrolled in GEMS Gambia site 
 DEC Pathotype Case (N = 519) 
No. (%) 
Control (N = 746) 
No. (%) 
Total (N = 1265) 
No. (%) 
OR (95% CI) P - value 
EAEC only 241 (46.44) 385 (51.61) 626 (49.49) 0.81(0.64-1.02) 0.07 
ETEC only 141 (27.17) 139 (18.63) 280 (22.13) 1.63(1.24-2.15) 0.0003 
EPEC only 87 (16.76) 124 (16.62) 211 (16.68) 1.01(0.74-1.38) 0.94 
EAEC+ETEC 21 (4.05) 36 (4.83) 57 (4.51) 0.83(0.46-1.48) 0.51 
EAEC+EPEC 14 (2.70) 37 (4.96) 51 (4.03) 0.53(0.26-1.02) 0.04 
ETEC+EPEC 13 (2.50) 20 (2.68) 33 (2.61) 0.93(0.42-1.99) 0.84 
EAEC+ETEC+EPEC 2 (0.39) 5 (0.67) 7 (0.55) 0.57(0.05-3.52) 0.50 
 
88 
 
 
Table 1.2: Distribution of Diarrhoegenic E. coli pathotypes from Diarrhoeal and Non-
Diarrhoeal Children enrolled in GEMS Gambia site 
DEC Pathotype Case (N = 571) 
No. (%) 
Control (N = 849) 
No. (%) 
Total (N = 1420) 
No. (%) 
OR (95% CI) P - value 
EAEC 278 (48.69) 463 (54.53) 741 (52.18) 0.79(0.63-0.98) 0.03 
ETEC 177 (31.00) 200 (23.56) 377 (26.55) 1.46(1.14-1.86) 0.001 
EPEC 116 (20.32) 186 (21.91) 302 (21.27) 0.90(0.69-1.19) 0.47 
 
 
 
 
 
Figure 1.7: Flow chart showing detail of death in GEMS study  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
42 Death 
7 Controls 35 Cases 
4 solely EAEC infection 
Age:   0-11mth x3;     12-23mth x1 
Sex:    3 girls;  1 boy 
Stool consistency: Opaque-watery  x3                                     
                                      Thick liquid  x1 
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Chapter 2: Research question, Hypotheses, Aims and Objectives 
 
The motivation to perform this study of further characterisation of Gambian EAEC strains 
from the GEMS case-control study was based on the GEMS result which, against to initial 
hypotheses, showed that EAEC - the most frequently isolated bacteria in the study - was not 
associated with diarrhoea among Gambian children <5 years of age. Such results contradict 
previous studies which have showed EAEC as a cause of persistent diarrhoea and acute 
gastroenteritis among children from developing countries including The Gambia. Therefore, I 
planned to conduct further investigation to characterise the EAEC strains isolated from 
diarrhoea and non-diarrhoea study children to reveal virulence factors harboured by the 
EAEC responsible for diarrhoeal disease.  
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2.1 Research questions 
1. What are the specific virulence factors harbours by EAEC that are responsible for 
diarrhoeal disease among children from rural Gambia? 
2. Can bacterial load assay confirm EAEC as a true cause of diarrhoea among children 
from rural Gambian? 
3. What role does biofilm play in the diarrhoea caused by EAEC among Gambian 
children? 
4. Can antimicrobial resistant EAEC be associated with diarrhoea among children? 
 
 
2.2 Hypotheses 
1. Combination of virulence genes found in EAEC cause moderate-to-diarrhoea 
among rural Gambian children 
2. High bacterial-load in EAEC associated with diarrhoea among rural Gambian 
children 
3. Biofilm producing EAEC  cause diarrhoea among Gambian children  
4. Presence of aggR gene combine with one or more of it regulatory genes in EAEC 
producing-biofilm can contribute to diarrhoeal illness among Gambia children 
5. Multiple antimicrobial resistant EAEC strains may be associated with diarrhoea 
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2.3 Aims 
 The aim of this study is to determine appropriate diagnostic tool that can be used to 
detect EAEC that cause diarrhoea disease among children and to characterise and 
evaluate the role of EAEC in diarrhoeal illness in children from rural The Gambia.  
 
 
 
2.4 Specific objectives  
 Determine the prevalence of EAEC known virulence genes among Gambian children 
with MSD and non-MSD from whom EAEC was isolated.  
 Determine a TaqMan-QPCR cut off threshold cycle to compare EAEC bacterial load 
MSD and non-MSD as a tool to diagnose EAEC diarrhoea 
 Evaluate phenotypic biofilm screening assays that include test-tube (TT), congo-red-
agar (CRA) and tissue culture plate (TCP) to establish the appropriate screening 
method that identify infectious EAEC among diarrhoeal children. 
 Determine biofilm producing genes in EAEC strains from MSD and non-MSD 
children 
 Determine the association of antimicrobial resistant EAEC strains with diarrhoea.  
 Determine the presence or absence of antimicrobial resistance genes in the EAEC 
isolates and compare with phenotypic resistance result.  
 Access the role of sequence types in children diarrhoea caused by EAEC 
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Chapter 3: Materials and Methods 
3.1 Laboratory settings at MRCG Basse field station and Fajara 
The MRCG Basse laboratory at Upper River Region (URR) of Gambia is well known for its 
reputation in the diagnosis of enteric pathogens. The laboratory serves as a training centre for 
laboratory technicians working in the government health centres within URR and Central 
River Region (CRR). The laboratory has served many experimental and observational studies 
for over 30 years. These studies include Pneumococcal Vaccine Trial (PVT), Meningococcal 
Vaccine Trial (MVT), Pneumo Aetiology of Child Health (PARCH), Global Enteric 
Multicentre Study (GEMS), Pneumo case-control study (PCS), Malaria In Pregnancy (MIP), 
Entomology Study (ES), Pneumococcal Surveillance Programme (PSP), the ongoing Vaccine 
Impact on Diarrhoea in Africa (VIDA) and others. In addition, the laboratory subscribed to 
external quality control assurance (EQA) oneworld Canada and GCLP accredited.  
The Fajara laboratory where the bacterial load (Taqman-QPCR) aspect of this study was 
conducted is internationally recognised as an excellent research centre in West-Africa. It 
houses multiple research laboratories and a World Health Organisation reference laboratory; 
molecular laboratories are fortified with state of the art equipment.        
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3.2 Study population:  
The study participants were children less than 5 years of age who have moderate-to-severe 
diarrhoea (MSD) and non-diarrhoeal children belonging to a censused population of 35,000 
children of URR. The enrolled MSD children are those seeking care at referral Health Centre 
Basse and five sentinel health centres (SHCs), while, the enrolled 1-3 matched controls are 
from the community for each index case. Having determined the eligibility criteria for cases 
and controls, enrolment was subject to obtaining an informed verbal and documented consent 
from parent or guardian of children. 
 
3.3 Case Definition of Moderate-to-Severe Diarrhoea (MSD)   
This is described by Farag et al as “a child with diarrhoea (≥3 abnormally loose stools) within 
the previous 24 hours with onset within the previous 7 days, following at least 7 days without 
diarrhoea, and accompanied by evidence of clinically significant dehydration (loss of skin 
turgor, sunken eyes, or a decision by the clinician to administer intravenous fluids), dysentery 
(blood in the stool), or a clinical decision to hospitalize the child” (Farag, Nasrin et al. 2012).  
 
3.4 Definition of Control  
A child without diarrhoea within 14 days of presentation of the index case; and of the same 
sex, within the same age strata and from the same village or neighbourhood (Farag, Nasrin et 
al. 2012). 
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3.5 Study approval  
Approval for this study was given by MRCG Scientific Coordinating Committee (SCC) 
followed by ethical approval by Gambia-Government/MRCG joint ethics committee 
(Appendix A – SCC and Ethics letter).  
 
3.6 Good Clinical Laboratory Practice (GCLP) 
This study was conducted according to the internationally recognised GCLP guideline – 
DAID, MRC Good Research Practice (MGRP) and conformed to the International 
Conference on Harmonisation Good Clinical Practice (ICH-GCP). To ensure principles of 
GCLP are complied with MRCG conducted series of training on GCLP/GCP that were 
attended by the laboratory staff involved in this study (Appendix B – GCP/GCLP 
certificates).  
 
3.7 Sample selection 
Being a retrospective study, 428 EAEC strains were randomly selected from a total of 741 
EAEC samples. A flow chart showing how the sampling was achieved is detailed below 
(figure 3.1). The selected EAEC strains were sub-cultured and amplified for re-identification 
and detection.   
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Figure 3.1: Flow chart of study samples 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
400 EAEC (Case 150, Control 250) 
for Biofilm screening 
 
2,598 - Total stool samples cultured  
(Case 1,029, Control 1,569) 
 
2,422 – E. coli isolated 
(Case 950, Control 1472)  
 
1,265 – DEC detected 
(Case 519, Control 746)  
 
400 EAEC (Case 150, Control 250) 
for Antibiotic resistant test 
 
428  EAEC (Case 157, 
Control 271) for detecting 
21 virulence genes 
(Unmatched Case-Control) 
 
160 – (Case 80, Control 80) stool 
harboured EAEC for               
Bacterial load Assay                        
(Matched Case-Control) 
741 EAEC – (Case 278, 
Control 463) detected 
 
377 ETEC – (Case 177, 
Control 200) detected 
 
302 EPEC – (Case 116, 
Control 186) detected 
 
50 EAEC (Case 23, Control 27) for 
Whole Genome Sequencing 
G
EM
S 
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3.8 Detection of EAEC 
In GEMS study, the detection of EAEC was by culturing faecal sample on selective media 
and isolating suspect colonies, identifying the colonies as E. coli and detecting them as 
Enteroaggregative E. coli (EAEC) by polymerase chain reaction (PCR) an amplification 
method.  
 
3.9 Bacteriology 
Stool samples received in transport media Cary Blair (CB) and Buffered Glycerol Saline 
(BGS) were aseptically streaked on to the multipurpose and selective solid media that 
includes McConkey, Xylose lysine deoxycholate, Ryan, Thiosulfate Citrate Bile Salt Sucrose 
(TCBS)/Alkaline-peptone-water (APW) and Campylobacter Blood agar for the isolation of E. 
coli, Shigella /Salmonella species, Aeromonas species, Vibrio species and Campylobacter 
species respectively. Also, other opportunistic bacterial flora that cause diarrhoea were 
isolated and identified.  Following overnight incubation at 37
o
C cultured agar plates were 
examined for aforementioned bacterial pathogens except Campylobacter agar plate that is 
examined after 48 hours incubation at 42
o
C. Specifically from MacConkey agar plate, three 
suspected colonies of E. coli (often lactose fermenting) were purified and identified as E. coli 
by performing gram stain reaction, detecting release of indole using Kovac‟s reagent (figure 
3.2) and conducting other enzymatic and fermentation test using biochemical reagent kit 
Analytical Profile Index (API) 20 E (BioMeriux 09567D).  
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3.9.1 Gram stain reaction 
Principle: This stain classified bacteria as Gram-positive or Gram-negative depending on 
whether the bacteria retain the stain crystal violet (Gram-positive) or are decolourised and 
take up the red counter stain (Gram-negative). 
The four steps involved are crystal violet, the primary stain, followed by Lugol’s iodine, 
which acts as a mordant by forming a crystal violet iodine complex, then alcohol, which 
decolourises and lastly, neutral red or safranin, the counter stain.      
Procedure  
Air or heat dried smear  
Cover with crystal violet stain for 30-60 seconds 
Rapidly wash off the stain with clean water 
Tip off all the water, and cover the smear with Lugol‟siodine for 30-60 seconds 
Wash off the iodine with clean water 
Decolourise rapidly with acetone-alcohol 
Wash immediately with clean water 
Cover the smear with neutral red stain for 2 minutes 
Wipe clean the back of the slide, and place in a draining rack to air dry 
Examine microscopically with X100 objective lens  
Interpretation of results: 
Gram-negative bacteria……………………………………….Pale to dark red 
Gram-positive bacteria………………………………………...Dark purple 
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3.9.2 Indole production:  
Principle: The ability of a bacterial agent to split amino acid tryptophan to form indole 
compound. The enzyme tryptophanase hydrolysed amino-acid tryptophan to produce three 
possible end products that include indole, pyruvate and ammonium. The production of indole 
is detected by Kovac‟s reagent which contains 4-(p)-dimethylaminobenzaldehyde that reacts 
with the indole to produce a red colour in the surface layer (meniscus) of broth medium 
(figure 3.2) 
 
 
 
Figure 3.2: Showing positive and negative indole tests 
 
 
 
 
Indole positive Indole negative 
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3.9.3 Biochemical identification kit – Analytical Profile Index 20 Enteric (API 20E) 
Summary: The standardised identification system for Enterobacteriaceae and other non-
fastidious Gram-negative bacilli that include E. coli is the Analytical Profile Index (API) 20 
E (bioMerieux, catalogue number 20120). The system has 21 miniaturised biochemical tests 
and a database was used for the biochemical identification of E. coli isolates. 
 
Principle: The API 20 E strip consists of 20 microtubes containing dehydrated substrates. 
These tests are inoculated with a test bacterial suspension that reconstitutes the media. During 
incubation, metabolism produces colour change, which are either spontaneous or revealed by 
the addition of reagents.  
The reactions are read according to the reading table and the identification is obtained by 
referring to the Analytical Profile Index or using the identification software.   
 
 
Procedure 
Prepare an incubation box (tray and lid) and distribute about 5 ml of distilled water into the 
honey-combed wells of the tray to create humid atmosphere 
Record the strain reference on the elongated flap of the tray  
Remove the strip from its packaging 
Place the strip in the incubation box and cover with the lid until ready for inoculation 
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Prepare a sterile tube (bijou bottle) to contain 5ml sterile saline or distilled water without 
additives 
Using a sterile pipette, remove a single well-isolated test colony from a cultured plate of 18-
24 hours old 
Carefully emulsified to achieve a homogenous bacterial suspension, which is used 
immediately to inoculate the strip 
Using a sterile pipette, fill both tube and cupule of the tests citrate, VogePokers and gelatine 
with bacterial suspension 
Fill only the tube (and not the cupule) of the other tests 
Create anaerobiosis in the tests Arginine Dehydrolase (ADH), Lysine Decarboxylase (LDC), 
Ornithine Decarboxylase (ODC), Hydrogen sulphide (H2S) and Urease by over laying with 
mineral oil 
Close the incubation box 
Incubate at 36
o
C (+/- 2
o
C) for 18-24 hours.    
After the incubation period, and adding the require reagent to the required tests, read the strip 
by referring to the Reading Table. 
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Interpretation of results   
Obtain the identification with the numerical profile as follow; 
On the result sheet, the tests are separated into groups of 3 and a value 1,2, and 4 is indicated 
for each. By adding together the values corresponding to positive reactions within each 
group, a 7-digit number is obtained for the 20 tests of the API 20 E strip. The oxidase 
reaction constitutes the 21
st
 test and has a value of 4 if it is positive. 
Identification is then performed using the database and or by looking up the numerical 
profiles in the list of profiles. 
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3.10 Isolation of Genomic DNA  
A confirmed and pure colony of E. coli was purified on a non-inhibitory Nutrient agar 
medium. Following 24 hrs incubation at 37
o
C, the colonies were harvested and suspended 
with 500 µl RNAse and DNAse free molecular graded H2O in 1.8 ml cryo-tube and boil for 
20 minutes in a water bath and swiftly cool on ice. The heat-treated bacterial suspension is 
centrifuge at 3000 rpm for 10 minutes and 5µl of the supanantant was used as DNA template 
in the PCR. 
 
 
 
 
3.11 Molecular detection of EAEC target aatA and aaiC genes 
In this study we performed monoplex PCR on each isolates that has initially showed presence 
of EAEC in GEMS E. coli multiplex PCR protocol. The target sought for EAEC are  the 
EAEC plasmid-encoded gene aatA (primer CVD432F – sequence 5‟-
CTGGCGAAAGACTGTATCAT-3‟and primer CVD432R – sequence 5‟-
CAATGTATAGAAATCCGCTGTT-3‟) and the EAEC chromosomally encoded aaiC 
(primer AAIC F – sequence 5‟-ATTGTCCTCAGGCATTTCAC-3‟ and primer AAIC R  - 
sequence 5‟-ACGACACCCCTGATAAACAA-3‟, these two loci are known virulence 
determinants.  
PCR assay was performed in a final reaction volume of 20µl, which contained 2.5µl buffer 
(2mM MgCl2), 10.65µl H2O, 2µl dNTP (1.25mM), 0.4µl each primer (20pmol/µL) forward 
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and reverse for marker gene aatA and aaiC, 0.25µL Taq polymerase and 3µl of boiled 
bacterial lysate as the DNA template. PCR were performed using thermocycler (TECHNE 
Flexigen, Model FFG02FSD, Serial 11733 -1) to achieve preheat at 96
o
C for 4 minutes, 
denaturation at 95
o
C for 20 seconds, annealing at 57
o
C for 20 seconds, elongation at 72
o
C for 
1 minute and run for 35 cycles and final extension at 72
o
C for 7 minutes. E. coli strain 042 
was used as control for EAEC (aaiC and aatA) strain. Distilled water was used as negative 
control. PCR products were analysed on a 2% agarose gel containing ethidium bromide (0.1 
µl ml-1 in 1 x TBE buffer) and visualise on the 2% (w/v) agarose gel under ultral-violet (UV) 
radiation. The gel image was captured digitally with a gel documentation system.   
 
 
 
3.12 PCR amplification to detect 21 EAEC virulence genes 
EAEC colonies were investigated for the presence of the twenty-one putative virulence genes 
using four multiplex PCR as previously described [28]. The 21 genes were grouped into four. 
On each group multiplex-PCR was performed. On group 1 (sat, sepA, pic, sigA, pet and 
astA), multiplex-PCR master mix was achieved using Qiagen kit (Catalogue number 206143) 
following the manufacturer‟s instructions. Multiplex-PCR assay was performed in a final 
reaction volume of 25µl  that consists, 12.5 µL mastemix (MM), 2.5µl Q-solution, 6µl 
primer(MM), 2.5µl H2O and 1.5µl DNA template. PCR reaction cycles were as follows: 15 
minutes preheating at 95
o
C at the start, 50 seconds denaturation at 94
o
C, annealing for 1.5 
minutes and extension at 72
o
C for 1.5 minutes with 35 cycles returning to step 2. The final 
extension was 10 minutes at 72
o
C (figure 3.3).     
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On group 2 (aatA, aggR, aaiC, aaP and ORF3), group 3 (aafC, agg3/4C, agg3A, aafA, aggA, 
agg4A) and group 4 (air, capU, ailA and ORF61) Fementers kit (Catalogue # K0171) was 
used for the PCR master mix (2X) following the manufacturer‟s instructions. Multiplex-PCR 
assay was achieved in a final reaction volume of 25µl that compose of 12.5µl (MM), 1µl 
(25mM Magnesium chloride (MgCl2), 5µl primer (MM), 5µl of H2O and 1.5µl DNA 
template. PCR reaction cycles were achieved as follows: 2 minutes preheating at 95
o
C at the 
start, 50 seconds denaturation at 94
o
C, annealing at 57
o
C (58
o
C for Group 3&4) for 1.5 
minutes and extension at 72
o
C for 1.5 minutes with 35 cycles returning to step 2. The final 
extension was 10 minutes at 72
o
C.  
Amplifications were performed using Thermocycler (TECHNE Flexigen, Model FFG02FSD, 
Serial 11733 -1, manufactured in USA) Amplified PCR products were analysed on a 2% 
agarose gel containing ethidium bromide (0.1 m ml-1 in 1 x TBE buffer and visualise on the 
2% (w/v) agarose gel under ultral-violet (UV) radiation. The gel images were captured 
digitally with a gel documentation system.  
The E. coli strains used as controls for detection of the target genes are; C1010-00 (sat, sepA, 
agg3/4C & agg4A) , JM221 (sat & aggA), 042 (pic, pet, astA, aatA, aggR, aaiC, aap, ORF3,  
aafC, aaFA, air, capU & eilA), 55989 (sigA, agg3A/4C, agg3A), 63 (sigA, agg3/4C & 
agg4A) and 17-2 (aggA) (Boisen, Scheutz et al. 2012). GIBCO distilled water (DNase/RNase 
free, Catalogue no. 10977-035) was used as negative control.   
Gel electrophoresis for virulence genes 
Amplified PCR products were analysed on a 2% agarose gel containing ethidium bromide 
(0.1 m ml-1 in 1 x TBE buffer and visualise on the 2% (w/v) agarose gel under ultral-violet 
(UV) radiation. The gel images were captured digitally (figure 3.4) with a gel documentation 
system. 
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Table 3.1: Primer sequence for the detection of 21 EAEC Virulence associated genes 
Target 
Gene 
Function/Description of encoded 
proteins (Plasmid (P) / Chromosome 
(C) 
Primer Sequence (5’ – 3’) 
Primer Forward 
Primer Reverse 
Control 
Strains 
PCR 
Product 
base –pair 
(bp) 
Reference 
(GenBank 
Accession 
No.) 
sat Secreted autotransporter toxin  (C) TCAGAAGCTCAGCGAATCATTG 
CCATTATCACCAGTAAAACGCACC 
C1010 
JM221 
930 AE014075 
sepA Shigella extracellular proteins A  (P) GCAGTGGAAATATGATGCGGC 
TTGTTCAGATCGGAGAAGAACG 
C1010 794 Z48219 
pic Protein involve in Intestinal 
Colonisation  (C) 
ACTGGATCTTAAGGCTCAGGAT 
GACTTAATGTCACTGTTCAGCG 
042 572 AF097644 
sigA IgA protease-like homolog  (C) CCGACTTCTCACTTTCTCCCG 
CCATCCAGCTGCATAGTGTTTG 
63, 
55989 
430 NC_004337 
pet plasmid-encoded enterotoxin  (P) GGCACAGAATAAAGGGGTGTTT 
CCTCTTGTTTCCACGACATAC 
042 302 AF056581 
astA (EAST1) EAEC heat-stable enterotoxin 
1  (P) 
ATGCCATCAACACAGTATAT 
GCGAGTGACGGCTTTGTAGT 
042 110 L11241 
aatA Dispersin transporter protein  (P) CTGGCRAAAGACTGTATCAT 
CAGCTAATAATGTATAGAAATCCGC
TGT 
042 642 AY351860 
aggR AAF/I and AAF/II transcriptional 
activator  (P) 
GCAATCAGATTAARCAGCGATACA 
CATTCTTGATTGCATAAGGATCTGG 
042 426 Z18751 
aaiC AaiC, secreted protein  (C) TGGTGACTACTTTGATGGACATTGT 
GACACTCTCTTCTGGGGTAAACGA 
042 313 ........ 
aap Anti-aggregation protein (dispersin)  (P) GGACCCGTCCCAATGTATAA 
CCATTCGGTTAGAGCACGAT 
042 250 Z32523 
ORF3 Cryptic protein  (P) CAGCAACCATCGCATTTCTA 
CGCATCTTTCAATACCTCCA 
042 121 .......... 
aafC Aggregative adherence fimbriae C - 
Usher, AAF/II assembly unit  (P) 
ACAGCCTGCGGTCAAAAGC 
GCTTACGGGTACGAGTTTTACGG 
042 491 AF114828 
agg3/4C Usher, AAF/III-IV assembly unit  (P) TTCTCAGTTAACTGGACACGCAAT 
TTAATTGGTTACGCAATCGCAAT 
TCTGACCAAATGTTATACCTTCAYT
ATG 
C1010 
55989, 
63 
409 AF411067 
AB255435 
EU637023 
agg3A AAF/III fimbrial subunit  (P) CCAGTTATTACAGGGTAACAAGGG
AA 
TTGGTCTGGAATAACAACTTGAACG 
55989 370 AF411067 
aafA Aggregative adherence fimbriae A – 
AAF/II fimbrial subunit  (P) 
CTACTTTATTATCAAGTGGAGCCGC
TA 
GGAGAGGCCAGAGTGAATCCTG 
042 289 AF012835 
aggA AAF/I fimbrial subunit  (P) TCTATCTRGGGGGGCTAACGCT 
ACCTGTTCCCCATAACCAGACC 
JM221, 
17-2 
220 Y18149 
AY344586 
agg4A AAF/IV fimbrial subunit  (P) TGAGTTGTGGGGCTAYCTGGA 
CACCATAAGCCGCCAAATAAGC 
C1010, 
63 
164 EU637023 
air Enteroaggregative immunoglobulin 
repeat protein  (C) 
TTATCCTGGTCTGTCTCAAT 
GGTTAAATCGCTGGTTTCTT 
042 600 .......... 
capU Hexosyltransferase homolog  (P) CAGGCTGTTGCTCAAATGAA 
GTTCGACATCCTTCCTGCTC 
042 395 AF134403 
eilA Salmonella HilA homolog  (C) AGGTCTGGAGCGCGAGTGTT 
GTAAAACGGTATCCACGACC 
042 248 ........... 
ORF61 Plasmid encoded haemolysin  (P) AGCTCTGGAAACTGGCCTCT 
AACCGTCCTGATTTCTGCTT 
042 108 ............ 
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Figure 3.3: PCR reaction cycle pattern used in the amplification of the 21 virulence genes  
 
 
 
 
Denaturation: Heat 
briefly to separate 
DNA strands 
Annealing: Cool to 
allow primers to form 
hydrogen bond with 
ends of target 
sequence 
Extension:             
DNA polymerase adds 
nucleotides to the 3‟ 
end of each primer 
 
Cycle 2             
Yields 4 molecules 
 
 
 
Cycle 1            
Yields 2 molecules 
Cycle 3                          
Yields 8 molecules          
2 molecules (in white 
boxes) match target 
sequence 
Thermal cycler 
Target 
sequence 
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Figure 3.4: Gel image of group 1 (sat, sepA, pic, sigA, pet and astA) of the 21 putative 
virulence genes  
 
 
Lane Test 
 
Base pair Genes  Lane Test Base pair Genes 
1. Ladder 100-1200bp 100 - 1200  13. 103434 110, 302, 572 astA, pet, pic 
2. Negative No band No gene to 
amplify 
 
 
14. 103448 110, 572 astA, pic 
3. C1010 572, 794, 930 pic, sepA, sat  15. 103449 794 sepA 
4. 63 430, 572, 794 sigA, pic, sepA  16. 103451 110, 572, 930 astA, pic, sat 
5. 042 110, 302 astA, pet  17. 103454 572 pic 
6. 55989 110, 430, 572 astA, sigA, pic  18. 103490 572, 930 pic, sat 
7. JM221 572 pic  19. 103494 110 astA 
8. 103396 930 sat  20. 103506 572, 930 pic, sat 
9. 103399 110 astA  21. 103509 572, 930 pic, sat 
10. 103400 No band Nil  22. 103526 930 sat 
11. 103412 110, 572, 794 astA, pic, sepA  23. 103527 110, 572 astA, pic 
12. 103412 794 sepA  24. 103529 No band  
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3.13 Statistical analyses 
Bivariate analysis was applied to compare prevalence of virulence factors 
between cases and controls in different age group using STATA 12 reporting 
Odds ratios (OR) with 95% confidence intervals (CI).  A two-sided p-value < 
0.05 was considered statistically significant 
Additionally, we used Classification and Regression Tree (CART) pro-Version 
6.0 (Salford systems) software to input 21 factors of interest as binary 
(present/absent) independent variables. Case-control status was input as the 
binary dependent outcome variable. 
3.14 Significance of Combinations of EAEC Genes:  
We generated a virulence factor score (VFS), representing the collective number 
of virulence loci present in each strain. To consider the combinations factors, we 
employed CART analysis (figure 4.1 and figure 4.2), which builds a model in 
stepwise fashion to yield the combination of factors most strongly associated with 
the queried outcome. Each branch of a CART output tree ends in a terminal 
“node”; each observation falls into exactly 1 terminal node; and each terminal 
node is uniquely defined by a set of rules, such as having or not having a certain 
factor.  
We considered all genotypic and phenotypic assays performed and considered the 
association with case status versus control status (figure 4.1 and figure 4.2).   
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3.15 Quantification of Bacterial load for EAEC  
3.15.1 DNA extraction from cultured EAEC 042 strain  
Genomic DNA was extracted from a pure culture of EAEC 042, grown overnight at 37
o
C , 
and extracted with QIAmp mini kit (Qiagen London, UK). The DNA concentration 
quantified using nanodrop was performed in duplicate (56 ng and 54 ng) and the average 
yielded 55ng, the EAEC 042 genome size is 5,355323 base pairs (b)p (5.3Kb). The mass of 
the genome was calculated by inserting the bacterial genome size value in the formula 
M=[n][1.096e-21g/bp], where n=genome size, M=mass and e-21 = x10
-21
 (AppliedBiosystem 
2003). The obtained mass 5.5e-15g was converted to picogram (pg) resulting 0.0055pg that 
was used to obtain the final concentration (C2) of 13750 pg/µl of DNA, the genomic DNA 
concentration (55ng or 55000pg/ µl) was C1 and the final volume (V2) was 100ul. So the 
resultant V1(25µl) stock EAEC 042 genomic DNA was made up to 100ul by 75µl of diluent 
(nuclease free water) and ten-fold serial dilutions were prepared to determine the detection 
limit for the standard control. Please see detail calculation in Appendix C. 
 
3.15.2 Total DNA extraction directly from stool samples 
The extraction of DNA from stool was achieved with the use of QIAamp DNA stool Mini Kit 
(catalogue no. 51504, Qiagen, Valencia, CA, USA). Isolating DNA requires that, the faecal 
sample undergoes a lysate preparation process and includes mechanical disruption by bead 
beating. In brief, 370 mg of 0.1 mm glass beads, acid-washed 212-300 µM (50-70 U.S. sieve) 
(Sigma G1277-500G) was dispensed in 180-220 mg of each stool sample; 1400ul lysis buffer 
(previously incubated at 70
o
C for 15 minutes to ensured precipitate fully dissolved) was 
added along with 1µl of Phocine Herpesvirus (PhHV) as extrinsic control to evaluate DNA 
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extraction and amplification efficiency. Bead beat at maximum speed for 3 minutes using 
BioSpec Mini-Beadbeater (BioSpec 693, Mini-Beadbeater-8 USA) for vigorous 
homogenization of samples. The cell slurry or the mixture was incubated at 100
o
C for 5 
minutes. Following votexing and centrifuging, 1.2 ml of the supernatant was collected into a 
separate 2 ml microcentrifuge tube and 1 inibitEX Tablet (supplied in the QIAamp DNA 
stool Mini Kit) added to the supernatant to absorbed inhibitors. Following 1 minute 
incubation at room temperature and 3 minute centrifugation supernatant was pipetted into a 
new 2 ml microcentrifuge tube and pellet discarded. 400µl of the supernatant is added to the 
30ul proteinase K, followed with the addition of AL buffer and thorough votexing the 
mixture was incubated at 70
o
C for 10 minutes. Following brief centrifuging 400µl ethanol 
(96-100%) was added to the lysate. Six-hundred microlitre (600µl) of the lysate was applied 
to the QIAamp spin column and processed and elute to obtained total DNA.  DNA is then 
stored at -80 for testing. Each day extractions are performed a blank is included through the 
complete protocol and later assayed to rule out contamination during the extraction process. 
 
3.15.2a In a order to develope a well designed primers and probes which are a prerequisite for 
successful qPCR we adhered to the rules that guide primers and probe design. We first 
designed the probes by following the guidelines probe design which are; 
Use of a well recognised probe design software „Primer-Blast‟, choosing the probe length for 
aaiC – 22 bases with GC content 31.8% and probe length for aatA – 24 bases with GC 
content 41.7%. Consideration during the process was to ensured that the melting temperature 
(Tm) 62
o
C is 5
oC higher than the melting temperature (Tm) of the primers and that the 5‟ end 
is couple to a T and not 5‟ end G this will help avoid the quenching of many flurophores that 
include FAM.  
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Also, we designed primers by following the guidelines for primer design which are;  
Use of a well recognised software tool called „Primer-Blast‟, choosing the primers length and 
GC% (aaiC forward – 20 bases, GC – 45% & aaiC reverse 20 bases, GC 45%) and (aatA 
forword 20 bases, GC 45% & aatA reverse 22 bases, GC 36.4%), and the Tm of 56
o
C-70
o
C 
was selected, and finally the designed primers and probes were sent to „microbiom 
international‟ to develop and prepare and then sent back to me for use.  
  
3.15.3 qPCR amplification for the 160 total DNA extractions  
TaqMan-based real-time polymerase chain reaction (qPCR) assay for quantification of 
TaqMan-qPCR was performed on 160 DNA samples using the Bio-Rad CFX Manager 
software, Russian Edition that works with the UK English setting of the Windows operating 
system to provide a localized environment. Individual qPCR reactions consisted of a total 
volume of 25 µl/reaction that includes 12.5 µl of Bio-Rad iQTM multiplex Powermix (UK), 
10.575 µl nuclease free water, 0.1 µl of primer forward and reverse for target genes aaiC and 
aatA, 0.2 ul of primer forward and reverse for the PhHV, 0.05 µl, 0.025 µl, and 0.05µl were 
used for aaiC, aatA and PhHV probe respectively and 1 µl of sample DNA was added. Also, 
positive and negative reactions are set up in the process. Detail of primer sequence and probe 
used for the detection and quantitation of aaiC, aatA and PhHV genes are shown in table 3.2 
The primers and probe from metabion international AG (Lena-Christ-Strasse-44/I, D-82152 
Martinsried/Deutschland) were diluted and used following the manufacturer guidelines. Hot 
start of 95
o
C for 3 minutes was used as initial denaturation and Taq activation. PCR 
amplification and target detection were performed for 40 cycles of Denaturation at 96
o
C for 
15 seconds, annealing, at 60
o
C for 30 seconds extension at 72
o
C for 40 seconds (Table 3.2a). 
Gene copies were determined by absolute quantification using standard curve fitted for 96-
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well plate. The standard curve was constructed from EAEC 042, R
2
 values of a linear model 
fit to the standard curves of cycle threshold (Ct) versus log dilution of DNA in the standard 
ranged from 1.00 to 0.988 (figure 3.6 & 3.7).   
 
Table 3.2: Oligonucleotide sequence of primers and probe used  
Gene Reaction Nucleotide sequence (5‟-3‟) GenBank 
Sequence # 
Reference 
aaiC F 
aaiC R 
Forward 
Reverse 
5'-ATT GTC CTC AGG CAT TTC AC-3'→ 
5'-ACG ACA CCC CTG ATA AAC AA-3'← 
 
FN554766.1 Boisen 2008 
aatA F 
aatA R 
Forward 
Reverse 
5'-CTG GCG AAA GAC TGT ATC AT-3'→ 
5'-TTT TGC TTC ATA AGC CGA TAG A-3'← 
 
AY351860 Boisen 2008 
PhHV-gB F 
PhHV-gB R 
Forward 
Reverse 
5'-GGGCGAATCACAGATTGAATC-3'→ 
5'-GCGGTTCCAAACGTACCAA-3'← 
 
S81228.1  
aaiC Probe  5'-TAG TGC ATA CTC ATC ATT TAA G-3'→ FN554766.1  
aatA Probe  5'-TGG TTC TCA TCT ATT ACA GAC AGC-3'→ AY351860  
PhHV Probe 
Quasar 670 
 5'-TATGTGTCCGCCACCATCT-3'→ S81228.1  
 
Key: → Direction of synthesis (forword),           ← Direction of synthesis (reverse) 
 
Table 3.2a: Showing amplification run information for the TaqMan assay 
40 cycles Denaturation 96
o
C for 15 seconds 
 Annealing 60
o
C for 30 seconds 
 Extension  72
o
C for 40 seconds 
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3.15.4 Amplification efficiency and limit of detection (LoD) or Quantitation of bacterial 
load 
Standard curves were constructed using known quantities of genomic DNA (serial dilution 
10
7
, 10
6
, 10
5
, 10
4
, 10
3
, 10
2
, 10
1
 and 10
0
) extracted from EAEC 042 strain. The standard curve 
was performed in duplicate, and analyses were achieved by plotting the threshold cycles (CT) 
against the corresponding log input quantity DNA determining the detection limit of the 
assay.   For comparison of PCR amplification efficiencies and detection sensitivities among 
sample assays, slopes of the standard curves were calculated by a linear regression analysis 
with Bio-Rad detection system (figure 3.6 and figure 3.7). Quantification cycles (Cqs) are the 
PCR cycle values at which the fluorescence from amplification exceeds background that acts 
as an inverse metric of quantity of nucleic acid. By using the standard curves constructed in 
this study, the highest concentration of bacteria load is detected at Log Starting Quantity 6.6 
at Cq 16, and the lowest concentration of the bacteria is detected at Log Starting Quantity 1.6 
at Cq 38 (figure 3.7a). In order to determine the low and high bacterial load, a cut-off was 
obtained by constructing a slope from the point where Cq 16 intercept with the 1.6 log 
starting quantity to the point it intercept the slope of the standard curve. At the later intercept 
point Cq 32 is obtained (figure 3.7a).  Therefore, detection of a Cq ≥33 is considered low 
bacterial load (LBL) while detection of a Cq ≥16≤32 is considered high bacterial load (HBL). 
It is important to know that our objective is not to identify presence or absence of a pathogen 
which obviously uses limit of detection or lowest concentration of the two-fold dilution of the 
standard but to identify values for HBL and LBL 
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Figure 3.6: Showing 
quantification 
progression of gene 
aatA (HEX)  
  
HEX (aatA): E=70.8%, 
R^2=0.977,                                         
Slope= -4.301, y-int=44.789  
Figure 3.7: Showing 
quantification 
progression of gene 
aaiC (FAM)  
FAM (aaiC): E=84.9% 
R^2=0.970,                                        
Slope=-3.748 y-int=43.195 
Figure 3.7a: Showing 
highest concentration 
of standad at Cq 16 
and at log starting 
quantity 6.6. Similarly, 
lowest concentration 
at Cq 38 and at log 
start quantity 1.6 of 
gene aatA (HEX)  
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3.15.5 Statistical Analysis 
Statistical analysis was performed using stata software version 12 (StataCorp). To determine 
the accuracy of qPCR in detecting disease, we used receiver operating characteristic analysis. 
Also, sensitivity and specificity of the qPCR was determined using the detection of EAEC as 
independent measure of standard. The distribution of Ct values from EAEC-high bacterial 
load and EAEC-low load of cases and controls were compared using student‟s t-test.  
Conditional logistic regression was used to determine the association between EAEC 
bacterial load and diarrhoea. A crude model showing the relationship of EAEC bacterial load 
and diarrhoea was fitted. Then, this model was adjusted for potential confounders one at a 
time and the association between EAEC bacterial load and diarrhoea noted in the presence of 
each potential confounder. A forward selection procedure was used to build the final 
multivariable model starting with the variable with the lowest p-value. Variables with a p-
value >0.2 were not added to this model.  
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3.16 Biofilm production in EAEC strains  
3.16.1 Strains 
A total of 400 confirmed EAEC strains from symptomatic and non-symptomatic children 
were studied for production of biofilm or slime layer. The target virulent factor(s) to detect 
EAEC using amplification technique are either both aatA (CVD32) and aaiC or one of the 
two.  In this study, we used three recognised phenotypic biofilm screening methods that 
include tube test (tt), Congo red agar (CRA) and tissue culture plate (TCP) screening 
methods. The tube (figure 3.8) and CRA (figure 3.9) are qualitative methods whilst TCP 
(figure 3.10) is quantitative method. Known biofilm producing E. coli strain (EAEC) 042 and 
non-biofilm producing E. coli strain HB101 were included as controls in the three methods.    
 
3.16.2 Tube screening method 
Principle: The visual observation of adherence of 24 hours enriched cultured bacteria to 
smooth surface of a glass tube following stained with simple stain such as Safranin predicts 
biofilm/slime production (Christensen, Simpson et al. 1985).                                         
Procedure 
10ml TSB in Borosilica tube 
Inoculate the medium with the 24 hrs fresh isolate of the test bacteria  
Incubate at 35
o
C or 37
o
C for 48 hrs 
Discard the supernatant 
Stain the borosilica tube with 0.1% Safrannin or 0.1% crystal violet solution 
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Wash with distilled/H2O three times 
Air dry and Examine for slime production 
Presence of adherence of slime to the inner wall of tube ----------- Positive 
Stained ring at the liquid-air interface -------------------------Negative 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Test tube method for screening 
biofilm – Tube A, B, C and D serves as 
positive controls whilst tube E and F serves as 
negative controls  
A B C F E D 
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3.16.3 Congo red agar screening method 
Principle: The enhancement of exopolysaccharide production by bacteria using enriched 
medium such as brain-heart-infusion-broth with 5% sucrose supplement that detects glucan 
production and Congo red (CR) is added to stain presence of exopolysaccharide which is 
slime produced by aquatic Gram negative bacilli (Freeman, Falkiner et al. 1989). Although 
the exact mechanism of the phenomenon is unclear however an explanation given in an 
unpublished report revealed that the black colouration seen in Congo red agar (CRA) plate is 
due to the presence of curlie fibres which contributes to the formation of exopolysaccharide. 
The curli fibre is distinguishable due to its binding characteristics with CR in a cultured 
medium.   
Procedure 
 Inoculate the CRA plate with a 24 hrs fresh bacteria growth from either BHI or TSB 
Incubate the cultured CRA plate at 37
o
C for 24 hrs to 48 hrs 
Examine the plate for the biofilm production 
Darkening or blackening in and around the growth bacteria ---------------------Positive 
Absence of darkening or blackening in and around the growth bacteria -------Negative  
                               A                                                     B   
 
E. coli  HB101 - No Biofilm formation E. coli  042 - Biofilm formation 
Figure 3.9: Congo red Method for 
screening biofilm – Dack black 
colonies B indicate biofilm formation 
whilst pink-red colonies A indicate 
absence of biofilm 
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3.16.4 Tissue culture plate screening method 
Principle: Quantitative biofilm assay that involves incubation of bacterial overnight in rich-
glucose medium Tryptic soy broth medium in a polystyrene microtitre plate. The plate was 
stained with crystal violet following washing, and the biofilm quantified using an enzyme-
linked immunosorbent assay plate reader (Christensen, Simpson et al. 1985).    
Procedure 
Inoculate 10ml Tryptic soy broth of 1% glucose with a 24 hour fresh isolates of the test 
bacteria 
Incubate at 37
o
C for 24 hours 
Dilute cultures in 1:100 with fresh medium of TSB-1% glucose (2µl culture + 198µl TSB) 
Mix well in 96-well plates 
Set up +ve and –ve controls  
Incubate at 37
o
C for 24 hours 
Remove each well content by gentle tapping 
Wash well with 0.2ml of Phosphate Buffer Saline (PBS) 4 times 
Add 10% formaldehyde (25% v/v formalin) to fix the biofilm for 30 minutes. Or, Air dry at 
60
o
C for 45 minutes to fix the biofilm) 
Apply 0.1% crystal violet to stain biofilm for 5 minutes 
Remove excess stain using distilled water 
Air dry the plate   
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Add 200 µl of 95% ethanol to the well to solubilise 
Quantify at 570nm single-wavelength mode (lambda) using ELISA plate reading machine  
Background staining is assessed in control wells inoculated with sterile TSB 
 
 
  A1                                                            A2 
 
Figure 3.10: Tissue culture plate screening method for the presence or absence of biofilm – 
Well A1 is Biofilm positive and well A2 is Biofilm negative. Also, well H1-to- H9 and H11 
are Biofilm negative while well H10 and H12 are biofilm positive. 
 
 
 
 
 
 
E. coli 042 – Biofilm formation E. coli HB101 – No Biofilm formation 
H lane 
        1         2         3         4         5         6         7         8         9        10       11      12 
A 
B 
C 
D 
E 
F 
G 
H 
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3.17 Antibiotic resistance Assay  
3.17.1 Summary 
Antimicrobial susceptibility testing has two purposes. First, it is used clinically to predict 
through an in vitro assessment the likelihood of successfully treating a patient‟s infection 
with a particular antimicrobial agent. Second, it can provide a quantitative measurement of 
susceptibility, which can be used to monitor the emergence and prevalence of antimicrobial 
resistance. Thus, changes in the selective ecological pressure of antibiotic can also change the 
resistant patterns of the epidemic (or endemic) strains. Currently, the three most popular 
susceptibility-testing methods are disk diffusion, agar dilution/broth microdilution and E-test 
techniques.  
 
3.17.2 Antibiotic resistance using disk diffusion method 
Principle: Discs of blotting paper were impregnated with a known volume and appropriate 
concentration of different antimicrobial agents, these are placed on a plate of sensitivity 
testing agar carpet inoculated with the test organism (EAEC). The antimicrobial agent 
diffuses from the disc into the medium. Following overnight incubation at 37
o
C, the culture is 
examined for areas of no growth around the discs (inhibition zones). Bacterial strains 
sensitive to the antimicrobial agents are inhibited at a distance from the disc whereas resistant 
strains grow up to the edge of the disc. The width of the inhibition zones is measured in 
millimetres and gives an indication of the sensitivity of the EAEC to antimicrobial agents 
being tested. In this method, two techniques are often used. Stokes comparative disc diffusion 
technique involves a control organism that is inoculated on the sample plate. While the 
Kirby-Bauer used in this study involves the control strain E. coli ATCC 25922) inoculated on 
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a separate plate. The Kirby-Bauer allows categorization of bacterial isolates as susceptible, 
resistant, or intermediate to ten commercially acquired antimicrobial agents which include; 
Ampicillin 10µg, Sulphamethoxazole-trimethoprim 25µg, Tetracycline 30µg, Ceftazidime 
30µg, Ciprofloxacin 5µg, Ceftriaxone 30µg, Cefoxitin 30µg , Chloramphenicol 30µg, 
Gentamicin 30µg and Amoxicillin-clavulanic acid 30µg (Oxoid, Hampshire, UK) were used. 
The Clinical Laboratory Standard Institute (CLSI 2012) guidelines were followed for the 
antibiotic resistance assay.  
 
Procedure 
Viable four-hundred EAEC isolates stored at -70
o
C were recovered for the antimicrobial drug 
resistance investigation by sub cultured on MacConkey agar medium (oxoid 333M) and 
incubate at 37
o
C overnight. 
Touch the growth single colony of EAEC with sterile straight wire loop. Transfer growth into 
2ml sterile distilled water. The suspension is matched and adjusted with the density of the 0.5 
McFarland standard (BioMeurieux SA, France). 
Within 15 minutes after adjusting the turbidity of the inoculum suspension, a sterile non-toxic 
swab is dipped into the adjusted suspension of EAEC. The swab is rotated several times and 
pressed firmly on inside wall of the tube above the fluid level to remove excess inoculum 
from the swab. 
The dried surface of a Mueller-Hinton agar (Oxoids, Basingstoke, England, Unipath 
catalogue number CM337) plate (88 mm in dm) is inoculated by streaking the swab over the 
entire sterile agar surface. The streaking procedure is repeated two more times, rotating the 
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plate approximately 60
o
C each time to ensure an even distribution of inoculum. This will 
enhance zone of inhibition to be uniformly circular for a confluent lawn of growth. 
The appropriate concentration of impregnated discs of different antimicrobial agents is placed 
on the surface of the inoculated/streaked Mueller-Hinton agar plate with sterile forceps. The 
discs were gently pressed down to ensure complete contact with the agar surface without 
movement.  
The plates were inverted and incubated aerobically at 36
o
C-37
o
C for 18-24 hours (using 
LEEC Compact Incubator, England).  
The plates were examined for susceptibility assay after 18-24 hours incubation 
Interpretation of result:     
Zones of inhibition of the control strains (ATCC 25922 Escherichia coli) and the test EAEC 
strains are measured in millimetre in diameters with a ruler.  
The zone of inhibition for the control strain and the test strains were confirmed to fall 
within the acceptable zone range following CLSI 2016 guideline. 
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3.18 Whole Genome Sequencing of Enteroaggregative Escherichia coli (EAEC) strains  
 
3.18.1 Isolation of genomic DNA from EAEC isolates  
Preparation of EAEC isolates  
Base on the antibiotic sensitivity pattern, fifty-one EAEC Isolates were randomly selected 
retrieved from the -70
o
C, sub-cultured on MacConkey agar medium and purified on Nutrient 
agar medium. Following overnight incubation at 37
o
C a pure colony was picked and 
inoculated in sterile enrichment medium tryptic soya broth (TSB). Also, this culture was 
incubated at 37
o
C overnight.  
Preparation of Reagents and materials 
 Equilibrate the sample to room temperature (15–25°C). 
 Heat 2 water baths or heating blocks: one to 56°C and one to 70°C. 
 Equilibrate Buffer AE or distilled water to room temperature for elution. 
 Ensure that Buffers AW1 and AW2 have been prepared according to the instructions 
in the manual. 
 If a precipitate has formed in Buffer ATL or Buffer AL, dissolve by incubating at 
56°C. 
 
Procedure 
1. Add 1ml of an overnight liquid culture Tryptone Soya Broth (TSB) to a 1.5ml 
microcentrifuge tube. 
2. Centrifuge at 13,000–16,000 × g for 2 minutes to pellet the cells. Remove the supernatant.  
3. Add 180μl of Buffer ATL Solution. Gently pipet until the cells are resuspended. 
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4. Add 20 μl proteinase K, mix by vortexing, and incubate at 56°C for 1 hour or until the 
tissue is completely lysed. (Vortex occasionally during incubation to disperse the sample, or 
place in a shaking water bath or on a rocking platform). 
 
5. Briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from the inside of the 
lid. 
 
6. Add 200 μl Buffer AL to the sample, mix by pulse-vortexing for 15 s, and incubate at 70°C 
for 10 min. Briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from inside 
the lid. 
 
7. Add 200 μl ethanol (96–100%) to the sample, and mix by pulse-vortexing for 15 s. After 
mixing, briefly centrifuge the 1.5 ml microcentrifuge tube to remove drops from inside the lid 
 
8. Carefully apply the mixture from step 7 (including the precipitate) to the QIAamp Mini 
spin column (in a 2 ml collection tube) without wetting the rim. Close the cap, and centrifuge 
at 6000 x g (8000 rpm) for 1 min. Place the QIAamp Mini spin column in a clean 2 ml 
collection tube (provided), and discard the tube containing the filtrate 
 
9. Carefully open the QIAamp Mini spin column and add 500 μl Buffer AW1 without wetting 
the rim. Close the cap, and centrifuge at 6000 x g (8000 rpm) for 1 min. Place the QIAamp 
Mini spin column in a clean 2 ml collection tube (provided), and discard the collection tube 
containing the filtrate 
 
10. Carefully open the QIAamp Mini spin column and add 500 μl Buffer AW2 without 
wetting the rim. Close the cap and centrifuge at full speed (20,000 x g; 14,000 rpm) for 3 min 
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11. Place the QIAamp Mini spin column in a new 2 ml collection tube (not provided) and 
discard the old collection tube with the filtrate. Centrifuge at full speed for 1 min. This step 
helps to eliminate the chance of possible Buffer AW2 carryover 
 
12. Place the QIAamp Mini spin column in a clean 1.5 ml microcentrifuge tube (not 
provided), and discard the collection tube containing the filtrate. Carefully open the QIAamp 
Mini spin column and add 200 μl Buffer AE or distilled water. Incubate at room temperature 
for 5 min to increase DNA yield, and then centrifuge at 6000 x g (8000 rpm) for 1 min 
 
Keep the first 200 µl of extracted DNA for further experiments and label the tube with ID# 
and “_1DNA” code.   
Repeat step 12: Keep the second 200 µl of extracted DNA for further experiments and label 
the tube with ID# and “_2_DNA” code.  
 Repeat step 12: Keep the third 200 µl of extracted DNA for further experiments and label 
the tube with ID# and “_3_DNA” code. (A third elution step with a further 200 μl Buffer AE 
will increase yields by up to 15%). 
Store the extracted DNA microtubes in duplicate at -70
o
C.  
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 3.18.2 DNA Quality Control  
The minimum DNA concentration required to run whole genome sequencing (WGS) is 20 
ng/µl. All samples used for the WGS are well above the 20 ng/µl (table 3.3).  The instrument 
used for quantitation was Qubit Fluorometric Quantitation (Thermo Fisher scientific) 
following manufacturer‟s instructions. 
 
Table 3.3: Concentration of DNA extracts used for Whole Genome Sequencing 
Sample Number Sample Name Conc. (ng/µl) Elution Vol (µl) 
1 102191_1_DNA 25.8 200 
2 102106_1_DNA 27 200 
3 100801_1_DNA 42 200 
4 100722_1_DNA 68 200 
5 100503_1_DNA 41.6 200 
6 100427_1_DNA 41.2 200 
7 100415_1_DNA 61.4 200 
8 100382_1_DNA 89.6 200 
9 100125_1_DNA 120 200 
10 100020_1_DNA 61.4 200 
11 103069_1_DNA 98.8 200 
12 103047_1_DNA 77.8 200 
13 102742_1_DNA 36.4 200 
14 102296_1_DNA 57 200 
15 100119_1_DNA 50.8 200 
16 103530_1_DNA 30.8 200 
17 103275_1_DNA 55.2 200 
18 100404_1_DNA 23.8 200 
19 103076_1_DNA 46 200 
20 100096_1_DNA 69.4 200 
21 100191_1_DNA 47.6 200 
22 103016_1_DNA 102 200 
23 100590_1_DNA 41.4 200 
24 103709_1_DNA 42.6 200 
25 102602_1_DNA 79.8 200 
26 102871_1_DNA 64.6 200 
27 100715_1_DNA 37.4 200 
28 102274_1_DNA 22 200 
29 103070_1_DNA 26 200 
30 103446_1_DNA 62.4 200 
31 100127_1_DNA 87.4 200 
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32 100138_1_DNA 116 200 
33 100182_1_DNA 108 200 
34 100342_1_DNA 106 200 
35. 100569_1_DNA 24.1 200 
36 100796_1_DNA 98.2 200 
37 102031_1_DNA 71.6 200 
38 102098_1_DNA 118 200 
39 102375_1_DNA 77.2 200 
40 102425_1_DNA 100 200 
41. 102469_1_DNA 40 200 
42 102705_1_DNA 65.0 200 
43 102806_1_DNA 63.2 200 
44. 102820_1_DNA 40.3 200 
45 102906_1_DNA 40.2 200 
46 102951_1_DNA 82 200 
47 103276_1_DNA 40.6 200 
48 103278_1_DNA 78.4 200 
49. 103400_1_DNA 40.7 200 
50. 103691_1_DNA 28.6 200 
51 103693_1_DNA 99.0 200 
52 ENC 1 Too low  
53 ENC 2 Too low  
54 ENC 3 Too low  
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3.18.3 Library preparation (Fragmentation) 
 Library preparation usually includes shearing the DNA either mechanically or enzymatically, 
adding adaptors and barcodes/indexes and amplification, was done using the NEBNext® 
Ultra
TM
 II DNA Library Prep Kit Illumina® (E7645).  
Genomic DNA was fragmented at 400 base pairs (bp) via sonication (Covaris 
TM 
M220 
Focussed-ultrasonicator 
TM
 Instrument) and tagged for multiplexing with NEBNext® 
adaptors. 
 
Reagents in the NEB #E7645 kit required for Library Preparation 
Package 1: Store at –20°C. 
 (green) NEBNext Ultra II End Prep Enzyme Mix 
 (green) NEBNext Ultra II End Prep Reaction Buffer 
 (red) NEBNext Ultra II Ligation Master Mix 
 (red) NEBNext Ligation Enhancer 
 (blue) NEBNext Ultra II Q5 Master Mix  
Required Materials 
 80% Ethanol (freshly prepared) 
 Nuclease-free Water 
 0.1X TE (1 mM Tris-HCL, pH 8.0, mM EDTA) 
 DNA LoBind Tubes 
 Magnetic rack / stand 
 PCR Machine 
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Procedure 
NEBNEXT End Prep 
Add to sterile nuclease-free tube; 
NEBNext Ultra II End Prep Enzyme Mix      --------------- 3 µl 
NEBNext Ultra II End Prep Reaction Buffer --------------- 7 µl 
Fragmented DNA    ---------------------------------------------- 50 µl                              
Mix well and do a quick spin to collect all liquid from the sides of the tube 
Place the End Prep Reaction Mixture in a heated lid thermocycler set to ≥75oC, and run the 
following programme; (1) 30 minutes at 20
o
C, (2) 30 minutes at 65
o
C and (3) Hold at 4
o
C 
 
Adaptor Ligation 
Add the components below to the 60 µl End Prep Reaction Mixture; 
NEBNEXT Ultra II Ligation Master Mix   -------------------------- 30 µl 
NEBNext Ligation Enhancer    ---------------------------------------- 1 µl 
NEBNext Adaptor for illumine    ------------------------------------- 2.5 µl  
Incubate the Ligation Mixture at 20
o
C for 15 minutes 
Add 3 µl Enzyme to the ligation mixture 
Mix well and incubate at 37
o
C for 15 minutes with the heated lid set to ≥ 47oC 
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3.18.4 Size Selection of Adaptor-ligated DNA  
Do size selection if starting material is ≥50 ng. Do clean up if starting material is ≤ 50 ng.   
Size selection enriches for molecules that were shred to the desired size and have an adaptor 
ligated to each end. Size selection is accomplished using magnetic beads. 
There are two round of selection. First round removes DNA fragment larger than the desired 
size. Second round removes DNA fragment smaller than desired size. These are 
accomplished using specific ratios of the beads solution to total volume. Volume of beads 
required varies depending on the desired fragments.  
 
Library Amplification by PCR 
This step increases the amount of library and also select for molecules that have an adaptor 
ligated to each end (for multiplex library – idecies or barcodes can be introduced at this step 
if the NEBNext Adaptor and primer are used) 
 
Clean up PCR Reaction 
Introduce magnetic-beads of about 45 µl to the PCR reaction and mix well. DNA library 
bound to the beads. Incubate at room temperature for five minutes. Place the tube/plate on an 
appropriate magnetic stand to separate the beads from the supernatant. Wash beads with 200 
µl 80% ethanol, wait 30 seconds and then remove the ethanol. Air dry the beads (do not over 
dry). Elute the library from the beads using 0.1 X TE buffer. Mix well. Put the sample in the 
magnetic field until the sample clear. Remove about 30µl of the supernatant containing the 
library to a new tube. This library can be stored at -20
o
C  
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3.18.5 Library Analysis 
Confirm the library size distribution by diluting 1 µl of library 5 folds with 10mM Tris-HCl 
or 0.1 X TE buffer. Run it on Bioanalyser using the high sensitive chip. 
Library Quantitation - KAPA 
Final library is quantitated using qPCR-based methods, such as NEBNext Library QUANT-
Kit or electrophoretic methods like the Bioanalyzer 
 
3.18.6 Template Preparation and Automated Sequencing 
Template preparation was accomplished by bridge amplification and or emulsion PCR. 
Automated Whole genome sequencing was achieved using the Illumina MiSeq platform with 
2 x 250 bp reads. The MiSeq illumina is based on sequencing by synthesis of the 
complementary strand and fluorescence-based detection of reversibly blocked terminator 
nucleotides. The template includes multiple instruments with varying throughput range from 
0.3 to 15 Gb and read length 1 x 36 to 2 x 300 bp with scalability. MiSeq instrument (figure 
3.13) is an attractive choice for diagnostic and public health laboratories as it offers low to 
mid sample throughput, affordable pricing and user friendly.  
 
Data Analysis in the Sequencer 
Sequencing from pool liberary are separated base on the unique indicies introduced during 
the samples prepararion. Local clustring that involves reads with similar sequence base call 
are localy cluster together. Forward reads and reverse reads appear to create contiguous 
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sequence are align back to the reference genome for variant identification. The pair-end 
information is use to resolve to make alignment.  
 
3.18.7 Raw Data Quality Control 
Short Illumina reads were quality controlled using FastQC (v0.11.5;). This is done to 
ascertain the quality of the sequence products prior proceeding to analysis of the data. 
Therefore, FastQC checks for sample contamination, Reads quality, problematic reads, 
number of reads mapped, percentage genome covered, quality scores and filters supporting 
reads and sample present (figure 3.11 and figure 3.12). 
 
Figure 3.11: FastQC: Quality Score Per read base 
 
Good 
quality 
Poor 
quality 
Satisfactory 
quality 
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Figure 3.12: Distribution of Quality score across all sequences 
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3.18.8 Sequencing analysis 
Short Illumina reads were quality controlled using FastQC (v0.11.5;). Based on the FastQC 
report, we used the following pipeline employed in Nullarbor (v1.3dev; (Seeman 2016)) for 
our downstream analysis. Low quality reads as well as adaptors were trimmed from both end 
of reads for each genome using trimmomatic (v0.36; (Bolger, Lohse et al. 2014)). Reads were 
then de-novo assembled to generate contigs for each genome using SPAdes (v3.11.1; 
(Bankevich, Nurk et al. 2012)) and coding sequences (CDS) predicted and annotated by 
Prokka (v1.12 (Seemann 2014)). Multi locus sequence types for each genome was 
determined by MLST (v2.8). Resistance genes as well as virulence genes for each genome 
was inferred using Abricate (v0.7). Also core and accessory genome analysis was determined 
using roary software (v3.11.2; (Page, Cummins et al. 2015)) and E. coli str. K-12 substr. 
MG1655 reference genome. The detail of tools used to perform analysis is shown in the table 
3.4. 
 
3.18.9 Phylogenetic analysis 
Sequencing reads were mapped to E. coli str. K-12 substr. MG1655 reference genome using 
BWA MEM (v0.7.17-r1188; (Li and Durbin 2009)) (downloaded from NCBI  8
th
 May 2018).  
Single nucleotide polymorphisms were called using Snippy (v.4.0 deb2) and approximate 
maximum likelihood phylogenetic tree reconstructed using FastTree (v.2.1.10; (Price, Dehal 
et al. 2010)). We used iTOL web tools to annotate the output Phylogenetic tree 
(https://itol.embl.de/login.cgi?logout=1).    
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Figure 3.13: Whole Genome Sequencing work flow 
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Table 3.4: Bioinformatic analysis performed and detail of tools used 
Analysis Tools Version 
Pipeline software   
Generate complete reports from 
sequenced isolates 
Nullarbor  1.30-dev  
Virulome (Virulence genes) From 
assembly 
Abricate  0.7  
Resistome (Resistance genes) 
From assembly 
Abricate + 
Resfinder 
0.7 
Alignment method 
Aligning short reads, map more 
reads with high sequencing error, 
greater sequence variation.  Accept 
reads only in fasta or fastq 
BWA MEM  0.7.17-r1188  
Infer core SNP phylogeny 
Maximum likelihood  
FastTree  
2.1.10 Double precision (No SSE3), OpenMP 
(32 threads)  
Bayesian variant detector – 
design to find small polymorphism 
(SNPs) 
FreeBayes  1.1.0-dirty  
Species identification  
(k-mer analysis against known 
genome database) 
Kraken  1.0  
MLST – From assembly w/ 
automatic scheme detection 
MLST + 
PubMLST 
2.8  
De novo assembly MegaHit  1.1.2  
Process Phylogenetic trees 
Functions include re-rooting, 
extracting subtrees, trimming, 
pruning, condensing, drawing  
Newick-Utils – 
Unix shell tools 
(unable to determine version)  
Annotation   
Adding features to assembly 
Prokka  1.12  
Pan genome   
From annotated consigns 
Rosary  86_64-linux-gnu/perl/5.22/Encode.pm line 59.  
Generic format for storing large 
nucleotide sequence alignment 
SAM tools  1.7  
De novo assembly Spades  3.11.1  
Core genome SNPs Snippy-core 4.0-dev2  
Variants – From reads aligned to 
reference 
Snippy + VFDB 4.0-dev2  
Infer core SNP phylogeny 
SNP distance matrix 
snp-dists  0.2  
Reads and Write Sequences 
Extract sequences from database & 
display sequences  
seqret  6.6.0.0  
Clean reads – Remove adaptors, 
low quality bases and reads 
Trimmomatic  0.36  
Annotate the output phylogenetic 
tree 
iTOL Web base tool (https://itol.embl.de) 
138 
 
 
Figure 3.14: Dichotomous decision tree to determine the phylogenic group of an EAEC 
isolate by the presence or absence of chuA, yjaA and TspE.C2 from WGS virulence gene 
result 
 
 
                                                         +                                                         - 
 
 
 
    
                                       +                               -                            +                           - 
 
 
 
 
 
 
 
 
 
 
ChuA 
yjaA TspE4.C2 
B1 or A B2 or D 
A B1   D B2 
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Chapter 4: Prevalence of Virulence genes among EAEC strains 
from MSD and non-MSD children 
 
4.1 Introduction 
Enteroaggregative E. coli (EAEC) is an important causative agent of both acute 
and persistent diarrhoea among adults and children worldwide (Nataro, Steiner et 
al. 1998) and it has been among the  most common E. coli pathotypes causing 
diarrhoea among children less than five years of age in some developing 
countries. (Moyo, Maselle et al. 2007). Several outbreaks of EAEC diarrhoea 
have been reported in both developed and developing nations and infants are the 
most affected (Cobeljic, Miljkovic-Selimovic et al. 1996; Itoh, Nagano et al. 
1997; Pai, Kang et al. 1997; Smith, Cheasty et al. 1997). EAEC has been 
implicated in travellers‟ diarrhoea (Adachi, Jiang et al. 2001; Januszkiewicz, 
Szych et al. 2012) and persistent diarrhoea among human immunodeficiency 
virus (HIV) infected individuals (Samie, Obi et al. 2007). This pathotype was 
implicated in a massive outbreak of haemolytic uremic syndrome (HUS) in 
Germany in 2011 (Bielaszewska, Mellmann et al. 2011). The clinical presentation 
of EAEC infection is characterized by watery and mucoid diarrhoea with low-
grade fever and insignificant vomiting (Bhan, Khoshoo et al. 1989; Paul, 
Tsukamoto et al. 1994). 
The pathogenesis of EAEC diarrhoea is thought to comprise colonization of the 
intestinal mucosa, followed by elaboration of enterotoxins and cytotoxins and the 
release of proinflamatory cytokines from infected epithelial cells (Harrington, 
Strauman et al. 2005; Harrington, Dudley et al. 2006), induced by the EAEC 
adherence factors called Aggregative Adherence Fimbriae (AAFs). Additionally, 
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EAEC strains characteristically enhance mucus secretion from the mucosa, 
potentially trapping the bacterium in a bacterium-mucus biofilm (Nataro, Steiner 
et al. 1998). A distinctive feature of EAEC is its ability to elicit characteristic 
stacked brick-like aggregative adherence to HEp-2 or HeLa cells, a test that 
remains the gold standard to identify this pathotype (Nataro and Martinez 1998). 
EAEC strains express several genes that may confer virulence and are highly 
heterogeneous regarding the combination of these virulence genes, which are 
encoded on the bacterial chromosome or on an EAEC-specific plasmid 
designated pAA. The majority of EAEC strains harbour a transcriptional activator 
of the AraC/XyIS fairly called AggR, which control genes on both the plasmid 
and the chromosome. Among the genes under AggR control includes those that 
encode the Aggregative Adherence Fimbriae (AAFs) where at least five variants 
exist. These genes encoding the major structural pilin subunits are designated as 
aggA (AAF/I), aafA (AAF/II), agg3A (AAF/III), agg4A (AAF/IV) and agg5A 
(AAF/V) (Nataro, Yikang et al. 1994; Czeczulin, Balepur et al. 1997; Jonsson, 
Struve et al. 2015). Other plasmid-borne potential virulence factors include the 
EAEC heat-stable enterotoxin 1 EAST1 (encoded by the astA gene) (Savarino, 
Fasano et al. 1991), an anti-aggregation protein called dispersin (encoded by the 
aap gene), and a transporter apparatus for dispersin called Aat (encoded by the 
aat genes). EAEC frequently harbour members of the serine protease 
autotransporters of Enterobacteriaceae (SPATEs), which have been described as 
enterotoxins and cytotoxins.  The heat-labile enterotoxin/cytotoxin called Pet 
(Plasmid-encoded toxin) (Nataro, Steiner et al. 1998) has been implicated in 
causing cytotoxic effects on the human intestinal mucosa. Other SPATEs carried 
by EAEC strains include the cryptic protease called SepA, and the mucinase 
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called Pic (protein involved in intestinal colonization) (Henderson, Czeczulin et 
al. 1999; Kahali, Sarkar et al. 2004) which is encoded on the chromosome.  Other 
important chromosomal gene that encodes virulence markers include (i) Irp2 
(iron repressible high-molecular-weight protein 2) a protein responsible for 
yersiniabactin biosynthesis and (ii) flagellin, which interacts with the epithelial 
cells, leading to the secretion of an intestinal interleukin-8 (Steiner, Nataro et al. 
2000). The EAEC genome has been found to be markedly mosaic, thus the 
various putative virulence factors are found inconsistently among individual 
strains, suggesting that some strains considered EAEC may be truly virulent, and 
others not (Nataro, Steiner et al. 1998).  
Several studies have shown that EAEC is the most frequently detected E. coli 
pathotype in humans, particularly among children from both developed and 
developing countries (Presterl, Nadrchal et al. 1999; Knutton, Shaw et al. 2001; 
Cohen, Nataro et al. 2005). The GEMS comprised of a case-control study of 
moderate-to-severe diarrhoea among children less than five years of age at four 
sites in sub-Saharan Africa and three in south Asia showing high frequency of 
EAEC (Kotloff, Nataro et al. 2013). Although, EAEC was not associated with 
moderate-to-severe diarrheal disease in GEMS,  a subsequent analysis of the 
association of individual EAEC genes alone and in combination among EAEC 
isolates from moderate-to-severe diarrhoea cases and controls of GEMS site in 
Bamako Mali found that SepA protease was associated with moderate-to-severe 
diarrhoea (Boisen, Scheutz et al. 2012). In this chapter we replicated the analysis 
by Boisen et al. (2012), scoring the presence of twenty-one putative EAEC 
virulence factors from 428 EAEC isolates randomly selected among 741 EAEC 
isolates obtained from diarrheal and non-diarrheal children enrolled in the GEMS 
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study to characterize the virulence genes in children from these isolates from The 
Gambia. We analyzed these EAEC virulence genes by age strata (0-11, 12-23 and 
24-59 months).  
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4.2 Result 
Among all EAEC strains in cases and controls (n = 428), the age and sex distribution 
were similar among cases and controls except for a lower EAEC prevalence in children 
above 23 months among cases (table 4.1). Overall, orf61 (aar) was the most commonly 
detected gene, (69.6%). This was followed by the cryptic ORF3 (64%), capU (62%), 
aggR (60.1%), astA (51.4%), eilA (48.3%) and aap (46.3%); the rest of the genes were 
present in less than 40% of isolates (Table 4.2). Analysis of the EAEC virulence genes 
in all age groups together, showed that only four of the twenty-one genes assayed 
(sepA, pet, astA and capU) were more prevalent among cases. Prevalence of AAF/I 
encoded by aggA gene was slightly higher in cases than controls (29.9% versus 22.9%) 
(OR 1.4, 95% CI 0.89-2.29, P = 0.106). The frequency of other AAF pilin genes, 
AAF/II (aafA) and AAF/III (agg3A) were low in both cases and controls but slightly 
high for AAF/IV (agg4A) in cases compared to controls.  However, the AAF usher-
encoding gene agg3/4C was similar in cases and controls (36.9% vs 35.4% 
respectively).  Of the five SPATE genes (sat, pet, sigA, pic and sepA), prevalence of 
sepA (OR 1.6, 95% CI 0.99-2.49, P = 0.041) and pet (OR 1.9, 95% CI 0.97-3.56, P = 
0.042) genes were higher among diarrhoea cases (Table 4.2).   
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Table 4.1: Baseline information of study population  
Demographic 
factors 
Case (N = 157) 
No. (%) 
Control (N = 271) 
No. (%) 
Total (N = 428) 
No. (%) 
 OR (95% CI) P - Value 
Age (month) 
0-11 
 
85 (54.1) 
 
132 (48.7) 
 
217 (50.7) 
 
1.2 (0.82-1.88) 
 
0.278 
12-23 61 (38.9) 105 (38.8) 166 (38.8) 1.0 (0.65-1.53) 0.982 
24-59 11 (7.0) 34 (12.6) 45 (10.5) 0.5 (0.23-1.10) 0.071 
Abbreviation: EAEC, enteroaggregative Escherichia coli, OR, odds ratio, CI, 
confidence intervals 
 
Table 4.2: Distribution of EAEC virulence genes from cases and controls children 
(age 0-59 month) 
Gene 
Class 
Virulence 
Gene 
Case (n=157) 
No. (%) 
Control (n=271) 
No. (%) 
Total (n=428) 
No. (%) 
Odd Ratio  
(95% CI) 
 
X
2
 
P-
value 
 
 
 
 
 
 
pAA 
P 
L 
A 
S 
M 
I 
D 
 aatA 51 (32.5) 82 (30.3) 133 (31.1) 1.1  (0.71-1.73) 0.2 0.631 
aggR 97 (61.8) 161 (59.4) 258 (60.3) 1.1  (0.72-1.69) 0.2 0.628 
aaP 77 (49.0) 121 (44.7) 198 (46.3) 1.2  (0.78-1.80) 0.8 0.379 
ORF3 106 (67.5) 168 (62.9) 274 (64.0) 1.3  (0.82-1.98) 1.3 0.251 
capU 108 (68.8) 158 (58.3) 266 (62.2) 1.6  (1.02-2.45) 4.7 0.031 
aar 110 (70.1) 188 (69.4) 298 (69.6) 1.0  (0.66-1.63) 0.1 0.880 
A 
D 
H 
E 
S 
I 
N 
aafC 7 (4.5) 16 (6.0) 23 (5.4) 0.7  (0.25-1.97) 0.4 0.522 
agg3/4C 58 (36.9) 96 (35.4) 154 (36.8) 1.1  (0.69-1.64) 0.1 0.752 
agg3A 10 (6.4) 28 (10.3) 38 (9.8) 0.6  (0.25-1.29) 1.9 0.164 
aafA 3 (1.9) 15 (5.5) 18 (4.2) 0.3  (0.06-1.20) 3.2 0.071 
aggA 47 (29.9) 62 (22.9) 109 (25.5) 1.4  (0.89-2.29) 2.6 0.106 
agg4A 15 (9.6) 16 (6.0) 31 (7.2) 1.7  (0.74-3.75) 1.9 0.160 
T 
O 
X 
I 
N 
S 
astA 91 (58.6) 129 (47.6) 220 (51.4) 1.5  (1.00-2.30) 4.3 0.038 
sat 29 (18.5) 56 (20.7) 85 (19.9) 0.9  (0.51-1.47) 0.3 0.583 
sepA 50 (31.9) 62 (22.9) 112 (26.2) 1.6  (0.99-2.49) 4.1 0.041 
pet 24 (15.3) 24 (8.9) 48 (11.2) 1.9  (0.97-3.56) 4.1 0.042 
CH 
RO 
MO 
SO 
ME 
pic 55 (35.0) 88 (32.5) 143 (33.4) 1.1  (0.72-1.73) 0.3 0.588 
sigA 18 (11.5) 31 (11.4) 49 (11.5) 1.0  (0.50-1.93) 0.0 0.993 
 aaiC 44 (28.0) 97 (35.8) 141 (32.9) 0.7  (0.44-1.09) 2.7 0.099 
air 41 (26.1) 57 (21.0) 98 (22.9) 1.3  (0.81-2.15) 1.5 0.227 
eilA 79 (50.3)  128 (47.2) 207 (48.4) 1.1  (0.75-1.71) 0.4 0.538 
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The distribution of the characterized virulence genes varied across the age strata. In 0-
11 month stratum, prevalence of pet (OR 6.9, 95% CI 2.06-29.20, P < 0.001), aggA 
(OR 2.2, 95% CI 1.16-4.29, P = 0.008), and capU (OR 1.9, 95% CI 1.02-3.51, P = 
0.028) genes were more common in cases compared to controls (Table 4.3). Similar 
higher prevalence pattern was observed for pet (OR 15.0, 95% CI 1.35-750.0, P = 
0.003) and capU (OR 4.3, 95% CI 1.27-18.54, P = 0.009) when the virulence factors 
were characterized among the sole EAEC pathogen from MSD children 0-11 month 
age in cases and controls (Table 4.4). 
Prevalence of virulence genes that were proportionately higher in cases compared to 
controls in children 0-11 months were sepA (36.5% vs 26.5%), astA (54.1% vs 41.7%), 
aggR (71.8% vs 62.1%), aap (56.5% vs 44.7%) and ORF3 (75.3% vs 63.6%). The astA 
gene was found more often in cases (67.2%) than in controls (49.5%) in the age stratum 
12-23 months (OR 2.1, 95% CI1.03-4.27, P = 0.026); none of the putative virulence 
factors were found to be significantly more common in MSD children ≥ 2 years of age 
(Table 4.3).  Furthermore, results obtained from the characterisation of EAEC 
pathotypes that are sole pathogen among younger children showed significant 
association of pet gene with diarrhoea with OR 15.0, 95% CI 1.35-750, P = 0.003 (Table 
4.4). 
In addition to considering each virulence factor individually, we also considered the 
importance of combinations of potential EAEC virulence factors by employing 
classification and regression tree (CART) analysis. The CART analysis builds a model 
in stepwise fashion to yield the combination of factors most strongly associated with 
the queried outcome, in this case the combinations of factors most strongly associated 
with MSD. Each branch of a CART output tree ends in a terminal “node”; each 
146 
 
observation falls into exactly 1 terminal node; and each terminal node is uniquely 
defined by a set of rules, such as having or not having a certain factor. 
We examined all 21 virulence genes including aatA, aggR, aaiC, aap, ORF3, sat, sepA, 
pic, sigA, pet, astA, aafC, agg3/4C, aafA, agg3A, aggA, agg4A, air, capU, eilA, aar  as 
well as considering the collective number of virulence loci present (generating a 
virulence factor score, VFS) (figure 4.1 and 4.2). 
As noted, prevalence of the virulence genes were significantly higher in cases 
compared to controls in children 0-11 months and applying the CART analysis (Figure 
2) showed that the presence of pet (Node 1), regardless of the presence or absence of 
any other scored genotype among the pet-positive strains, provided a strong association 
with diarrhoea. Among the pet-negative strains, CART analysis suggested two 
additional trait clusters that were associated with moderate to severe diarrheal: Node 2 
includes those strains with a VFS <=8 in combination with sepA, whereas Node 3 
includes a VFS > 8, suggesting a combination of typical EAEC factors in addition to 
the toxin EAST-1 toxin. 
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Table 4.3: Distribution of EAEC virulence genes in case and control children in three age strata 
 
Virulence genes 
0-11 months (N = 217) 12-23 months (N= 166) 24-59 months (n = 45) 
Case (n = 85) 
No.  (%) 
Control (n = 132) 
No.  (%) 
  
OR (95% CI) 
 
P-Value 
Case (n = 61) 
No.  (%) 
Control(n =105) 
No.  (%) 
  
OR (95% CI) 
 
P-Value 
Case (n = 11) 
No.  (%) 
Control(n =34) 
No.  (%) 
     
OR (95% CI) 
 
P-Value 
aatA 33 (38.8) 48 (36.4) 1.1 (0.60-2.02) 0.714 16 (26.2) 26 (24.8) 1.1 (0.48-2.34) 0.833 2 (18.2) 8 (23.5) 0.7 (0.06-4.71) 0.710 
aggR 61 (71.8) 82 (62.1) 1.5 (0.82-2.93) 0.143 33 (54.1) 62 (59.1) 0.8 (0.41-1.62) 0.534 3 (27.3) 17 (50.0) 0.4 (0.05-1.95) 0.187 
aaP 48 (56.5) 59 (44.7) 1.6 (0.89-2.88) 0.090 28 (45.9) 46 (43.8) 1.1 (0.54-2.15) 0.793 1 (9.1) 16 (47.1) 0.1 (0.00-0.98) 0.024 
ORF3 64 (75.3) 84 (63.6) 1.7 (0.91-3.37) 0.071 37 (60.7) 63 (60.0) 1.0 (0.51-2.06) 0.933 5 (45.5) 21 (61.8) 0.5 (0.10-2.53) 0.341 
capU 59 (69.4) 72 (54.6) 1.9 (1.02-3.51) 0.028 42 (68.9) 62 (59.1) 1.5 (0.75-3.18) 0.208 7 (63.6) 24 (70.6) 0.7 (0.14-4.20 0.665 
aar 62 (72.9) 98 (74.2) 0.9 (0.48-1.82) 0.831 42 (68.9) 70. (66.7) 1.1 (0.53-2.32) 0.772 6 (54.6) 20 (58.8) 0.8 (0.17-4.24) 0.802 
aafC 3 (3.5) 7 (5.3) 0.7 (0.10-2.96) 0.543 3 (4.9) 6 (5.7) 0.9 (0.13-4.18) 0.827 1 (9.1) 3 (8.8) 1.0 (0.01-14.6) 0.978 
agg3/4C 34 (40.0) 51 (38.6) 1.1 (0.58-1.91) 0.840 20 (32.8) 33 (31.4) 1.1 (0.50-2.19) 0.856 4 (36.4) 12 (35.3) 1.0 (0.18-5.18) 0.948 
agg3A 3 (3.5) 18 (13.6) 0.2 (0.04-0.83) 0.014 5 (8.2) 8 (7.6) 1.1 (0.26-3.96) 0.893 2 (18.2) 2 (5.9) 3.6 (0.22-53.6) 0.212 
aafA 1 (1.2) 3 (2.3) 0.3 (0.01-6.51) 0.557 2 (3.3) 10 (9.5) 0.3 (0.03-1.59) 0.134 0 (0) 2 (5.9) 0.0 (0.00-16.8) 0.410 
aggA 32 (37.7) 28 (21.2) 2.2 (1.16-4.29) 0.008 13 (21.3) 25 (23.8) 0.9 (0.37-1.95) 0.711 2 (18.2) 9 (26.5) 0.6 (0.05-3.94) 0.578 
agg4A 10 (11.8 12 (9.1) 1.3 (0.48-3.55) 0.524 4 (6.6) 2 (1.9) 3.6 (0.49-40.7) 0.121 1 (9.1) 2 (5.9) 1.6 (0.02-33.4) 0.710 
astA 46 (54.1) 55 (41.7) 1.7 (0.91-2.96) 0.072 41 (67.2) 52 (49.5) 2.1 (1.03-4.27) 0.026 4 (36.4) 22 (64.7) 0.3 (0.05-1.56) 0.098 
sat 20 (23.5) 24 (18.2) 1.4 (0.66-2.84) 0.338 9 (14.8) 24 (22.9) 0.6 (0.22-1.43) 0.207 0 (0) 8 (23.5) 0.0 (0.00-1.69) 0.076 
sepA 31 (36.5) 35 (26.5) 1.6 (0.84-2.86) 0.119 16 (26.2) 23 (21.9) 1.3 (0.56-2.79) 0.526 3 (27.3) 4 (11.8) 2.8 (0.33-20.1) 0.217 
pet 15 (17.7) 4 (3.0) 6.9 (2.06-29.20) <0.001 9 (14.8) 16 (15.2) 1.0 (0.34-2.51) 0.933 0 (0) 4 (11.8) 0.0 (0.00-4.78) 0.233 
pic 24 (28.2) 34 (25.8) 1.1 (0.58-2.18) 0.687 28 (45.9) 41 (39.1) 1.3 (0.66-2.63) 0.387 3 (27.3) 13 (38.2) 0.6 (0.08-3.18) 0.509 
sigA 4 (4.7) 5 (3.8) 1.3 (0.24-6.01) 0.740 10 (16.4) 20 (19.1) 0.8 (0.32-2.04) 0.668 4 (36.4) 6 (17.7) 2.7 (0.42-15.0) 0.194 
aaiC 22 (25.9) 34 (25.8) 1.0 (0.51-1.95) 0.983 19 (31.2) 48 (45.7) 0.5 (0.25-1.09) 0.065 3 (27.3) 15 (44.1) 0.5 (0.07-2.47) 0.321 
air 26 (30.6) 34 (25.8) 1.3 (0.66-2.32) 0.437 13 (21.3) 21 (20.0) 1.1 (0.45-2.50) 0.840 2 (18.2) 2. (5.9) 3.6 (0.22-53.6) 0.212 
eilA 37 (43.5) 54 (40.9) 1.1 (0.61-2.00) 0.702 35 (57.4) 52 (49.5) 1.4 (0.69-2.72) 0.328 7 (63.6) 22 (64.7) 1.0 (0.19-5.38) 0.948 
 
 
 
 
148 
 
Table 4.4: Characterization of virulence factor in the EAEC pathotype obtained as sole 
pathogen from cases and control children age 0-11 month 
 
Virulence Gene 
0-11 months (n=105) 
Case (n=25) 
No. (%) 
Control (n=80) 
No. (%) 
Total (n=105) 
No. (%) 
     Odd Ratio  (95% CI)  
X2 
P-value 
sat 7 (28.00) 15 (18.75) 22 (20.95) 1.69 (0.49-5.23) 1.0 0.32 
sepA 7 (28.00) 22 (27.50) 29 (27.62) 1.03 (0.32-3.03) 0.0024 0.96 
Pic 4 (16.00) 17 (21.25) 21 (20.00) 0.71 (0.16-2.52) 0.3 0.57 
sigA 2 (8.00)  1 (1.25) 3 (2.86) 6.87 (0.33-410.2) 3.1 0.08 
Pet 4 (16.00) 1 (1.25) 5 (4.76) 15.0 (1.35-750.0) 9.14 0.003 
astA 12 (48.00) 34 (42.50) 46 (43.81) 1.25 (0.46-3.38) 0.2 0.63 
aatA 11 (44.00) 31 (38.75) 42 (40.00) 1.24 (0.45-3.38) 0.2 0.64 
aggR 19 (76.00) 52 (65.00) 71 (67.62) 1.71 (0.57-5.80) 1.1 0.30 
aaiC 7 (28.00) 17 (21.25) 24 (22.86) 1.44 (0.43-4.39) 0.5 0.48 
aaP 15 (60.00) 36 (45.00) 51 (48.57) 1.83 (0.67-5.13) 1.7 0.19 
orf3 21 (84.00) 49 (61.25) 70 (66.67) 3.32 (0.98-14.42) 4.4 0.04 
aafC 0 (0.00) 4 (5.00) 4 (3.81) 0.00 (0.00-3.07) 1.3 0.25 
agg3/4C 11 (44.00) 26 (32.50) 37 (35.24) 1.63 (0.58-4.48) 1.1 0.29 
agg3A 0 (0.00) 10 (12.50) 10 (9.52) 0.00 (0.00-1.12) 3.5 0.06 
aafA 0 (0.00) 1 (1.25) 1 (0.95) - 0.3 0.57 
aggA 10 (40.00) 18 (22.50) 28 (26.67) 2.30 (0.77-6.57) 3.0 0.08 
agg4A 3 (12.00) 7 (8.75) 10 (9.52) 1.42 (0.22-6.89) 0.2 0.63 
air 10 (40.00) 18 (22.50) 28 (26.67) 2.30 (0.77-6.57) 3.0 0.08 
capU 21 (84.00) 44 (55.00) 65 (61.90) 4.29 (1.27-18.54) 6.8 0.009 
eillA 7 (28.00) 34 (42.50) 41 (39.05) 0.52 (0.17-1.52) 1.7 0.20 
orf61 19 (76.00) 59 (73.75) 78 (74.29) 1.12 (0.37-3.92) 0.05 0.82 
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Figure 4.1: Association of virulence factors with diarrhoea in children aged 0-59 months. Each branch of 
the classification and Regression Tree ends in a terminal “node” (red boxes), and each terminal node is 
uniquely defined by the presence or absence of a predictive factor such as a gene or virulence factor score  
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Figure 4.2: Association of virulence factors with diarrhoea in children aged 0-11 months. Each branch of 
the classification and Regression Tree ends in a terminal “node” (red boxes), and each terminal node is 
uniquely defined by the presence or absence of a predictive factor such as a gene or virulence factor (VFS) 
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4.3 Discussion 
EAEC is a common cause of diarrhea worldwide (Cennimo, Abbas et al. 2009). The 
assessment of the 21 genes in the 428 EAEC strains in this study showed that the 
frequency of most genes correlated well with similar studies, particularly the study 
from the GEMS Gambia neighboring site, in Bamako Mali (Boisen, Scheutz et al. 
2012). In this study, more than half of the study participants were younger than 1 year 
of age, although there were no statistical differences between cases and controls in 86% 
of the virulence genes using the p-value. However, when odd ratio (OR), a measure of 
association is used to assess the association of virulence factors with diarrhoea among 
the children 0-11 month, we found that over 80% of the virulence genes were 
associated with diarroeal disease by having OR >1. And a sharp contrast of association 
was observed among the older age children 24-59 month with only 19% of the 
virulence genes been associated with diarrhoeal disease having OR >1. Similarly, 
among 12-23 month old children 52% of the virulence genes with OR >1 were found to 
be associated with diarrhoea The explanation to this difference is that younger age 
children (infancy) are more susceptible to EAEC infection majorly due to their 
immature innate and adaptive immune system, which matures and acquires memory as 
they grow. This speculation has been corroborated in a study (Philipson Bassaganya et 
al. 2013) modelling immunity to EAEC which showed the importance of Th17 cells in 
host responce to EAEC facilitating bacteria clearance. The discovery followed the 
initial EAEC T cell differentiation model that depicts EAEC infection, antigen 
presentation, and host adaptive immune response to pathogen. This probably explains 
stronger immunity with acquisition of memory immune cells of previous EAEC and 
other enteric infection in the older age children.  Therefore, there was a decline in the 
proportion of virulence genes association with diarrhoea using OR >1 from infant to 
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older age children (table 4.3). Association between sepA gene and MSD in Mali study 
is stronger compared to this study, and the reason for the difference is unclear but it can 
be genetic and or environmental factor. SepA is a SPATE protease that was initially 
found in S. flexneri strains (Benjelloun-Touimi, Sansonetti et al. 1995), but has 
subsequently been found commonly among EAEC (Boisen, Ruiz-Perez et al. 2009). 
The protease has been implicated in causing increased inflammation in Shigella strains 
but it may also have enterotoxic activity. 
In this study, the virulence genes aggA encoding for AAF/1, capU and pet, encoding a 
member of Class 1 serine protease autotransporters of Enterobacteriaceae (SPATEs) 
family, were statistically implicated as genes responsible for EAEC diarrhoea in 
younger children < 12 months. 
Our study highlights significant heterogeneity in gene profiles among the EAEC 
isolates. Of the twenty-one genes targeted, none of the EAEC isolates characterized 
genetically harbours more than 15 virulence genes.  The heterogeneous nature of EAEC 
enables it to display variation in causing clinical illness, (Cennimo, Abbas et al. 2009) 
although factors responsible for its virulence are not well understood. 
Several studies have shown possible genes that confer virulence on EAEC (Cennimo, 
Abbas et al. 2009; Opintan, Newman et al. 2010). Our data show three virulence genes 
associated with diarrhoea in infants. Interestingly, the three incriminated virulence 
genes are plasmid genes that include plasmid-encoded toxin (pet), AAF/1 fimbrial 
subunit (aggA) and hexosyltransferase homolog (capU). The Pet toxin is a 108-kDa 
protease, which secretes enterotoxin that generates high toxicity in human epithelial 
cells resulting in structural damage to the cell. Following internalization via receptore-
mediated endocytosis, pet is delivered to the cytoplasm by means of retrograde 
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trafficking which is accompanied by cleavage of spectrin known as actin-binding 
protein fodrin, within microvilli cytoskeleton leading to cell elongation, rounding and 
finally, the release of cells from the substractum (Navarro-Garcia, Sears et al. 1999; 
Villaseca, Navarro-Garcia et al. 2000; Navarro-Garcia, Canizalez-Roman et al. 2001; 
Dutta, Cappello et al. 2002). In Mexico, the Pet gene was initially detected from EAEC 
strain 049766 implicated in a highly virulent outbreak of diarrhoea in which some 
infants died (Eslava 1993). Also, the reported enterotoxic activity of EAEC induced by 
Pet is consistent with the secretory diarrhea seen in most patients with EAEC enteritis 
(Eslava, Navarro-Garcia et al. 1998). A recent report from Iran alluded that pet gene is 
more prevalent among EAEC strains isolated from adult diarrhoeal patients (Bafandeh, 
Haghi et al. 2015). Therefore, our findings support the role of Pet gene in EAEC 
causing diarrhea in infants (figure 4.1; Table 4.3). However, earlier EAEC virulence 
factor study conducted in Southwest Nigeria over a decade ago showed that the Pet 
gene was equally distributed among EAEC strains isolated from children <5 years with 
or without diarrheal (Okeke, Lamikanra et al. 2000). Seemingly, our study also showed, 
no association of Pet with diarrheal disease in the children <5 years but the effect is 
only seen in EAEC strains isolated from children < 1 year and so the differences 
between our findings could be due to age stratification, which again explains the poor 
status of infants adaptive immune system, permitting pet enterotoxin to proliferate 
mucosal epithelial cells leading to diarrhoea in infant.  
Generally, innate immune system provides an early first line defence against invading 
pathogens by involving cells that include neutrphils, monocytes, macrophages and 
dendritic cells, which all interact with the adaptive immune system. So at birth, immune 
system is muted in order for the foetus to tolerate only non-shared maternal antigens 
and to avoid high level of stress and remodelling that takes place during development. 
154 
 
This makes the newborn baby relatively susceptible to bacterial and viral infections. In 
the adaptive immune system, T cells develop in the thymus which is largest at birth and 
during first years of life. The function of early-life T cells is different from adult T 
cells.  B cells are present  in secondary lymphoid organs and in the bone marrow, they 
contribute to humoral response of the adaptive immune system. So, most antibody 
responses, including those to bacterial proteins, bacterial polysaccharides and to 
polysaccharide-protein conjugate vaccines are dependent on T-cell help. 
A study showed that EAEC pet gene participates as an immunostimulant molecules for 
machrophages, which activates both their mobility and cytokine expression (Rocha-
Ramirez, Hernandez-Chinas et al. 2016). Prior this study, our understanding was that 
only AAF variants and other virulent genes participate in the activation of early 
inflammatory response without the participation of pet gene which explains why host 
T-helper cell does not have memory of pet antibody.   
AAF/I was associated with diarrhoea in the first year of life, also, this study showed 
significant association of aggA with diarrhoea in younger children. Therefore, there is 
likelihood of synergistic interaction between the enterotoxin producing gene (pet) and 
the adherence factor aggA that codes for aaf/I to cause damage to mucosal epithelial 
cells leading to diarrhoeal disease and potentially malnutrition among younger age 
children. Again, the Shiga toxin producing EAEC strain implicated in the German 
outbreak expressed AAF/I (Scheutz, Nielsen et al. 2011).  
Hexosyltransferase homolog (capU), a plasmid-encoded protein was significantly high 
among the younger children. Its role in EAEC diarrhoea is not clearly defined.   
Notably, the capU gene was the third most common gene found (62%) among genes 
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investigated in this study. This probably highlights the importance of genes acting in 
concert. 
astA encodes a heat-stable enterotoxin (EAST1) that is related to the heat-labile 
enterotoxin of enterotoxigenic E. coli. The relevance of astA gene in EAEC diarrhoea 
has been reported in several studies (Vila, Gene et al. 1998; Paiva de Sousa and 
Dubreuil 2001; Toshima, Uenaka et al. 2004; Veilleux, Holt et al. 2008), and EAST1 
was found to be associated with diarrhoea in combination with other genes in the Mali 
study (Boisen, Scheutz et al. 2012). astA is not restricted to EAEC but is widely 
distributed among other enteric pathogens (Menard and Dubreuil 2002; Zhou, 
Ogasawara et al. 2002), as well as commensal E. coli. 
Classification Regression Tree (CART) Analysis: Following the proportional and 
statistical analysis of individual virulence factor, CART analysis was employed to 
investigate combinations of the potential EAEC virulence factors. In children 0-59 
months, CART analysis showed the significance association of pet with diarrhoea in the 
presence of capU and in the absence of aaiC (Node 1) while in the prensence of capU 
and in the absence of aaiC and pet the air and aatA genes were not associated with 
diarrhoea (figure 4.1). Similarly in the same cluster, the aafA, agg4C and sat gene were 
not associated with diarrhoea in  the presence of capU and aaiC. In the cluster that had 
capU present sepA is not associated with disease. Also, when capU and sepA were 
absent aggA was not associated with disease but pet was significantly associated with 
diasese (Node 2) (figure 1). In children 0-11 months, CART analysis utilised both the 
combination of virulence factors and virulence factor score (VFS) (figure 4.2). CART 
analysis among the younger age children (0-11 months) distinctly showed pet 
significant association with diarrhoeal disease (Node 1). While the absence of pet and 
absence of agg3A with equal or less than 8 VFS (<=8 vfs) sepA was found to be 
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associated with disease (Node 2). In the absece of pet gene Agg3A did not show any 
association with diarrhoea. Surprisingly, EAST1 showed significant association with 
diarrhoea with VSF<=11 in the absence of many virulence related genes. The common 
observation from the two trees ploted is the importance of pet gene among the 
diarrhoeal infants in the rural Gambia.  
Microbiome: Intestinal microbiome plays a pivotal role in preventing infectious 
diseases as early as birth (Harris, Haak et al. 2017). But it is unclear whether 
microbiome play a role in the expression of virulence genes causing disease. An infant 
may first be exposed to bacteria as early as in utero and upon delivery undergoes rapid 
intestinal colonisation. The patterns of colonisation are in part non-random and can be 
shaped by mode of delivery, breastfeeding, geography, genetics, antibiotics and age 
(Yatsunenko, Rey et al. 2012), and it is evidence that specific bacterial colonisation is 
required for normal neonatal immune development (Chung, Pamp et al. 2012). 
Therfore, microbes are important symbiotic modulators of physiological, metabolic and 
immunological function in the mammalian host (Durack and Lynch 2019). Recent data 
indicate that the developing gut microbiota of human infants affects the progression of 
intestinal mucosal IgA responses, and perturbations to these nascent microbial 
communities cause long-lasting metabolic and immunological dysregulation (Ruiz et 
al., 2017; Lynn et. al. 2018). For example, the study showed macrolide treatment of 
conventional, neonatal mice perturbs their gut microbiota with depletion of 
Bifidobacterium and segmented filamentous bacteria, resulting in decreased numbers of 
intestinal CD4+IL-17A+ lymphocytes and faecal IgA concentrations. Similar events 
may have happened in this characterisation study of EAEC where host natural 
antibiotics or administered antibiotics might have possibly cause down-regulation of 
expression of some virulence genes.  Factually, a study cataloguing functional genes in 
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the human gut microbiome identified as many as 9.9 million unique microbial genes 
across 1,200 healthy subjects from three different continents (Li et al. 2014).   
Globally, EAEC strains have shown a low to high level of resistance to antimicrobial 
agents (Mendez Arancibia, Pitart et al. 2009). Our data from the antimicrobial 
susceptibility investigation highlights high resistant pattern of the EAEC strains against 
Cotrimoxazole, and Ampicillin. The first line of antibiotics prescribed for patient 
management in our region are Cotrimoxazole and Ampicillin, which may explain the 
high resistance against these antibiotics. An increase in resistance of EAEC strains to 
Chloramphenicol, Nalidixic acid and Quinolones was observed in this study compared 
to a similar study on a member of enterobacteriaceae family from the same region 
(Ikumapayi, Antonio et al. 2007) and in eastern Asia (Aslani, Alikhani et al. 2011). 
Twenty percent of the EAEC strains tested showed multidrug resistance to 3 
antimicrobial agents whereas six percent showed resistant to more than 3 antimicrobial 
agents. This finding is in contrast to a similar study conducted in India, showing 75% of 
strains with multidrug resistance, i.e. > 3 antimicrobial agents (Raju and Ballal 2009).  
The limitations of this study included exclusion of multiple comparisons such as 
malnutrition and other enteric co-infections. Hence future studies can consider these 
essential confounders. 
 
4.4 Conclusion 
Our study has strengthened the role of pet and EAST1 genes of EAEC in the cause of MSD 
in African infants. The EAEC virulence gene profiles found in this study have also proven the 
heterogeneity of the genetic component of the EAEC isolates studied. However, further 
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investigations are needed to establish the specific or combination of gene(s) that are 
associated with EAEC diarrheal in different age strata, particularly children from developing 
countries 
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Chapter 5: A quantitative assessment of clinical significance of 
EAEC in diarrhoea using TaqMan-QPCR  
 
5.1 Introduction 
Diarrhoea is a predominant cause of childhood illness and mortality particularly in 
developing countries (Okeke 2009). Enteroaggregative E. coli (EAEC) is best known for 
causing acute and persistent diarrhoeal illness in developing countries as well as in travellers 
and immunocompromised individuals (Harrington, Dudley et al. 2006; Boll, Struve et al. 
2013). Major diarrhoeal studies have implicated Enteroaggregative E. coli (EAEC) strain 
among the most important etiologic agents of diarrhoea both in industrialised and low income 
countries (Pabst, Altwegg et al. 2003; Cohen, Nataro et al. 2005; Rappelli, Folgosa et al. 
2005; Nataro, Mai et al. 2006; Boisen, Scheutz et al. 2012). EAEC in diarrhoeal outbreaks is 
a more common occurrence than ever before and in large scale studies EAEC has been the 
commonest bacterial pathogen identified in diarrhoeal stool samples (Croxen, Law et al. 
2013; Ikumapayi 2014). EAEC infection has been associated with severe intestinal 
inflammation leading to childhood malnourishment and growth impairment (Steiner, Lima et 
al. 1998; Roche, Cabel et al. 2010), although, little is known about this claim in West-Africa 
countries. However, the recent report of an outstanding observational diarrhoea study showed 
no association of EAEC with diarrhoeal among moderate-to-severe diarrhoea (MSD) children 
from developing countries particularly those from the Gambia (Kotloff, Nataro et al. 2013).  
EAEC  is a heterogeneous category of an emerging enteric pathogen (Kaur, Chakraborti et al. 
2010). The difficulty in the diagnosis of EAEC causing diarrhoea is inherent in its 
heterogeneity since strains are found equally in both symptomatic and asymptomatic 
individuals and/or even more in asymptomatic children (Kotloff, Nataro et al. 2013). To 
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elucidate our understanding of the cause of diarrhoeal episodes among children from a 
developing country we seek to evaluate causal relationship between the bacterial quantity and 
the diarrhoeal symptoms.  
 This study is nested to a large case-control study (GEMS) where samples for this study were 
obtained. In order to determine the clinical relevance of the presence of EAEC in a faecal 
sample from diarrheic individuals, we hypothesize that high bacterial load of EAEC is 
associated with diarrhoeal disease among children under five. The marker/target genes for the 
detection of EAEC infection and quantitative-qPCR assays are aaiC (a chromosomal) and 
aatA (a plasmid) gene based on GEMS recommendation (Panchalingam, Antonio et al. 
2012). The aaiC gene (aggR-activated island C) encodes a type VI secretion system that is 
located in a conserved chromosomal sequence in EAEC DNA (Dudley, Abe et al. 2006). The 
aatA (anti-aggregation protein transporter A) gene composes of EAEC-ABC transporter-A 
which consists of a DNA fragment from the EAEC plasmid which encodes an outer 
membrane protein of the ABC transporter complex (Lima, Boisen et al. 2013). We target 
both aaiC and aatA genes for PCR and qPCR assays in our investigation.    
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5.2 Result 
The Taqman qPCR assay was performed in duplicate on two different days and similar 
results were obtained from the 160 (80 cases and 80 controls) samples. The average of the 
obtained results was used in the final analysis.  
There was a huge difference in the qPCR detection of aaiC and aatA among the 160 samples 
investigated. The two genes combined were qPCR detected and measured in 24 (15%) of the 
160 DNA samples, whilst aaiC and aatA alone were qPCR detected and measured in 16 
(10%) and 120 (75%) of the 160 DNA samples respectively. So, we are obligated to choose 
aatA that has 90% qPCR detection and quantification for the analysis of the bacterial load 
data. 
The cut-offs for the high bacterial load (HBL) and low bacterial load (LBL) has been 
explained in detail in chapter three „materials and method section‟ of this thesis. In summary, 
cut-offs were achieved by constructing a slope from the point where Cq 16 and Cq 38 
intercept, to the point it intercept the slope of the standard curve. At the later intercept point 
Cq 32 is obtained (figure 3.7a).  Therefore, detection of a Cq ≥33 is considered low bacterial 
load (LBL) while detection of a Cq ≥16≤32 is considered high bacterial load (HBL) (figure 
3.7a).  
Of the 160 samples, 106 (48 [30%] cases and 58 [36.2%] controls) had high bacterial load 
(HBL) EAEC, whilst, 54 (32 [20%] cases and 22 [13.8%] controls) account for low bacterial 
load (LBL) EAEC. Proportionately, higher bacterial load EAEC is less in MSD children 
compared with community matched control.  
The crude association of high bacterial load and diarrhoea for the MSD and non-MSD 
children showed (OR 0.61, 95% CI [0.3132281-1.182877] and p-value 0.143) (Table 5.1). 
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The univariable analysis showed association of some confounders in the presence of HBL, 
these include cows and rodents in the household, usage of well-water, presence of a co-
infection, presence of other animals that include either a horse, donkey, dog or cat in the 
household, underweight and lower score Mid Upper Arm Circumference (MUAC) with 
having EAEC high bacterial load that results in diarrhoea to be statistically significant among 
MSD children (table 5.1). In the final model, presence of cows in a household, presence of 
rodents, presence of having a co-infection, underweight and lower score MUAC were found 
to be the most significant factors associated with having HBL that results in diarrhoea (Table 
5.2). 
 
 
Table 5.1: Univariable analysis showing effect of each confounder on the Association 
between being a case/control and High bacterial load (HBL) 
Variable Odd Ratio 95% CI p-value 
High Bacterial load (HBL) 0.61 0.3132281 - 1.182877 0.143 
Cow + HBL 5.50 1.87856  -  16.11824 0.002 
Fowl + HBL 1.93 0.4743  -  7.891345 0.358 
Rodent + HBL 3.13 1.396007 - 6.996583 0.006 
*Domestic animals + HBL 1.04 0.3310954 - 3.282651 0.943 
**Other animals + HBL 3.98 1.478566   -  10.70114 0.006 
Well water + HBL 4.80 1.252331   - 18.40323 0.022 
Breastfeed + HBL 1.65 0.5441415 - 5.016002 0.376 
Co-infection + HBL 2.23 1.125549  -  4.418939 0.022 
Underweight + HBL 4.27 1.870679  -  9.742075 0.001 
Lower-score-MUAC + HBL 3.58 1.610876  -  7.965095 0.002 
 
 
 
 
163 
 
Table 5.2: Multivariable analysis showing effect of all the confounders on the Association 
between being a case/control and High bacterial load 
Variable 
 
Odd Ratio 95% CI p-value 
High Bacterial load 0.45 0.1240591  -  1.668576 0.235 
Cow 11.83 1.664311  -  84.03794 0.014 
Fowl 2.23 0.1151228  -  43.08074 0.596 
Rodent 6.96 1.725073  -  28.10618 0.006 
*Domestic animals 0.99 0.1172411  -  6.905467 0.919 
**Other animals 2.16 0.5063242  -  8.513867 0.310 
Well water 4.33 0.4171896  -  44.95957 0.220 
Breastfeed 1.50 0.2571136  -  8.786691 0.651 
Co-infection 3.20 1.014459  -  10.10321 0.047 
Underweight 4.09 1.036919  -  16.10511 0.044 
Lower-score-MUAC 4.94 1.185023  -  20.59792 0.028 
*Domestic animals (Goat and Sheep) and ***Other animals (Donkey, Horse, Dog and Cat) 
 
 
 
Proportional distribution of stool consistency among MSD children with sole infection of 
EAEC showed that formed, soft, thick-liquid, opaque-watery and rice-water with high 
bacterial load account for 0%, 0%, 100%, 79% and 0% respectively, and low bacterial load 
account for 100%, 100%, 0%, 21% and 0% respectively (figure 5.1).                                           
One death was recorded among the high bacterial load MSD children with stool consistency 
opaque-watery (figure 5.1).  
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Figure 5.1: proportional distribution of stool consistency in EAEC sole infection among 
MSD with high and low bacterial load 
 
 
 
 
 
 
 
We investigated a set of earlier detected 21 virulence factors (Ikumapayi, Boisen et al. 2017) 
for possible association on high or low bacterial load from among MSD and non-MSD 
children using pathogenicity index (in this case virulence index) calculation. Interestingly, 
results showed that only pet gene was associated with high bacterial load yielding 
pathogenecity index (PI) 9.27, odd ratio 12.3 and p-value 0.005. The only gene associated 
with low bacterial load was astA gene yielded PI 2.67, odd ratio 6.0 and p-value 0.040 (table 
5.3).    
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Table 5.3: Analysis showing virulence/pathogenicity index of each virulence factor on high 
and low bacterial load among MSD and non-MSD children age less than 5 years old (n=93) 
Virulence 
genes 
High bacterial load (n=69) Low bacterial load (n=24) 
Case (n=36) 
No. (%) 
Control (n=33) 
No. (%) 
Pathogenicity / 
Virulence index 
Case (n=12) 
No. (%) 
Control 
(n=12) 
No. (%) 
Pathogenicity / 
Virulence index 
aatA 13 (36.1) 13 (39.4) 0.92 4 (33.3) 6 (50) 0.67 
aggR 25 (69.4) 23 (69.7) 0.99 6 (50) 10 (83.3) 0.60 
aap 18 (50) 11 (33.3) 1.50 5 (41.7) 7 (58.3) 0.72 
orf3 25 (69.4) 23 (69.7) 0.99 7 (58.3) 9 (75) 0.78 
capU 25 (69.4) 19 (57.6) 1.20 8 (66.7) 6 (50) 1.33 
orf61 26 (72.2) 25 (75.8) 0.95 9 (75) 8 (66.7) 1.12 
aafC 1 (2.8) 0 (0) NA 1 (8.3) 2(16.7)  0.49 
agg3/4C 12 (33.3) 16 (48.5) 0.69 6 (50)  4 (33.3) 1.50 
agg3A 2 (5.6)   6 (18.2) 0.31 2 (16.7) 1 (8.3) 2.01 
aafA 1 (2.8) 1 (3.0) 0.93 0 (0.0) 0 (0.0) NA 
aggA 12 (33.3) 8 (24.2) 1.38 4 (33.3)  3(25) 1.33 
agg4A 2 (5.6) 4 (12.1) 0.46 0 1 (8.3) NA 
astA 18 (50) 15 (45.5) 1.10 8 (66.7) 3 (25) 2.67 
sat 8 (22.2) 6 (18.2) 1.22 2 (16.7) 3 (25) 0.67 
sepA 14 (38.9) 14 (42.4) 0.92 1 (8.3) 4 (33.3) 0.25 
*pet 10 (27.8) 1 (3.0) 9.27 0 (0) 1 (8.3) NA) 
pic 15 (41.7) 9 (27.3) 1.53 4 (33.3) 5 (41.7) 0.79 
sigA 6 (16.7) 2 (6.1) 2.74 2 (16.7) 3 (25) 0.67 
aaiC 11 (30.6) 11 (33.3) 0.92 1(8.3) 5 (41.7) 0.20 
air 10 (27.8) 12 (36.4) 0.76 5 (41.7) 4 (33.3) 1.25 
eilA 13 (36.1) 8 (24.2) 1.50 6 (50) 6 (50) 1.0 
*Distinct high pathogenicity index 9.27, odd ratio 12.3 and p-value 0.005 
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Also, we examined virulence factor score against bacterial load and other important 
variables that include age, sex, coinfection, stool consistency, type of water and type of 
animals in the study participant‟s house that are common to both symptomatic and 
asymptomatic children. The result showed no statistically significant association of virulence 
factor score with high bacterial load in both symptomatic and asymptomatic groups (table 5.4 
& 5.5).  
 We report a fatal case (SID100574) in table 5.4.  The child was infected solely with an 
EAEC high-bacterial-load infection and was malnourished the demographic characteristics 
and other details of the child were 10 month old, female, opaque watery stool consistency, 
had five types of animal (goat, sheep, cow, rodent and fowl) in the house backyard, the 
EAEC strain involved harbours 9 virulent factors that include aatA, aap, orf3, orf61, aggA, 
astA, sat, pet and air among the 21 virulent factors investigated (table 5.4) and was not 
coinfected with other intestinal pathogens targeted.   
Also, another fatal case (SID102095) in table 5.4 had EAEC high-bacterial-load coinfected 
with astrovirus only but not malnourished. The demographic characteristics and other details 
were 7 month old, male and opaque watery stool consistency, had 8 types of animal (goat, 
sheep, dog, cat, cow, rodent, fowl and donkey) in the house backyard and the EAEC strain 
involved harbours 3 virulent factors that include Orf61, agg3/4C and air.                                                                          
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Table 5.4: Virulent factor score against Bacterial load and other variables among MSD children (n=48) 
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100109 10 F Lo Y Tp Sf g, s, c, f, do, h 6                      8 
100574 10 F Hi N Tp Op g, s, c, r, f 5                      9 
102044 7 F Hi Y we Sf r, f 2                      2 
102055 8 M Hi Y we TL g, s, ca, r, f, do, h 7                      10 
102105 4 M Lo Y we Op g, s, d, c, f 5                      9 
102106 6 M Hi N we Op g, s, r, f, do, h 6                      9 
102155 6 M Hi Y Tp Op g, ca, r, f, do 5                      6 
102444 8 M Hi Y Tp Op g, c, r, f, do, h 6                      9 
102500 14 M Hi N we TL g, d, r, f, do  5                      6 
103180 22 M Lo Y we TL g, s, d, c, r, f, do 7                      8 
103193 11 M Hi N we Op g, s, d, ca, c, r, f do 8                      8 
103201 8 M Hi Y we Op r, f, do  3                      12 
103240 8 F Hi Y we TL  0                      8 
103275 5 M Hi N we TL g, s, d, r, f 5                      9 
103288 12 F Hi Y we Op g, r, f, do 4                      6 
103448 10 F Lo Y we TL g, s, c, r, f 5                      4 
100111 7 F Lo Y Tp Op g, s, ca, r, f, do, h 7                      10 
100513 20 F Lo Y Tp TL g, s, ca, r, f, do, h 7                      10 
102095 7 M Hi Y we Op g, s, d, ca, c, r, f do 8                      3 
102465 8 F Hi Y we Op g, ca, f 3                      6 
103039 13 M Hi Y Tp Op g, s, r, f, do, h 6                      8 
103445 20 M Hi Y we Op g,s,d, ca, c,r,f,do, h 9                      7 
103467 9 F Hi Y we Op g,s,d, ca, c,r,f,do, h 9                      9 
103693 7 M Hi N Tp Op g, s, c, r, f, 5                      10 
100119 7 M Lo Y Tp Op s, d, c, r, f, 5                      6 
100232 14 F Lo N Tp Fo g, s, c, r, f, do, h 7                      5 
100484 8 M Lo Y Tp Op g, s, d, c, r, f, do, h 8                      2 
100679 6 M Hi N we Op g, s, r, f, do  5                      8 
102258 4 F Hi Y Tp Op g, s, f 3                      9 
102334 18 M Lo Y we Sf g, s, c, r, f, h 6                      10 
102602 21 M Hi Y we Sf g, s, ca, r, f, do 6                      10 
100191 6 M Hi Y Tp Op g, s, c, r, f, do, h 7                      8 
100890 6 M Hi Y we Op R, f, h 3                      9 
102191 6 M Hi Y we TL g, s, d, ca, r, f, do,h 8                      9 
102192 10 M Hi Y we TL g, s, ca, r, f, do, h 7                      7 
102821 11 F Hi Y Tp Op g, s, r, f, do 5                      5 
103276 43 M Hi N Tp Op g, r, f, do 4                      6 
103663 16 M Hi N we Op g, s, ca, c, r, f 6                      2 
100313 5 M Hi N Tp TL g, s, d, c, r, f, do, h 8                      8 
100794 10 M Hi Y we Op g, s, d, r, f, do 6                      13 
100796 10 F Hi Y we Op g, s, d, r, f, do 6                      5 
102090 24 F Hi Y we TL g, s, c, r, f 5                      4 
103016 19 F Hi Y Tp Sf g, s, r, f, do, h 6                      9 
100713 10 M Hi N Tp Op g, s, r, f, do, h 6                      7 
102428 22 M Lo N we TL g, ca, c, r, f 5                      7 
102788 21 M Hi N Tp Op g, d, r, f, do, h 6                      6 
102845 5 F Hi N Tp TL g, s, f 3                      5 
103446 28 F Lo Y we TL s, r, f, do 4                      2 
Key: c – cow, ca – cat, d – dog, do – donkey, f – fowl, g – goat, h – horse, r – rodent and s – sheep      
Hi – high bacterial load, Lo – low bacterial load, Tp – tap-water, we – well-water, Y – yes, N – no,      
Op – opaque-watery, Sf – soft and TL – thick-liquid,        Present,       Absent 
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Table 5.5: Virulent factor score against Bacterial load and other variables among Asymptomatic children (n=45) 
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100099 3 M Lo Y Tp TL g, s, r, f  4                      5 
100123 10 F Hi Y Tp Sf g, s, c, f 4                      10 
102061 8 M Hi Y we Op g, s, d, r, f, do, h 7                      7 
102157 8 M Hi Y Tp Op r, f 2                      2 
103018 10 M Hi N Tp Sf g, r, f, do, h 5                      9 
103177 18 M Hi Y Tp Sf g, s, f, do 4                      7 
103192 18 M Hi N we Fo g, r, f, do 4                      4 
103203 10 M Hi N we TL g 1                      6 
103208 20 F Lo N Tp TL g, s, ca, r, f 5                      6 
103237 6 F Hi N we Fo r, f 2                      7 
103285 6 M Hi Y we TL g, s, r, f, do 5                      9 
103394 8 M Hi Y we Sf g, d, ca, c, r, f, do, h 8                      8 
100127 5 F Lo N Tp TL g, s, r, f 4                      9 
100525 23 F Hi N Tp Op g, r 2                      6 
102484 6 F Hi N we TL g, d, r, f, do 5                      2 
103042 13 M Lo N Tp TL g, s, d, ca, r, do, h 7                      9 
103273 18 M Lo N Tp Sf g, s, r, f, do, h 6                      7 
103460 19 M Hi Y we TL g, s, d, ca, c, r, f, do 8                      11 
103700 8 M Hi N Tp TL g, c, r, f, do 5                      11 
100138 5 M Hi N we Op g, s, d, f 4                      7 
100235 17 F Lo N Tp Sf g, s, ca, f 4                      11 
100255 8 M Hi N we TL g, s, d, c, r, f, do 7                      6 
100495 9 M Hi N Tp Sf g, s, d f 4                      6 
102287 6 F Hi N Tp Sf g, s, r, f 4                      9 
102341 18 M Hi N we Fo r, f 2                      5 
102614 22 M Hi N we Fo g, s, r, f 4                      7 
100896 7 M Hi N we Fo g, s, c, f 4                      8 
102210 7 M Hi N Tp Sf g, s, d, ca, f 5                      11 
102211 9 M Hi Y Tp Sf g, s, d, ca, f 5                      12 
102670 9 F Hi N Tp Sf g, f 2                      2 
102990 7 F Hi N Tp Op g, s, d, r, f, do 6                      6 
103396 8 M Lo N Tp Fo g, s, r, f 4                      8 
100018 10 M Hi N Tp TL g, s, r, f 4                      10 
100318 5 M Hi N Tp TL s, c, r, f 4                      6 
100801 10 M Lo Y Tp TL d, ca, f, do, h 5                      12 
100800 9 F Hi Y Tp Sf d, ca, r, f, do, h 6                      8 
102103 24 F Hi Y we Fo g, r, f, do, h 5                      4 
102154 7 M Hi Y Tp Sf g, r, f, do, h 5                      4 
103027 23 F Lo N Tp Fo g, s, r, f 4                      6 
103598 15 F Hi N Tp Fo g, s,  r, f, do, h 6                      4 
100715 9 M Hi Y Tp Sf g, f, do, h 4                      7 
102433 21 M Lo N we TL g, s, f, do, h 5                      8 
102792 21 M Lo Y Tp Op g, s,  r, f, do, h 6                      4 
102849 4 F Hi Y Tp TL g, s, f, do, h 5                      5 
103451 27 F Lo Y we Sf g, s,  r, f, do 5                      6 
Key: c – cow, ca – cat, d – dog, do – donkey, f – fowl, g – goat, h – horse, r – rodent and s – sheep      
Hi – high bacterial load, Lo – low bacterial load, Tp – tap-water, we – well-water, Y – yes, N – no,      
Fo – formed, Op – opaque-watery, Sf – soft and  TL – thick-liquid,        Present,        Absent 
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Our examination of the proportional association of Virulent Factor Score (VFS) and bacterial 
load among the MSD and non-MSD showed no association. In the MSD group virulent factor 
score was proportionately more in HBL compared with LBL for vfs ≥4≤6 (28% vs. 25%) and 
vfs ≥7 (64% vs. 58%), but in the non-MSD group virulent factor score  ≥4≤6 and ≥7 were 
proportionately more in LBL compared with HBL which are (42% vs. 36%) and (58% vs. 
55%) respectively (figure 5.2). 
 
Figure 5.2: proportional association of virulent factor score and bacterial load among MSD 
and non-MSD children 
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5.3 Discussion 
EAEC is a worldwide recognised diarrhogenic strain (Kaur, Chakraborti et al. 2010). Several 
studies have reported the implication of EAEC in diarrhoea among children and adults in 
both industrialised (Smith, Cheasty et al. 1997; Presterl, Nadrchal et al. 1999; Knutton, Shaw 
et al. 2001; Cohen, Nataro et al. 2005) and low income countries (Okeke, Lamikanra et al. 
2000; Okeke, Ojo et al. 2003; Kahali, Sarkar et al. 2004; Araujo, Tabarelli et al. 2007). 
However, in the GEMS that was conducted in four African and three Asian countries from 
2007-2010, it became clear that the relationship between presence of EAEC and disease 
among MSD children from low income countries is not absolute (Kotloff, Nataro et al. 2013) 
so a more sensitive, specific and practical diagnostic methods were needed to investigate the 
association of EAEC with disease. The gold standard for the identification EAEC is the Hep-
2 adherence test (Nataro, Kaper et al. 1987), but it is limited to reference laboratories, as it 
requires special facilities and skill. Despite many diagnostic methods developed, limited 
studies have had the opportunity to use a well-defined case-control data to quantify bacterial 
load to show that the relationship between the EAEC high bacterial load and diarrhoea is 
either causal or not. To date, there are no available data that validate a robust, easy and 
affordable method for the detection of infectious EAEC strain.  
In this study, we investigated the relevance of bacteria load measurement using Taqman-
QPCR as a reliable diagnostic tool to identify true pathogenic EAEC strains that cause 
diarrhoea. We choose aatA that has 90% qPCR detection and quantification for the analysis 
of the bacterial load data. Although it has been shown that plasmids may vary in gene content 
and have the potential to transfer to unrelated bacteria (Dobrindt 2005) nonetheless, previous 
studies have utilised aatA maker genes to detect and quantify EAEC presence (Nataro, Mai et 
al. 2006; Chattaway, Harris et al. 2013; Liu, Kabir et al. 2014). We used Cycle threshold (Ct) 
value as an indicator of bacterial load and defined a cut off that yielded 60% sensitivity and 
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27.5% specificity. These values clearly imply that estimation of bacterial load by Ct values of 
a qPCR for marker (aaiC and aatA) genes is a poor diagnostic test for EAEC infection that 
cause diarrhoea. Interestingly, a similar investigation conducted on routine faecal samples in 
the United Kingdom (Chattaway, Harris et al. 2013) corroborate our finding, the specificity in 
that study was also 60%. In our study, the results obtained for the crude model logistic 
regression analysis was in agreement with the diagnostic values as there was no association 
of EAEC high bacterial load with disease (OR 0.61 and p-value 0.143).  
The multivariable analysis showed that presence of cows and rodents in a household, having 
a co-infection, underweight, and lower score mid-upper-arm-circumference (muac) were 
associated with higher odds of diarrhoea. One possible explanation to this outcome is that if 
an EAEC infected child presented these variable symptoms there is liklyhood that the child 
harbourghs high bacterial load EAEC that can possibly result into diarrhoeal disease.    
No doubt, the complexity of interpreting pathogen isolated from faecal samples of children 
with diarrhoea and compared with asymptomatic colonisation is huge. That is why three 
(Environmental, bacterial and host) factors were often considered in many studies for suitable 
interpretation. There are numerous reports highlighting the role of environmental factors in 
diarrhoeal disease in which contaminated drinking water was implicated (Baker, O'Reilly et 
al. 2016), including a study conducted in The Gambia which showed filtering water through a 
cloth and of storing drinking water significantly associated with diarrhoeal episode in 
children (Baker 2011). Although well-water was not associated with EAEC high bacterial 
load in our multivariable analysis but a study has specifically incriminated EAEC in well 
water. For example, in 1996, a village outbreak of diarrhoea in India was epidemiologically 
associated with the drinking water from open well contaminated with EAEC (Pai, Kang et al. 
1997). An important environmental factor observed was the association of cow and rodent 
with high bacterial load EAEC among the diseased individuals which signals that these 
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animals may serve as risk factors for EAEC diarrhoea. A possible explanation for the 
assumption is that over 90% of the households in the area/region where this study was 
conducted consumed untreated raw cow milk that may have been exposed to EAEC 
contamination and rodents such as rats and mice common in the households often suck from 
spill milk that occurs during processing and aliquotting for consumption. Augmenting this 
speculation, a study implicated cheese made from unpasteurised sheep milk as likely source 
of EAEC infection in Italy (Scavia, Staffolani et al. 2008). Although EAEC strains are 
considered to be adapted to the human host (EFSA 2015) hence, no strains of EAEC 
pathotype was detected in studies that examined the faecal samples obtained from sick and 
healthy calves and lambs in Kashmir India (Wani, Hussain et al. 2013). Similarly, EAEC was 
not detected in the investigation of healthy cattle, sheep and pigs in UK slaughter house 
(Cassar, Ottaway et al. 2004). However, a study from a low income country have implicated 
animals such as cattle, chicken and pigs as possible risk factors for EAEC infection 
(Kagambega, Martikainen et al. 2012). So in a poor sanitation setting it can be possible that 
animals become exposed to EAEC originating from human waste. Another observation from 
our study revealed that goat and sheep which are commonly found in many households in 
rural Gambia are not associated with EAEC high bacterial load infection and it is not clear 
whether one or both these animals provide herd-effect against EAEC infection a speculation 
that requires further investigation. 
Studies from low income countries have shown cases of mixed infection particularly EAEC 
co-infecting with other diarrhoeal pathogens (Adachi, Jiang et al. 2001; Kotloff, Nataro et al. 
2013). However, other than few cases that involved malnourishment, our data showed that 
EAEC did not, independently but in the presence of another pathogen, particularly rotavirus 
and shigella cause disease. Our finding is strengthened by a study that uses three different 
advanced molecular methods that include PCR-Luminex, multiplex real-time PCR and 
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TaqMan array card to test for 15 enteric pathogens including EAEC (Liu, Kabir et al. 2014). 
Despite EAEC co-infecting with other pathogens the three methods showed no association of 
EAEC with symptomatic diarrhoeal children.  
Studies have given an assertion that a significant proportion of global malnutrition result 
from disorder of intestinal absorptive function resulting from repeated enteric infection 
(Black, Allen et al. 2008), and other studies have linked EAEC persistent diarrhoea to 
malnutrition and decreased physical and congnitive development in children (Guerrant, Oria 
et al. 2008). Likewise, studies have reported that malnutrition predisposes to EAEC and vice 
versa (Roche, Cabel et al. 2010), consistent with the trend seen in the results from our study 
which showed a high odds ratio of 4.09 and 4.94 for underweight and lower-score-MUAC 
respectively. Also, the results were further augmented with malnutrition and under-nutrition 
accounting for 21.25% (17/80) and 26.25% (21/80) respectively, although the two conditions 
are equally distributed between high and low bacterial load EAEC strains as indicated in the 
table 5.3. However, studies have showed that malnutrition predisposes host to diarrhoea 
caused by the pathotypes of E. coli (Nataro 2006) that include EAEC and vis versa. 
 In the proportional estimate of abnormal and normal stool consistency among EAEC sole 
infected MSD children we found out that abnormal thick-liquid account for 100% in the high 
load MSD children and zero percent in the low load MSD children. In the case of abnormal 
opaque-watery, high load MSD children account for 79%, low bacterial load MSD children 
account for 21% (figure 5.1). This finding throws more light on our understanding of a major 
symptom of EAEC characterised with opaque watery and thick-liquid or mucoid supporting 
previous studies (Nataro, Mai et al. 2006; Estrada-Garcia, Perez-Martinez et al. 2014).  
We are compelled to give account of the demography and other characteristics of a fatal case 
with opaque-watery stool consistency. The patient was a 10 month old female child 
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harbouring EAEC of high bacterial load with no other pathogen other than EAEC that consist 
of 9 virulent factors score (vfs) which are aatA, aap, orf3, orf61, aggA, astA, sat, pet and air. 
The patient had neither malaria infection nor bacteria growth from blood culture result, her 
source of drinking is tap-water and her compound harbours five type of animals that include 
goat, sheep, cow, rodent and fowl (table 5.4). A critical observation among these 
characteristics is the unique combination of virulent factors involved and despite the strain 
fatality it has no aggR factor which makes it atypical EAEC. So, a close descriptive study of 
the gene combination among symptomatic and asymptomatic children (table 5.4 & 5.5) 
suggest that combination of aatA, pet, aggA, orf3 and orf61 are required in an EAEC strain to 
cause a disease that can possibly result to fatality in this geographic area. This assertion 
requires further investigation since the scope of this study does not cover gene expression and 
gene functional and interaction investigation. More importantly host factors have to be 
considered as malnutrition was the major recognised risk factor in this particular case.  There 
was another fatal case with similar characteristics of stool consistency opaque-watery and 
high bacterial load of EAEC but co-infected with astrovirus and virulence factor score of 
three (orf61, Agg3/4C and air) genes, and the patient is 7 month old male without 
malnourishment and malaria, and no bacterial growth from blood culture (table 5.4). A total 
of three deaths have been observed in Gambia specific GEMS data that were attributed to 
EAEC co-infecting with astrovirus only. These incidences may not have happened by chance, 
so a thorough investigation is required to unveil potential mechanism of synergistic virulence 
been exhibited from the combination of the two organisms that often result to fatality. 
The association of virulent factor score and high or low bacterial load among MSD and non-
MSD children was proportionately investigated. There was no major/significant difference in 
VFS between the two groups but the irony was that there was high proportion of vfs ≥7 and 
vfs ≥4≤6 in the high bacterial load compared to low bacterial load respectively in the MSD 
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group, while in the non-MSD group there was high proportion of vfs ≥7 and vfs ≥4≤6 in the 
low bacterial load compared to high bacterial load, but in the vfs ≤3 it was a reverse (figure 
4). This result showed that there is high likelihood of having vfs ≥4 in EAEC strain with high 
bacterial load and vfs ≤3 in EAEC strain with low bacterial load from diarrhoeal children 
compared to non-diarrhoeal children. Several studies have showed virulent factor score and 
disease in EAEC strains (Samie, Obi et al. 2007; Boisen, Scheutz et al. 2012; Lima, Boisen et 
al. 2013; Jensen 2017) but none has shown association with bacterial load. However, this 
observation is not absolute for diagnosis.   
Our analysis of pathogenicity or virulence index of virulence factors in cases and controls of 
both high and low bacterial load showed pet as the only virulence gene that has high 
pathogenicity index of relevance and strong significant odd ratio and p-value. This outcome 
is not surprising because the pet gene was implicated in previous studies (Eslava, Navarro-
Garcia et al. 1998; Lima, Boisen et al. 2013; Bafandeh, Haghi et al. 2015; Ikumapayi, Boisen 
et al. 2017). However it may be important to considere the pet gene as a diagnostic marker 
when investigating infectious EAEC in this region. It is not clear whether host genetic factor 
play a role in the EAEC infection in the presence of pet gene even though its presence in 
EAEC strains is small but its significance in the EAEC diseased persons particularly children 
from developing countries is huge.  There can be a potential role of pet-toxin in relation to 
nutrients and other competing organisms. Studies have shown that some bacteria play a role 
in competing for the consumption of a limited resource by one strain restricting supply of 
nutrient to other competitors. The mechanisms used can be either through increased nutrient 
uptake or through the extracellular secretion of molecules that harvest nutrient (MacLean RC. 
and Gudeji I. 2006). An example of the former is Escherichia coli that can metabolically shift 
from fermentation to respiration when oxygen is present, generating high growth rates but 
low yield, allowing them to absorb nutrient faster than their competitors (Ghoul M and Mitri 
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S. 2016). The example of the latter competitive strategy is the production of digestive 
enzymes to degrade complex nutrient molecules, or sideropgores, which are iron-scavenging 
molecules that access insoluble iron. Pet is speculated to play a role in malnutrition using the 
latter strategy. For example it can be possible that enterotoxin and cytotoxin secreted by pet 
are use as a weapon to eliminate their competitors, and concurrently causing under nutrition 
among children. Pet toxins promote host inflammation that impedes commensal survival. The 
inflammation caused by toxin-mediated diarrhoea significantly decreases the number of 
commensal microbiota in the intestine, and in turn, increases the chance of colonization and 
proliferation of incoming pathogens because of less competition (Lupp C et al. 2007). This 
can be an area of future investigation of pet toxins. So, we suggest that pet gene be added to 
other diagnostic marker such as aatA, aaiC and aggR for detecting EAEC infection among 
children from developing countries.   
We have examined the utility of qPCR to assess the health implication of EAEC from among 
the diarrhoeal children from The Gambia using observational case-control data. The results 
obtained showed possible inappropriateness of TaqMan qPCR technique to link EAEC to 
diarrhoeal disease. A limitation of this study was our inability to consider using aggR marker 
to run similar assay. Although, this was done during pilot study and the results obtained was 
similar to the result obtained in this study.  
 
 
5.4 Conclusion 
Our study showed importance of EAEC pathotype that causes diarrhoea but has not been 
adequately diagnosed resulting in the under estimating the medical importance of EAEC in 
the region. It is obvious that there is critical relationship between EAEC strains that has 
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unique combination of virulence factors and malnutrition that requires thorough 
investigation. Additionally, further investigation on the host genetic factor interacting with 
EAEC infection will probably explain role of EAEC in malnourished children. Our analysis 
examined the use of qPCR to diagnose EAEC causing MSD in children but the method 
revealed poor sensitivity and specificity. So, it is either that TaqMan-based qPCR is not a 
useful diagnostic tool for the EAEC that cause diarrhoea in children or that the appropriate 
marker gene for the bacterial load approach is yet to be identified. Although we speculate that 
a qPCR assay that targets pet, aap, aatA and aggR to obtain bacterial load result may be 
adequate to confirm infectious EAEC that cause diarrhoea in children who are under 5 years 
old from West-Africa region. Many diagnostic tools have been developed and some are in 
progress yet our current understanding about the diagnosis of EAEC is that non-labour 
intensive diagnostic tool that identifies true infectious EAEC strain remains a challenge 
mainly due to heterogeneity of EAEC strains. Therefore, we recommend further investigation 
for the development of diagnostic tools that distinguish pathogenic EAEC strain from non-
pathogenic EAEC strain. 
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Chapter 6: Biofilm production in EAEC strains from diarrhoeal 
and non-diarrhoeal children    
 
6.1 Introduction 
In E. coli, the formation of a Biofilm requires three major components that include synthesis 
of curli, which allow cells to bind to various kinds of surfaces and to each other (Prigent-
Combaret, Prensier et al. 2000), colanic acid, a viscous capsular exopolysaccharide that 
allows the formation of voluminous biofilms (Danese, Pratt et al. 2000), and type 1 pili which 
are needed for the initial attachment of bacteria to inert surfaces and to other cells (Prigent-
Combaret, Prensier et al. 2000). Pili are proteinaceous appendages on the surfaces of bacteria, 
these structures accomplish adhension by overcoming electrostatic repulsive forces between 
substratum surfaces and the bacterial envelopes (Pratt and Kolter 1998).  
Bacterial biofilms are distinct structures that have mushroom-shaped micro-colonies encased 
in a highly hydrated matrix of exopolymeric substances, polisacharrides and protein that are 
produced by the resident microorganisms, and with flat layers firmly adhered to the surface 
or specific intracellular microcolonies (Busscher, Bos et al. 1995; Garnett and Matthews 
2012) (figure 6.1). The structure is common to many pathogenic bacteria and of huge 
importance for medicine and infectious disease (Goldberg 2002). The transcriptional lacZ 
reporter-gene fussions were used to described first set of specific genes that are involved in 
up or down-regulated in biofilm bacteria (Davies, Chakrabarty et al. 1993), the phenomenon 
that led to the understanding that bacteria attachment initiates the expression of a set of genes 
that culminates in a biofilm phenotype (figure 6.1) (Sauer 2003; Garnett and Matthews 2012). 
During biofilm formation many species of bacteria are able to communicate with one another 
through specific mechanism called quorum sensing, a system of stimulus to co-ordinate 
different gene expression (Garnett and Matthews 2012). Compared with their planktonic 
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(non-adherent) counterparts, biofilm associated cells are characterised by diverse functions 
that include enhanced resistance to conventional biocides or detergents, antimicrobial 
treatment, and host immune defense responses. In addition, a biofilm provides bacterial cells 
with high-osmolarity conditions, oxygen limitations and high cell density (Adamus-Bialek, 
Kubiak et al. 2015). Biofilms have been implicated in the colonisation of different medical 
devices and to be associated to human diseases, such as cystic fibrosis, burn wound infection 
and chronic otitis media with effusion, valve endocarditis (Sauer 2003) and persistent 
diarrhoea caused by Enteroaggregative E. coli (Tokuda, Nishi et al. 2010). It is extremely 
difficult to eradicate biofilms from living host due to its ability to tolerate antimicrobial 
agents within concentration range of 10-1000 times require to kill genetically planktonic 
bacteria and highly resistant to phagocytosis (Lewis 2001). Advances in the genetic and 
molecular basis of bacterial community behaviour can be employed to develop therapeutic 
targets-biofilm as a means to control infection due to formation of biofilm.      
 
Enteroaggregative E. coli (EAEC) has been shown to cause acute and persistent diarrhoeal 
particularly among children from developing countries (Okeke 2009). The strain has been 
implicated in diarrhoeal outbreaks that have resulted in fatal cases in Europe and in Japan 
(Wakimoto, Nishi et al. 2004; Bielaszewska, Mellmann et al. 2011). Diarrhoea caused by 
EAEC is usually watery, and it can be accompanied by mucus and or blood. Colonisation of 
EAEC can occur in the mucosa of both the small and large intestines, which can resulted to 
mild inflammation in the colon (Nataro, Steiner et al. 1998). Biofilms formed by EAEC are 
distinct from biofilms formed by non-pathogenic E. coli in that they can form biofilms in the 
absence of common factors that include flagella, curli and antigen 43 (Ag43) (Sheikh, Hicks 
et al. 2001). EAEC biofilms are encased in a thick mucus layer on the surface of enterocytes 
(Croxen and Finlay 2010). Likewise, EAEC has the capacity to free up itself by penetrating 
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the mucus layer through mucolytic activity of the protein involve in intestinal colonisation 
(pic) a class 1 SPATE family (Gutierrez-Jimenez, Arciniega et al. 2008). A few genes that are 
either plasmid-borne or chromosomal that encode proteins involving in the formation of 
biofilms have been identified and this includes genes that encode a type VI secretion system 
of which detail is unclear (Aschtgen, Bernard et al. 2008).  
Many diagnostic tools have been considered to detect EAEC that cause diarrhoea, but the 
gold standard remains characteristic-phenotypic aggregative adhension that involves the 
formation of a stacked-brick pattern of HEp-2 cells mediated by the genes found on a family 
of virulence plasmids called pAA plasmids. We aim to evaluate qualitative and quantitative 
screening of biofilm to identify EAEC causing diarrhoea among children less than five years 
old in rural Gambia. Few studies have employed phenotypic quantitative screening of biofilm 
to identify EAEC during outbreak of diarrhoea and for epidemiological studies (Wakimoto, 
Nishi et al. 2004; Boisen, Struve et al. 2008). Result from such study showed that quantitative 
of biofilm to identify EAEC causing diarrhoea can be reliable. The technique is very useful 
for direct detection of polysaccharide production as spectrophotometric measurements 
provide quantitative information on the ability of bacterial strains to rapidly grow while 
adhering to the substratum.   
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Figure 6.1: Schematic representation of Biofilm life-cycle: (1) free swimming bacteria (2) 
the bacterial cells adhered reversibly to the surface, at this stage (3) bacteria attachment 
became irreversible, this step is mediated mainly by exopolymeric substance, and the cells 
lose their flagella-driven motility, cells being to divide and the expression of further 
macromolecules allows them to stick together in small micro colonies. (4) These colonies 
grow and secrete a complex mixture of carbohydrates, proteins and lipids that encapsulate the 
bacteria. The biofilm matrix (fuzzy outline) provides protection and stability for the maturing 
biofilm. (5) When the biofilm reaches maturity, a number of factors will have developed a 
heterogeneous arrangement of cells and molecules within the biofilm, and given rise to 
solvent filled cavities and channels. This can result to dispersal of cells from the cellular 
mass. (6) Upon signal from the environment (waste build up or demand for nutrients, for 
example), molecules are released that cause lysis and matrix dissemination. Many planktonic 
cells are now released to find a new habitat. (Adapted from James A. Garnett and Steve 
Mathews 2012 – Interaction in Bacterial Biofilm Development: A structural 
Perspective. Current Protein and Peptide Science, 2012, 13, 739-755) 
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6.2 Results 
Biofilm formation was established using three phenotypic methods of which two were 
qualitative and one quantitative. The two qualitative methods are test-tube and Congo red 
agar (CRA) test (Freeman, Falkiner et al. 1989) whilst the quantitative is tissue culture plate 
(TCP) method (Christensen, Simpson et al. 1985) and all of these methods were described in 
detail in the materials and method section of this thesis (3.16.2, 3.16.3 and 3.16.4). The 
positive (E. coli 042) and control (E. coli HB101) reference bacterial strains were correctly 
identified by the three methods for the presence and absence of biofilm.  
 
Of the 400 EAEC isolates tested for the identification of biofilm, test-tube method detection 
rate was 6.5% (26/400), CRA account for 47% (188/400) and TCP was 54.75% (219/400) 
(table 6.1 & 6.2). In this study we adopted the data generated by the TCP method for all 
analysis relating to biofilm due to its reliability and widely approved screening technique 
although study showed that it has low specificity (Stepanovic, Vukovic et al. 2000). The 
biofilm mean (optical density) OD570nm value for the three positive controls (3.485, 3.697 and 
3.296) EAEC 042 was 3.4926 ±0.2006, whereas the mean OD570nm value for the three 
negative controls (0.5149, 0.5238 and 0.5324) EAEC HB101 was 0.5237±0.0.0087. A cut-off 
OD570 was obtained by taking the average of all the ODs of the negative control EAEC 
HB101 and thrice the value of standard deviation (SD) of the negative control was added to 
it. Therefore the cut-off used was the mean OD570nm (0.5237) of the negative control + (3 x 
0.0087) which, is 0.54. Therefore, EAEC strains are classified biofilm producer if the OD570 
reading was ≥0.54 and EAEC strains are classified non-biofilm producers if the OD570 
readings was ≤0.53. For all the EAEC strains investigated, the OD570nm readings ranged from 
0.2691 to 3.4956.  
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Therefore, result from  data generated by the TCP method showed that , biofilm producing 
EAEC are found more in controls 61% (134/219) compared to cases 39% (85/219) and 
similar proportionate of result 64% (116/181) and 36% (65/181) showed in non-biofilm 
producing EAEC for controls and cases respectively (figure 6.2 A&B) yielded p-value 0.550. 
Similarly, result obtained from sole-EAEC isolates (without co-infection) showed more 
biofilm producing EAEC in controls 69% (66/96) conmpared to cases (31%) (30/96) with 
similar proportional distribution among cases 24% (19/80) and controls 76% (61/80) in sole-
EAEC infection with non-biofilm producing EAEC (figure 6.2 C&D) yielded p-value 0.269.  
We studied the distribution of 21 virulence genes in both the biofilm producing and non-
biofilm producing EAEC isolates among cases and controls and found no evidence of an 
association with severity of diarrhoeal disease (table 6.3). However, further investigation 
revealed weak evidence (p=0.047) of an association between a virulence gene (aatA) and 
biofilm production (Table 6.4). Additionally, we investigated possible association of EAEC 
biofilm producer with virulence genes that have aggR gene in the background, interestingly, 
the result showed aatA, aaP, ORF63 and ORF61 genes to be highly significant among 
diarrhoeal children (table 6.5).  
Also, we performed similar analysis on association of antimicrobial resistance with biofilm 
formed (BF +) and non-biofilm formed (BF-) EAEC strains from diarrhoeal and non-
diarrhoeal children (table 6.6) but there was no evidence of an association. Again, 
comparison analysis of antimicrobial resistance and non-resistance among cases and controls 
between biofilm producing EAEC and non-biofilm producing EAEC were performed. The 
result showed similar distribution pattern of resistance among the resistant and non-resistant 
EAEC in the two groups (figure 6.3A, 6.3B, 6.4A & 6.4B). 
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Table 6.1: Evaluating the use of CRA for biofilm screening tests using TCP as gold standard 
     Congo-Red-
Agar 
Tissue culture plate 
Positive Negative Total % 
Positive 106 113 219 54.75 
Negative 82 99 181 45.25 
Total 188 212 400 100 
Sensitivity = 106/188 x 100 = 556.4%    
Specificity = 99/212 x 100 = 46.7% 
Positive Predictive Value (PPV) is 106/219 x 100 =48%,  
Negative Predictive Value (NPV) is 99/181 x 100 = 55% 
 
 
 
 
 
Table 6.2: Evaluating the use of TT for biofilm screening tests using TCP as gold standard 
Test-Tube Tissue culture plate 
Positive Negative Total % 
Positive 13 206 219 54.75 
Negative 13 168 181 45.25 
Total 26 374 400 100 
Sensitivity = 13/26 x 100 = 50%  
Specificity = 168/374 x 100 = 45% 
Positive Predictive Value (PPV) is 13/219 x 100 = 6% 
Negative Predictive Value (NPV) is 168/181 x 100 = 92% 
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Figure 6.2 (A, B, C and D): Proportional distribution of Biofilm in EAEC strains from cases 
and controls 
 
The statistical strength for both biofilm producing EAEC and non-biofilm producing EAEC 
in both cases and control (A and B) yielded p-value =0.550 which indicates that biofilm 
production were more among controls compared to cases. 
Likewise in both biofilm producing sole EAEC infection and non-biofilm producing sole 
EAEC infection, biofilm iwas produced far more in controls compared to cases (C and D) 
yielded p-value 0.269.      
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Table 6.3: Categigorising biofilm producing EAEC base on the intensity of biofilm produced (n=219) 
Intensity of biofilm 
produced 
Case (n=85) 
n (%) 
Control (n=134) 
n (%)  
P – value   
Strong biofilm produced 39 (46) 65 (49) 0.704  
Moderate biofilm produced 10 (12) 31 (23) 0.035  
Weak biofilm produced 36 (42) 38 (28) 0.032  
 
 
Figure 6.2a: Bimodal distribution of the mean Absorbance 
 
Key: SN – Strong Negative; WN – Weak Negative; WP – Weak Positive; MP – Moderate Positive and  
SP – Strong Positive  
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Table 6.4: Distribution of virulence genes in Biofilm producing and Non-Biofilm Producing 
EAEC strains among Cases and Controls 
Virulence Gene Biofilm Producing EAEC (n=219) Non-Biofilm Producing EAEC (n=181) 
 Case (n=85) 
No. (%) 
Control (n=134) 
No. (%) 
P-value Case (n=65) 
No. (%) 
Control (n=116) 
No. (%) 
P-value 
aatA 34 (40) 47 (35) 0.461 16 (25) 33 (28)  0.577 
aggR 54 (63.5) 89 (66) 0.661 41 (63 69 (59)  0.634 
aaP 44 (52) 69 (51) 0.968 32 (49) 48 (41)  0.307 
orf3 57 (67) 91 (68) 0.895 47 (72) 74 (64)  0.243 
capU 56 (66) 83 (62) 0.554 50 (77) 69 (59) 0.017 
aar 59 (69) 98 (73) 0.551 45 (69) 85 (73) 0.561 
aafC 6 (7) 9 (7) 0.922 1 (1.5) 6 (5)  0.223 
agg3/4C 29 (34) 44 (33) 0.844 26 (40) 48 (41)  0.856 
agg3A 3 (4) 16 (12) 0.031 6 (9) 11 (9)  0.955 
aafA 2 (2) 11 (8) 0.073 1 (1.5) 4 (3.5)  0.451 
aggA 26 (31) 37 (28) 0.635 20 (31) 21 (18)  0.050 
agg4A 6 (7) 6 (4) 0.413 9 (14) 10 (9)  0.271 
astA 50 (59) 65 (49) 0.136 36 (55) 54 (47) 0.254 
sat 17 (20) 28 (21) 0.873 10 (15) 27 (23) 0.206 
sepA 27 (32) 37 (28) 0.510 21 (32) 24 (21)  0.082 
pet 16 (19) 14 (10) 0.078 8 (12) 9 (8)  0.314 
pic 27 (32) 40 (30) 0.764 26 (40) 47 (41)  0.945 
sigA 8 (9) 16 (12) 0.559 9 (14) 13 (11) 0.602 
aaiC 23 (27) 51 (38) 0.093 21 (32) 44 (38) 0.449 
air 27 (32) 31 (23) 0.158 13 (20) 26 (22)  0.704 
eilA 42 (49) 65 (49) 0.896 31 (48) 52 (45)  0.710 
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Table 6.5: Association of virulence factor and the formation of biofilm (BF +) and the non-
formation of biofilm (BF -) among EAEC isolates from diarrhoeal and non-diarrhoeal 
children (n=400) 
Virulence Gene Diarrhoeal Children (n = 150) Non-Diarrhoeal Children (n= 250) 
 BF +  (n=85) 
No. (%) 
BF -  (n=65) 
No. (%) 
P-Value BF +  (n=134) 
No. (%) 
BF -  (n=116) 
No. (%) 
P-Value 
aatA 34 (40) 16 (24.6) 0.047 47  (35) 33 (28) 0.262 
aggR 54 (63.5) 41 (63) 0.954 89 (66) 69 (59) 0.256 
aaP 44 (51.8) 32 (49) 0.758 69 (51) 48 (41) 0.110 
orf3 57 (67) 47 (72) 0.489 91 (68) 74 (64) 0.493 
capU 56 (65.9) 50 (76.9) 0.141 83 (62) 69 (59) 0.691 
aar 59 (69) 45 (69) 0.980 98 (73) 85 (73) 0.979 
aafC 6 (7) 1 (2) 0.112 9 (6.7) 6 (5) 0.608 
agg3/4C 29 (34) 26 (40) 0.458 44 (32.8) 48 (41) 0.162 
agg3A 3 (3.5) 6 (9) 0.145 16 (12) 11 (9.5) 0.532 
aafA 2 (2) 1 (1.5) 0.724 11 (8) 4 (3.5) 0.113 
aggA 26 (31) 20 (31) 0.980 37 (27.6) 21 (18) 0.075 
agg4A 6 (7) 9 (13.9) 0.169 6 (4.5) 10 (8.6) 0.181 
astA 50 (59) 36 (55) 0.673 65 (48.5) 54 (46.6) 0.757 
sat 17 (20) 10 (15) 0.465 28 (21) 27 (23) 0.650 
sepA 27 (32) 21 (32) 0.943 37 (27.6) 24 (20.7) 0.203 
pet 16 (19) 8 (12) 0.280 14 (10.5) 9 (7.8) 0.463 
pic 27 (31.8) 26 (40) 0.295 40 (30) 47 (40.5) 0,077 
sigA 8 (9) 9 (13.9) 0.395 16 (12) 13 (11) 0.856 
aaiC 23 (27) 21 (32) 0.484 51 (38) 44 (38) 0.983 
air 27 (32) 13 (20) 0.106 31 (23) 26  (22) 0.892 
eilA 42 (49) 31 (48) 0.834 65 (48.5) 52 (44.8) 0.560 
After adjusting for multiple testing using Bonferroni method (0.05/21) that resulted in cut of 
P-value 0.002, only aafC gene was found to be associated with diarrhoea in the presence of 
biofilm production. BF+ (Biofilm present) and BF- (Biofilm absent). 
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Table 6.6: Association of EAEC biofilm producer and diarrhoea with virulence genes having 
AggR in the background 
Virulence 
genes 
Diarrhoeal Children (n = 85) Non-Diarrhoeal Children (n= 134) 
BF + / aggR+  
(n=54) 
No. (%) 
BF + / aggR-  
(n=31) 
No. (%) 
P-Value BF +  / aggR+ 
(n=89) 
No. (%) 
BF + / aggR-   
(n=45) 
No. (%) 
P-Value 
aatA 31 (57) 3 (10) <0.001 43 (48) 17 (38) 0.246 
aap 39 (72) 8 (26) <0.001 60 (67) 21 (47) 0.020 
orf3 48 (89) 14 (45) <0.001 74 (83) 31 (69) 0.058 
capU 38 (70) 18 (58) 0.249 58 (65) 25 (56) 0.279 
orf61 41 (76) 13 (42) 0.001 68 (76) 28 (62) 0.085 
aafC 2 (4) 4 (13) 0.110 6 (7) 3 (7) 0.986 
agg3/4C 20 (37) 9 (29) 0.453 31 (35) 13 (29) 0.489 
agg3A 3 (6) 0 (0) 0.181 13 (15) 3 (7) 0.180 
aafA 1 (2) 1 (3) 0.687 10 (11) 1 (2) 0.072 
aggA 21 (39) 5 (16) 0.028 29 (33) 8 (18) 0.070 
agg4A 4 (7) 2 (6) 0.868 5 (6) 1 (2) 0.369 
astA 30 (56) 10 (32) 0.038 47 (53) 18 (40) 0.161 
sat 13 (24) 4 (13) 0.215 15 (17) 13 (30) 0.105 
sepA 24 (44) 6 (19) 0.019 32 (36) 5 (11) 0.002 
pet 11 (20) 5 (16) 0.630 11 (12) 3 (7) 0.308 
pic 18 (33) 9 (29) 0.681 30 (34)   10 (22) 0.170 
sigA 6 (11) 2 (6) 0.478 12 (13) 4 (9) 0.438 
aaiC 17 (31) 6 (19) 0.225 38 (43) 13 (29) 0.120 
air 17 (31) 10 (32) 0.940 22 (25) 9 (20) 0.540 
eilA 22 (41) 20 (65) 0.034 37 (42) 28 (62) 0.023 
Note: In order to adjust for multiple testing Bonferronni method was applied to obtain a cut 
off p-value (0.05/20) 0.0025. Thus, four virulent genes that include aatA, aap, orf3 and orf61 
were found to be statistically associated with diarrhoea in the presence of biofilm production 
and aggR in the background. aggR+ (aggR present) and aggR- (aggR absent); BF+ (Biofilm 
present) and BF- (Biofilm absent). 
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Table 6.7: Association of Antimicrobial resistance and the biofilm formation (BF +) and the 
non-biofilm formation (BF-) from diarrhoeal and non-diarrhoeal children (n=400) 
Antibiotics Diarrhoeal Children (n=150) Non-diarrhoeal Children (n=250) 
Resistance BF+  (n=85) 
No. (%) 
Resistance BF- (n=65) 
No. (%) 
Resistance BF+ (n=134) 
No. (%) 
Resistance BF- (n=116) 
No. (%) 
Ampicillin 70 (82) 54 (83) 94 (70) 87 (75) 
Amoxicillin/Clav 5 (6) 4 (6) 6 (4.5) 6 (5) 
Chloramphenicol 23 (27) 15 (23) 25 (19) 30 (26) 
Ciprofloxacin 0 (0) 0 (0) 1 (1) 3 (2.6) 
Gentamicin 2 (2) 1 (1.5) 2 (1.5) 1 (0.8) 
Ceftriaxone 2 (2) 0 (0) 2 (1.5) 2 (1.7) 
Cefotaxime 3 (4) 2 (3) 3 (2) 1 (0.8) 
Ceftazidime 3 (4) 0 (0) 3 (2) 3 (2.6) 
Co-Trimoxazole 74 (87) 55 (85) 109 (81) 91 (78.4) 
Tetracyline 64 (75) 49 (75) 89 (66) 89 (76.7) 
 
The above table 6.6 showed equal distribution of antibiotic resistance among biofilm 
producing and non-biofilm producing diarrhoeal children. There was no distinct evidence of 
biofilm formation limiting effect of at least six antibiotics such as amoxicillin-clavulanic 
acid, ciprofloxacin, gentamycin, ceftriaxone, cefotaxime and ceftazidime against the EAEC 
strains.    
 
 
 
 
 
 
191 
 
Figure 6.3 (A & B): Comparison of Antibiotic resistance pattern of biofilm producing- EAEC 
between cases and controls (n=219) 
 
 
Key: Amp –Ampicillin, Amx-Clav – Amoxacillin-Clavulanic acid, CHL – Chloramphenicol,                      
CIP – Ciprofloxacin, CN – Gentamicin, CRO – Ceftriaxone, CTX – Cefotaxime, CZ – 
Ceftazidime,        SXT – Co-Trimoxazole and TET – Tetracycline  
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Figure 6.4 (A & B): Comparison of Antibiotic resistance pattern of non-biofilm producing 
EAEC between cases and controls (n=181) 
 
 
Key: Amp –Ampicillin, Amx-Clav – Amoxacillin-Clavulanic acid, CHL – Chloramphenicol,                      
CIP – Ciprofloxacin, CN – Gentamicin, CRO – Ceftriaxone, CTX – Cefotaxime, CZ – 
Ceftazidime,        SXT – Co-Trimoxazole and TET – Tetracycline  
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6.3 Discussion 
An important characteristic of EAEC strains is adherence to small and large intestinal 
mucosal surfaces in a thick aggregating biofilm (Nataro, Hicks et al. 1996). The ability of 
EAEC to form biofilms helps the strain to survive within the mucus layer, consequently 
colonise the host by evading host immune apparatus, presenting a barrier to the host 
antibacterial factors and hinders therapeutic agents to reach target (Torres, Zhou et al. 2005). 
EAEC producing biofilms often contribute to mucoid stool, malnutrition and persistent 
colonisation with prolong diarrhoea mostly among children from low income countries, 
(Kaur, Chakraborti et al. 2010). The goal of this investigation was to determine the 
prevalence of EAEC producing biofilm and association of various EAEC virulence factors 
with biofilm production among EAEC strains obtained from diarrhoeal and non diarrhoeal 
children from rural Gambia.  Many studies have shown the importance of biofilm production 
by EAEC as a diagnostic tool to screen EAEC pathotypes causing diarrhoea illness 
(Wakimoto, Nishi et al. 2004; Mohamed, Huang et al. 2007). In this study, three detection 
methods that include test-tube (TT), Congo-red agar (CRA) and tissue culture plate (TCP) 
were used. The CRA and TT methods were evaluated using tissue culture plate method as 
gold standard considering its high sensitivity and specificity in previous studies (Wakimoto, 
Nishi et al. 2004; Bangar and Mamatha 2007; Hassan, Usman et al. 2011). Using the total 
number of EAEC that formed biofilm as denominator we obtained TT positive rate 12% 
(26/219) and CRA 86% (188/219). Because of the high rate (86%) for CRA, the result 
demonstrates usefulness of CRA in screening EAEC for the production of biofilm. However, 
when the evaluation was carried out using measures of diagnostic test of accuracy the results 
showed the CRA sensitivity 56.4% and specificity 46.7%, result for TT showed sensitivity 
50% and specificity 45%. Thus, results for the CRA and TT suggest that the two methods 
may not be appropriate to screen for biofilm in EAEC isolates. One of the studies that 
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evaluates different detection methods of biofilm among clinical isolates recommended TCP 
over TT and CRA due to its reliability and sensitivity (Hassan, Usman et al. 2011). However, 
some previous studies have shown high sensitivity and specificity of CRA and TT to detect 
biofilm among enterobacteriacae that include E. coli isolates implicated in the catheter 
associated urinary tract infectios (Dadawala 2010; Niveditha, Pramodhini et al. 2012). 
Additionally, studies have demonstrated high detection rate of biofilm in Staphylococcus 
species using CRA and TT methods with high sensitivity and specificity rate (Oliveira and 
Cunha Mde 2010). However, studies looking at formation of biofilm in EAEC from cases and 
controls using phenotypic screening assay were scarce.  Overall, results from the present 
study showed higher rate of EAEC forming biofilm accounting for 54.75% (219/400) 
compared to non-Biofilm EAEC 45.25% (181/400). Interestingly, also the result revealed that 
biofilm-EAEC in healthy control account for 61% (134/400) compared to cases 39% 
(85/400). These proportional differences were consistent in all the three methods used. In this 
study, we plot a graph to demonstrate biamudal distribution of absorbance readings of 
concentration of biofilm produced by EAEC isolates. The graph showed the order of 
abscence to presence of biofilm with steady increase in concentration (figure 6.2a). 
Several studies have employed the use of multiplex PCR to detect many virulence genes in E. 
coli isolates to identify EAEC strains (Cerna, Nataro et al. 2003; Boisen, Scheutz et al. 2012; 
Ikumapayi, Boisen et al. 2017). The role of some of these virulence genes in the formation of 
biofilm in EAEC strains have been elucidated (Sheikh, Czeczulin et al. 2002; Boisen, Struve 
et al. 2008), these studies found that the fimbrial adhesion AAF/II that encodes aafA gene is 
required for formation of stable biofilms and in that same study fis and yafK were found to 
have the capacity to activate biofilm formation by regulating the transcription of the AAF/II 
biogenesis and activator aggR (Sheikh, Czeczulin et al. 2002). AggR is considered a global 
regulon for EAEC virulence genes that include aatA and aap that play important role in the 
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formation of biofilms (Boisen, Struve et al. 2008) and Dispersin, encoded by aap speculated 
to counteract aggregation mediated by AAFs to form biofilms (Sheikh, Hicks et al. 2001). 
Surprisingly however, the fact was that there was no statistical significant difference in the 
distribution of 21 virulence genes in Biofilm producing and Non-Biofilm Producing EAEC 
strains among Cases and Controls (table 6.3). This outcome suggest that biofilm formation 
among EAEC strains is a common phenomenon irrespective of whether the EAEC infected 
children from this region became symptomatic or remain healthy. Our this observation was 
contrary to previous study (Mohamed, Huang et al. 2007) and the reason for this outcome is 
unclear but could be due to singly studying the distribution of genes rather than study the 
combination of genes. One particular study has demonstrated the incidence of aatA in 
biofilm-EAEC strains and was found in all the EAEC strains that strongly produced biofilm 
of OD570nm  >0.2 in that study (Wakimoto et al. 2004) but this did not corroborate with the 
findings from our study. However, interesting results from this study was that some virulence 
genes that have aggR in the background together with the formation of biofilm showed strong 
association with diarrhoea (table 6.5). The virulence genes involved are aatA p-value <0.001, 
aap p-value <0.001, orf3 p-value <0.001 and orf61 p-value 0.00172. This significant outcome 
suggests that biofilm-produced by typical-EAEC (EAEC with aggR) combined with one or 
more of its regulatory genes are likely to be more virulent compared to the biofilm-produced 
by atypical-EAEC (EAEC without aggR). These unusual findings were also reported in a 
similar study that showed significant association of in vitro production of biofilms from 
EAEC isolates with aggR and its regulated genes that include astA, pet, aap, irp2, and set1A 
in the background, although the EAEC isolates in that study were obtained from travellers 
(with or without diarrhoea) to EAEC endemic region (Mohamed, Huang et al. 2007). Thus, it 
is tempting to speculate that the presence of biofilm by typical EAEC indicates a functional 
aggR gene. The limitation of this study is our inability to utilise PCR method to detect genes 
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that are soley responsible for the expression of biofilm in EAEC strain to serve as gold 
standard method.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
This study further examined the effect of biofilm production on the antimicrobial resistance 
pattern among diarrhoeal and non-diarrhoeal children but the result showed no significance 
difference among the two groups Table 6.6). Similar distributions were observed when we 
compared antibiotic resistance pattern in biofilm producing-EAEC and non-biofilm 
producing- EAEC between cases and controls (figure 6.3A, 6.3B, 6.4A and 6.4B). There was 
a huge proportional resistance of ≥75% observed against Ampicillin, Tetracycline and 
Sulphamethoxazole-trimethoprim which proven the presence of antimicrobial-resistant-
EAEC strains circulating in the community. There are limited investigations that have 
specifically shown antibiotic resistance distribution among biofilm and non-biofilm 
producing EAEC strains to compare our finding against. However, studies have demonstrated 
biofilm and non-biofilm producing urinary E. coli been 100% resistant against Ampicillin 
and 90% against Sulphamethoxazole-trimethoprim (Hassan, Usman et al. 2011). Also, 
another biofilm producing E. coli study showed resistance against Sulphamethoxazole-
trimethoprim 83% and Tetracycline 75% (Ponnusamy, Natarajan et al. 2012). These even 
distributions of antibiotic resistance among biofilm and non-biofilm producing E. coli 
corroborate our findings. However, Hassan et al study has shown ciprofloxacin to be 95% 
resistant in biofilm producing E. coli compared to 50% resistant in non-biofilm producing E. 
coli. Likewise Asian biofilm producing E. coli study showed 100% resistance against 
Chloramphenicol and Amoxyclav (Amoxicillin-clavulanic acid), 86% against Gentamicin 
and Cefotaxime, and 84% against Ceftazidim  (Ponnusamy, Natarajan et al. 2012). These 
studies report demonstrated effect of biofilm production by uropathogenic E. coli against the 
antibiotics therapeutic action. This disproportional rate of resistance among biofilm 
producing and non-biofilm producing E. coli is not seen in our study. Although our current 
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study focuses on EAEC strains obtained from children less than 5 years old, besides, many 
studies from both developed and low-income countries have corroborated our findings by 
reporting that EAEC strains to be multidrug resistance mostly against Ampicillin, 
Sulphamethoxazole-trimetprime and Tetracycline (Kahali, Sarkar et al. 2004; Nguyen, Le 
Van et al. 2005; Aslani, Alikhani et al. 2011; Ali, Ahmed et al. 2014; Davoodabadi, 
Abbaszadeh et al. 2015; Hebbelstrup Jensen, Roser et al. 2016). Therefore, mechanisms of 
spread of EAEC-antibiotic resistant strain need to be well understood so that measures to 
deaccelerate the dissemination of the resistant strains are established and implemented. 
   
6.4 Conclusion 
The current study has demonstrated that TCP is probably the method of choice when 
screening for bacterial biofilm in epidemiologic samples. Also, the study showed that biofilm 
producing and non-biofilm producing EAEC is common among both diarrhoeal and non-
diarrhoeal children, and that this study discovered that biofilm producing EAEC were found 
more among non-diarrhoeal children compared to diarrhoeal children.  However, in vitro 
production of biofilm EAEC isolates that have aggR with one or more of its genes (aatA, 
aap, orf3 and orf61) that it regulates  in the background are associated with moderate to 
severe diarrhoeal children. Additionally, the study highlight even distribution of antimicrobial 
resistance among biofilm and non-biofilm producing EAEC isolates from both cases and 
controls which suggest that biofilm production may not always be responsible for the spread 
EAEC resistance against the three antibiotics that include Ampicillin, Tetracycline and 
Sulphamethoxazole-trimethoprim.  
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Chapter 7: Antibiotic resistance patterns of EAEC strains from 
diarrhoeal and non-diarrhoeal children from rural Gambia 
 
7.1 Introduction 
Antibiotics, which literarily means „against life,‟ are recognised as great warriors of modern 
medicines. These drugs have helped treated and cured infections that have threatened human 
life throughout history. The global beneficial effect of the advent of antibiotics is immense 
and well applauded. In developing countries where sanitation is critical, antibiotics have 
reduced morbidity and mortality caused by food-borne and other poverty related infections 
(CRSR 2005). Thus, the last century saw a stunning swing in human fortunes against 
bacteria. Humans have used antimicrobials often inappropriately, such as for promoting 
weight gain in farm animals leading to immense selective pressures.  A bacterium that 
develops a point mutation which impacts resistance or the incorporation of a mobile genetic 
element which provides a resistance gene will have a clear edge over its susceptible peers in 
the presence of antibiotic. Indeed, this is survival of the fittest. Many studies have performed 
antibiotic susceptibility testing on bacterial strains belonging to enterobacteriacae family 
(Aslani, Alikhani et al. 2011) particularly on urinary gram-negative rods commonly referred 
to as coliforms that include the well known E. coli pathotype Uropathogenic E. coli (UPEC). 
However, our knowledge of the antibiotic resistant patterns of diarrhoegenic E. coli (DEC) is 
limited and variable. 
Therefore, this chapter is set to study the antibiotic resistance patterns of EAEC strains from 
diarrhoeal and non-diarrhoeal children in order to elucidate our understanding on the 
magnitude of the cases of multidrug-resistant-EAEC strains associated to diarrhoea among 
children in the rural Gambia and the likely risk factors that contribute to the spread.   
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EAEC strains are recognised cause of diarrhoeal disease in developed as well as developing 
countries (Okeke 2009). Currently, EAEC has been associated with a wide range of 
diarrhoeal syndrome that include watery to invasive diarrhoea that can be acute or persistent 
(Nataro 2011). The strains can be recovered from symptomatic and asymptomatic individuals 
even among younger children in developing countries (Kotloff, Nataro et al. 2013). This 
likely explains the strain heterogeneity and role variation of host genetic factor, thus, some 
carrier become reservoir for the EAEC strain that can cause disease in more susceptible 
persons. At present, human is the only known reservoir for EAEC as other implicated risk 
factors such as animal have not been substantiated. The emergence and maintenance of 
diarrhoea caused by multidrug-resistant pathogenic bacteria have become significant public 
health problems that often results to increased morbidity, high mortality and huge health care 
costs due to treatment failures and longer hospital stays (Cho, Lim et al. 2011). Furthermore, 
global dissemination of plasmid-borne extended-spectrum Beta-lactamases (ESBLs) among 
enterobactraecae particularly E. coli is of huge concern (Imuta, Ooka et al. 2016). EAEC 
resistance to antimicrobial agents has been demonstrated in some part of the world 
(Hebbelstrup Jensen, Olsen et al. 2014) but little is known about pattern of EAEC resistance 
to antibiotic among children in sub-Sahara Africa. Heterogeneity, characteristics of the strain 
make the development of vaccine difficult. Hence, antibiotic likely remains useful therapeutic 
agent to treat persistent as well as acute diarrhoea caused by enteric bacterial pathogens that 
include EAEC.  
The aim of this study is to investigate the prevalence of antibiotic resistance in EAEC strains 
from under five year old diarrhoeal and non-diarrhoeal children to investigate possible 
association of antibiotic-resistant-EAEC strains to diarrhoeal disease. Additionally, we 
investigated risk factors such as virulence genes and backyard animals that may contribute to 
the spread of antibiotic-resistant-EAEC among children in rural setting.  
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7.2 Results 
In this study minimum inhibitory concentration (MIC) e-test method was performed on 20 
(5%) of the 400 EAEC isolates using available e-test strips of eight different antibiotics 
which include Ampicillin, Sulfamethaxazole-Trimethoprim, Chloramphenicol, Ciprofloxacin, 
Ceftaxime, Ceftazidime, Gentimacin and Tetracycline. Also, disk diffusion method was 
performed on the 400 EAEC isolates that include the 20 EAEC isolates MIC e-test was 
performed. The antibiotic sensitivity results obtained from the two methods had 100% 
concordance (Table 7.1a).  
The outcome of antimicrobial resistance patterns performed using ten antibiotics against each 
of 400 EAEC strains that constitute 150 (37.5%) diarrhoeal and 250 (62.5%) non-diarrhoeal 
children showed almost equal distribution among the two groups. Although high rate of 
resistance to Ampicillin, Sulphamethoxazole-Trimethoprim and Tetracycline were observed 
in both diarrhoeal and non-diarrhoeal groups, and the Ampicillin resistance showed moderate 
association to MSD (p-value 0.019), while Sulphamethoxazol-trimethoprim and Tetracycline 
had p-value 0.128 and p-value 0.368 respectively (Table 7.1).   
The rate of multidrug-resistant EAEC to two or more antibiotics is very high in all study 
children account for 90% and 83% in cases and controls respectively (figure 7.1). The 
proportionate grading for categories of drug resistance (DR) EAEC strains ranging from 0DR 
to 5DR, revealed the category of 3DR EAEC strain that account for 48% MSD and 41% non-
MSD children, whilst 0DR, 1DR and 5DR were less than 10% in both MSD and non-MSD 
(figure 7.2). 
Investigation of resistant patterns of the ten antibiotics among cases and controls of two age 
strata 0-11 month and 12-59 month showed similar distribution patterns among the two 
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groups except for Ampicillin (p-value 0.037) and Amoxicillin-clavulanic acid (P-value 0.051) 
in cases and controls of age stratum 0-11 months (Table 7.2).  
Two categories of MDR that involved ≥2MDR and ≤1DR were studied against three age 
strata 0-11, 12-23 and 24-59 month. The result showed strong evidence (p-value 0.0009) of 
association between ≥2MDR and age stratum 0-11month and there was steady decline of 
significance towards older age groups 12-23 and 24-59 months (table 7.3).  
The analysis of two categories of MDR (≤1DR and ≥2MDR) against six age strata of study 
children further revealed the age stratum that harboured the highest rate of ≥2MDR which 
was age 7-11 months (36%) and highest rate of ≤1MDR was in 18-23 months (34%) (figure 
7.3). Further analysis revealed comparison margin between ≥2MDR and ≤1DR within age 
stratum 7-11 month yielded p-value 0.010. The analysis of ≥2MDR that focuses on the six 
age strata of MSD children alone maintain age stratum 7-11 month harbouring the highest 
rate ≥2MDR at 39% followed by age stratum 3-6 months at 20% while the rest age strata 0-2, 
12-17, 18-23 and 24-59 harbours 1%, 16%, 19% and 5% respectively (figure 7.4). 
Further analysis of five categories of MDR EAEC strains that includes 0DR, 1MDR, 2MDR, 
3MDR, and ≥4MDR against the six age strata of all study children was performed. The 
frequency value obtained clearly showed that 3MDR EAEC strains was the most common 
that account for 70 and more concentrated in the age stratum 7-11 months, followed by 
2MDR, ≥4MDR, 1DR and 0MDR which account for 28, 26, 7 and 4 respectively (figure 7.5). 
Interestingly, similar pattern of distribution were obtained for analysis focusing on MSD 
children (figure 7.6) and non-MSD children (figure 7.7).     
Of the twenty-one virulence genes investigated against MDR only two showed evidence of 
association with MDR and these are agg3A and sepA genes (table 7.4). However, further 
analysis on the association of virulent genes with MDR revealed that combination of 2, 3 and 
202 
 
or 4 virulence genes were significantly associated with multiple drug-resistant. Hence, 
combination of virulent genes pic+sepA (P+S) showed over 40% association with ≥4MDR, 
while combination of genes aatA+Pet (A+P), aatA+aggR+Pet (A+A+P), aatA+Pet+aggA 
(A+P+A) and aatA+Pet+aggR+aggA (A+P+A+A) were associated with 3MDR in the 
proportion 50%, 60%, 60% and 75% respectively (figure 7.8).  
Investigation on the likelihood of animals as risk factor for the spread of MDR exonerate 
most animals that include goat, sheep, dog, cat, cow, rodent and fowl. Whilst donkey and 
horses are considered possible risk factors (Table 7.5) 
There are six villages where the study participants were recruited. These villages were 
analysed against MDR in order to establish whether any of the villages contribute to the 
spread of multi-resistant EAEC strains by harbouring high rate of study participants with 
≥2MDR. The result showed no evidence of association with spread of MDR-EAEC in all of 
the six villages in the study (table 7.6). 
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Table 7.1a: Comparing antibiotic sensitivity results from disk diffusion and MIC E-test methods 
SID 
Ampicillin Ciprofloxac Cefotaxime Chloramph Gentamicin Trim-Sulfam Tetracyclin Ceftazidime 
MIC           
E-test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
MIC           
E-
test 
Disk 
diffusion  
100041 R R S S S S S S S S R R R R S S 
100055 I I S S S S S S S S R R R R S S 
100096 S S S S S S S S S S S S S S S S 
100103 I I S S S S S S S S R R R R S S 
100107 R R S S S S R R S S R R R R S S 
100138 S S S S S S S S S S S S S S S S 
100161 R R S S S S S S R R R R R R S S 
100245 I I S S S S S S S S S S S S S S 
100404 S S S S S S S S S S S S S S S S 
100715 S S S S S S S S S S S S S S S S 
100716 R R S S I I S S S S S S R R S S 
100722 S S S S S S S S S S S S S S S S 
102274 S S S S S S S S S S S S S S S S 
102602 S S S S S S S S S S S S S S S S 
102866 R R S S S S S S S S R R R R S S 
102871 S S S S S S S S S S S S S S S S 
103069 S S S S S S S S S S R R S S S S 
103070 S S S S S S S S S S S S S S S S 
103240 R R S S S S S S S S R R R R S S 
103446 S S S S S S S S S S S S S S S S 
ATCC25922 S S S S S S S S S S S S S S S S 
ATCC25923 S S S S S S S S S S S S S S S S 
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Table 7.1b: Antimicrobial resistance patterns of EAEC strains from diarrhoeal and non-
diarrhoeal children 
 
Antimicrobial agent 
 
Concentration 
in µg 
Diarrhoeal 
children (n = 150) 
Non-Diarrhoeal 
children (n = 250) 
 
Odd Ratio 
 
P-Value 
Resistance 
n (%) 
Resistance 
n (%) 
Ampicillin* 10µg 124(83) 181 (72) 1.81 0.019 
Amox-Clav 30µg 9(6) 12 (5) 1.26 0.602 
Cefotaxime 30µg 5 (3) 4 (2) 2.12 0.257 
Ceftazidime 30µg 3 (2) 6(2.4) 0.82 0.793 
Ceftriaxone 30µg 2 (1) 4 (2) 0.83 0.831 
Chloramphenicol 30µg 38 (25) 55 (22)  1.20 0.444 
Ciprofloxacin 5µg 0(0) 4 (2) 0.00 0.119 
Gentamicin 10µg 3 (2) 3(1) 1.68 0.523 
Sulphamethoxazole-
Trimethoprim* 
25µg 129 (86) 200 (80)  1.54 0.128 
Tetracycline* 30µg 113 (75) 178 (71)  1.3 0.368 
The EAEC resistance patterns against the ten antibiotics are almost equally distributed 
between diarrhoeal and non-diarrhoeal children with the high rate of resistance attributed to 
three antibiotics that include Ampicillin, Cotrimoxazole-trimethoprim and Tetracycline in the 
two groups. 
 
Figure 7.1: Distribution of Multi-Drug-Resistant EAEC strains from case and control 
 
Multiple drug resistance of two or more antibiotics is exceptionally high in all study children 
account for 90% and 83% in cases and controls respectively 
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Figure 7.2: Antibiotic multi-resistance patterns of EAEC strains from MSD and non-MSD 
children 
 
The 0, 1 and 5 drug resistance (DR) were less than 10% in both MSD and non-MSD. 
However, three drug resistant (3DR) was proportionately higher 48% in MSD compared to 
41% in non-MSD. There are no multi-drug resistance of six or more antibiotics observed.  
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Table 7.2: Antibiotic Resistant Pattern of EAEC strains from two age strata diarrhoeal and 
non-diarrhoeal children 
 
Antimicrobial 
agent 
Resistant in age 0-11 month (n = 205) Resistant in age 12-59 month (n =195) 
Case (n=83)        
n (%) 
Control (n=122)     
n (%) 
P - value Case (n=67)       
n (%) 
Control (n=128)       
n (%) 
P - value 
Ampicillin 75 (90.4) 97 (79.5) 0.037 49 (73.1) 84 (65.6) 0.284 
Amoxicillin-
Clavulanic Acid 
7 (8.4) 3 (2.5) 0.051 2 (3.0) 9 (7.0) 0.244 
Cefotaxime 4 (4.8) 4 (3.3) 0.576   1 (1.5) 0 (0) -- 
Ceftazidime 3 (3.6) 5 (4.1) 0.860 0 (0) 1 (0.8) -- 
Ceftriaxone 2 (2.4) 4 (3.8) 0.717 0 (0) 0 (0) --- 
Chloramphenicol 22 (26.5) 28 (23.0) 0.560 16 (23.9) 27 (21.1) 0.655 
Ciprofloxacin 0 (0) 2 (2.0) -- 0 (0) 2 (1.6) --- 
Gentamicin 1 (1.2) 2 (1.6) 0.799 2 (3.0) 1 (0.8) 0.235 
Sulphamethoxazole-
Trimethoprim 
76 (92.0) 101 (83.0) 0.072 53 (79.1) 99 (77.3) 0.778 
Tetracycline 66 (79.5) 92 (75.4) 0.492 47 (70.2) 86 (67.2) 0.673 
The resistance patterns of the EAEC strains to the ten antibiotics in the two age strata (0-11 
months and 12-59 months) of unmatched case and control children were almost equally 
distributed. After adjusting for multiple testing (Bonferronni method) resistant to all of the 
ten antibiotics were not statistically significant between the case and control group in the two 
age strata. In the age strata 0-11 and 12-59 months the cut off p-value was (0.05/9) 0.0056 
and (0.05/6) 0.0083 respectively 
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Table 7.3: Distribution of MDR EAEC strains among three age strata of study children  
Age in Month ≥2 MDR (n=342) ≤1DR (n=58) Odd Ratio P - value 
0-11 189 (55.26) 16 (27.59) 3.24 0.00009 
12-23 123 (35.96) 30 (51.72) 0.52 0.022 
24-59 30 (8.77) 12 (20.69) 0.36 0.006 
 
 
 
 
Figure 7.3: Proportional distribution of MDR EAEC strains among age strata of study 
children (MSD and non-MSD combined) 
 
Figure 7.4: Rate of multi-drug-resistance in six age strata of study children revealed the age 
stratum 7-11 month that MDR is most common and there was some evidence (p-value 0.01) 
of a difference in resistance between ≥2MDR and ≤1DR. Similar finding was seen in figure 
7.5 that is specific for only MSD children where sole ≥2MDR was investigated.  
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Figure 7.4: Proportional distribution of MDR-EAEC strains among age strata of MSD 
children only 
 
It is obvious that two or more antibiotics are been resistant against by the EAEC isolates and the 
children most vulnerable are those within the age 7-11 month old.  
 
 
 
Figure 7.5: Distribution of MDR EAEC among MSD and non-MSD study children 
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Figure 7.6: Distribution of MDR EAEC among MSD children  
 
 
Figure 7.7: Distribution of MDR EAEC among non-MSD children 
 
Figure 7.6, 7.7 and 7.8 showed the patterns of different categories of MDR among six age strata. 
Result obtained for the figure 7.6 that combined data for both MSD and non-MSD, figure 7.7 MSD only and 
figure 7.8 non-MSD only showed similar patterns of multi-drug-resistance in the six age strata with age stratum 
7-11 month showing highest for 3MDR, 2MDR and ≥4MDR. 
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Table 7.4: Association between Multidrug resistant EAEC strains and the corresponding 
virulence factors 
Virulence factor ≥2 MDR (n=342) ≤1 MDR (n=58) Odd Ratio P-value 
aatA 115 (33.63) 15 (25.86) 1.45 0.243 
aggR 219 (64.04) 34 (58.62) 1.26 0.429 
aaP 166 (48.54) 27 (46.55) 1.08 0.779 
ORF3 235 (68.71) 34 (58.62) 1.55 0.129 
capU 223 (65.20) 35 (60.34) 1.23 0.474 
aar 248 (72.51) 39 (67.24) 1.29 0.409 
aafC 19 (5.56) 3 (5.17) 1.08 0.905 
agg3/4C 132 (38.60) 15 (25.86) 1.80 0.062 
agg3A 35 (10.23) 1 (1.72) 6.49 0.036 
aafA 16 (4.68) 2 (3.45) 1.37 0.676 
aggA 86 (25.15) 18 (31.03) 0.74 0.344 
agg4A 28 (8.19) 3 (5.17) 1.63 0.427 
astA 174 (50.88) 31 (53.45) 0.90 0.717 
sat 73 (21.35) 9 (15.52) 1.47 0.309 
sepA 100 (29.24) 9 (15.52) 2.24 0.029 
pet 38 (11.11) 9 (15.52) 0.68 0.335 
pic 123 (35.96) 17 (29.31) 1.35 0.325 
sigA 37 (10.82) 9 (15.52) 0.66 0.299 
aaiC 125 (36.55) 14 (24.14) 1.81 0.066 
air 86 (25.15) 11 (18.97) 1.43 0.309 
eilA 156 (45.61) 34 (58.62) 0.59 0.066 
All of the 21 virulence genes studied were found not to be associated with MDR following 
adjustment for multiple testing (Bonferroni method) that resulted in cut off p-value (0.05/21) 
0.002  
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Figure 7.8: Association of class II (pic & sepA) SPATE proteins and other specific gene 
combination with multi-drug-resistant EAEC strains 
Key: (Pi+S) – Pic + SepA, A+P – aatA + Pet, A+A+P – aatA+aggR+Pet, A+P+A – 
aatA+Pet+aggA and A+P+A+A – aatA+Pet+aggR+aggA. Observation showed specific gene 
combination resulting into more MDR EAEC.  
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Table 7.5: Association of animals as risk factors for multidrug resistant EAEC strains from 
children 
Animals Multidrug Resistant EAEC strains 
≥2 MDR (n=342) 
No. (%) 
≤1 MDR (n=58) 
No. (%) 
OR P-value 
Goat 263 (76.90) 45 (77.59) 0.96 0.908 
Sheep 255 (74.56) 42 (72.41) 1.11 0.729 
Dog 90 (26.32) 20 (34.48) 0.67 0.197  
Cat 59 (17.25) 11 (34.48) 0.39 0.002 
Cow 83 (24.27) 13 (22.41) 1.10 0.759 
Rodent 245 (71.64) 39 (67.24) 1.23 0.495 
Fowl 303 (88.60) 54 (93.10) 0.57 0.305 
Donkey 178 (52.05) 21 (36.21) 1.91 0.025 
Horse 113 (33.04) 10 (17.24) 2.36 0.015 
After adjusting for multiple testing all the nine animals in the table 7.5 were not implicated as 
part of risk factors for the spread of MDR EAEC in human.  The cut off p-value was (0.05/9) 
0.0056 
 
 
Table 7.6: Multidrug Resistance Patterns among study participant‟s recruitment zones 
(villages) 
Zone (Village) Multidrug Resistant EAEC strains 
 ≥2 MDR (n=342) 
No. (%) 
≤1 MDR (n=58) 
No. (%) 
Odd Ratio P-value 
Zone-1 122 (35.67) 17 (29.31) 1.34 0.346 
Zone-2 68 (19.88) 9 (15.52) 1.35 0.435 
Zone-3 47 (13.74) 11 (18.97) 0.68 0.296 
Zone-4 43 (12.57) 7 (12.07) 1.05 0.914 
Zone-5 39 (11.40) 7 (12.07) 0.94 0.883 
Zone-6 23 (6.73) 7 (12.07) 0.53 0.153 
Following scrutiny of study participants base on their respective villages, data showed that 
MDR is evenly distributed among villages without any of the villages solely responsible for 
spread of MDR.  
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7.3 Discussion 
EAEC usually associated with watery diarrhoea that is often persistent (Cohen, Nataro et al. 
2005). In children antimicrobial therapy is used in cases of severe diarrheal disease to reduce 
the duration of illness, particularly if associated with persistent diarrhoea. Since the 
characterisation of the EAEC pathovar in 1987 (Nataro, Kaper et al. 1987), many clinical 
isolates of EAEC developed multiple antibiotic resistance (Bangar and Mamatha 2008). In 
our investigation, resistant EAEC strains to two or three antibiotics that include Ampicillin, 
Sulphametaxazole-trimethoprim and tetracycline were greater than eighty percent. This 
finding corroborate with studies conducted in low income countries where high levels of 
resistance to Tetracycline, Spectinomycin, Streptomycin, Sulphamehoxazole-trimethoprim 
and Ampicillin were reported (Sang, Oundo et al. 1997; Vila, Vargas et al. 1999; Aslani, 
Alikhani et al. 2011). Studies from high income countries such as Denmark and Japan have 
shown similar finding (Jensen 2017; Kubomura, Misaki et al. 2017).  
This study, employed two antibiotic sensitivity testing methods which are disk diffusion on 
the 400 EAEC isolates and MIC e-test and on selected 20 EAEC isolates. The 100% 
concordance results obtained for the two methods showed that the less expensive disk 
diffusion method is reliable, valid and can still be recognised as a method of choice (table 
7.1a) but required experienced laboratory personnel. 
The highest number of antibiotics that constitute multi-resistance in this study was five and 
the most frequent and proportionately common was equal or greater than three antibiotics 
(≥3MDR) combined. Data from this study showed significant association of Ampicillin-
resistance to moderate-to-severe diarrhoea among children (p-value 0.019) (table 7.1). This 
may be due to direct exposure of sick children to frequent use of Ampicillin drug compared 
to other drugs. There was high prevalence of resistance to Cotrimoxazole-trimethoprim and 
214 
 
Tetracycline but without indication of association to diarrhoea. In our quest to understand the 
distribution of resistant EAEC strains among the 10 antibiotics in two age strata (0-11 and 
12-59 months) of both case and control groups, we observed that strains from diarrhoeal 
infant were more resistant to ampicillin yielded p-value 0.037 compared to other antibiotics. 
This is a moderate association consistent with previous studies (Nguyen, Le et al. 2005; 
Aslani, Alikhani et al. 2011).  
To further identify factors associated with an increased risk of spread of multidrug-resistant 
EAEC strains we stratified age of studied children in to three (0-11, 12-23 and 24-59 months) 
and in to six (0-2, 3-6, 7-11, 12-17, 18-23 and 24-59). Results from the three age strata of 
children showed association of age 0-11 months with high rate of ≥2MDR given p-value 
0.00009. In our analysis of six age strata of children, age 7-11 months was fund implacably 
associated with spread of ≥2MDR yielded p-value 0.010.  Further analysis showed high 
frequency of 2MDR, 3MDR and ≥4MDR been associated with 7-11 months age stratum in 
all study children combined, MSD children and non-MSD children (figure 7.6, 7.7 & 7.8). 
This kind of association in this age group is rare in previous investigations although a study 
in Demark has shown similar association implicating 6 month old children as carrier of 
multiple drug resistant bacteria (Hebbelstrup Jensen, Roser et al. 2016).  It is important to 
understand the risk factors involved in the association of multiple resistance strains in a 
particular age group 7-11 months. We speculate factors that include crawling period for 
children, underdeveloped immunity, non-exclusive breastfeeding, host genetic and genetic 
aspect of antimicrobial resistant bacteria and environmental factors may be the cause. At the 
crawling age increased mobility provides greater freedoms; however children may 
unknowingly infect themselves by coming into contact with unsanitary objects or surfaces. 
The immunity of children below 12 months is not fully developed, as a result the less 
developed host defence apparatus that are often overwhelmed by the infected antibiotic 
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resistant strains. Likewise, non-exclusive breast feeding or complete absence of breast 
feeding contributes, to lower immunity.  In The Gambia rural community, the proportion of 
exclusive breastfeeding is about 55% (NaNA 2015).  
In the genetics of antimicrobial resistance, intrinsic bacterial property and acquired resistance 
mechanisms play major role in the spreading of antibiotic resistance.  The acquired bacterial 
antibiotic resistance often stems either from a mutation of cellular genes or the acquisition of 
foreign resistance genes or a combination of the two. In our findings, we speculate that 
acquisition of foreign resistance genes strongly associated with high cases of drug resistance 
strains in younger children via direct case-contacts that include mothers, siblings, other 
household members and animals.  
Of the twenty-one virulence genes screened to identify virulence genes that may be 
associated with multiple antibiotic resistance, only two genes found to be possibly associated 
with MDR EAEC and they are agg3A and sepA with p-value 0.036 and 0.029 respectively. 
The two genes are plasmid genes, agg3A is adhesin producer and belongs to aggregative 
adherence fimbrial (AAF) family whilst sepA is a toxin and belongs to class II serine protease 
autotransporter (SPATE) protein family. Studies have implicated sepA as one of the 
important genes responsible for acute diarrhoea caused by EAEC among less than five years 
old from developing countries (Boisen, Scheutz et al. 2012; Ikumapayi, Boisen et al. 2017). 
No literature however, has reported possible association of the two genes with multiple drug 
resistance. Therefore, the mechanism of association with MDR requires further investigation. 
Additionally, observation from our analysis uncovered association of gene combination with 
MDR. For example, combination of pic (protein involve in colonisation) and sepA (Shigella 
extracellular protein A) showed association with MDR of four or more antibiotics (≥4MDR) 
whilst combination of  gene aatA+Pet, aatA+aggR+Pet, aatA+Pet+aggA and 
attA+Pet+aggA+aggR are associated with MDR of three antibiotics (3MDR) and strongest in 
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the later (figure 7.9).  Again, this pattern of gene combination has not been implicated to have 
association with MDR before now. Therefore, more investigations are needed to substantiate 
our findings.     
The transfer of resistant bacteria to humans by farm animals is well recognised. Studies have 
shown that resistant bacteria in farm animals reach consumers through meat products 
(Bartlett, Gilbert et al. 2013). The implication of resistant bacteria on environmental 
microbiome is also well documented, about 90% of the antibiotics given to livestock are 
excreted in urine and stool which in turn widely dispersed through fertilizer, ground-water 
and surface runoff (CDC 2013). So, non-judicious use of antibiotic in animal can cause 
spread of resistant bacteria. Our study implicated two animals that include horse and donkey 
been associated with MDR EAEC of two or more (≥2MDR) antibiotics. The explanation that 
supports the likelihood association of the two animals with MDR was that these animals are 
well look after and often treated with antibiotics against infectious diseases as they are used 
as a form of transportation and farm work to generate income. Humans are known reservoir 
for EAEC infecting other humans however, study from BurkinaFaso has implicated animal 
such as cattle, chickens and pigs as EAEC reservoir (Kagambega, Martikainen et al. 2012).  
 
Six villages were included in this study, study participants recruited from these villages were 
analysed for possible spread of MDR. However, statistical analysis of the distributions of 
MDR in the 6 villages showed even distribution of MDR in all the villages (table 7.6). Our 
finding was that no particular village was implicated solely in the spread of MDR EAEC 
strains. 
Many studies have demonstrated that the Extended-spectrum beta-lactamase (ESBL)-
producing Enterobacteriaceae is increasing (Overdevest, Willemsen et al. 2011) and has led 
217 
 
to numerous cases of healthcare associated infections and many death in developed countries 
such as United State of America (CDC 2013).  However, 56% (28/50) of the 50 randomly 
selected EAEC isolates for whole genome sequencing revealed only blaTEM-1B gene which 
belongs to beta-lactamase families predominant in 1980s and early 1990s and are presently 
recognise as non-ESBLs derivatives (Paterson and Bonomo 2005). Interestingly, there was no 
ESBLs CTX-M complex or CTX-M15 among the 50 EAEC isolates sequenced which 
suggest infrequent used of quinolone or other third generation  antibiotics in The Gambia 
rural regions both in human and animal likely, due to limited source of income to purchase 
the expensive third generation antibiotics.  
The high incidence of multi-drug resistant isolates of EAEC can be attributed to many factors 
that include sub-lethal exposure of bacteria to antibiotics. This often occurs  due to 
indiscriminate use of antibiotics in humans and animals leading to immense selective 
pressure on bacteria, a phenomenon that accelerates the emergence of bacterial resistance 
(Goldstone and Smith 2017), such as horizontal gene transfer (HGT) by acquisition of 
resistance genes from other microorganism and the spread of antibiotic resistance from 
chromosomal mutations.  
 
7.4 Conclusion 
Antimicrobial drug resistant bacteria are widespread across the globe. Many national and 
international public health organisations have described the rapid emergence of resistant 
bacteria as a crisis that could result into a catastrophic situation. Our study has 
epidemiologically showed infants less than 1 year old, particularly, those between 7-11 
months are at risk of been overwhelmed with multidrug-resistant EAEC and similar trend is 
speculated for other multidrug-resistant enterobactriaceae. Additionally, the study has 
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demonstrated that animals such as donkey and horses and even cattle can be responsible for 
the spread of MDR bacteria in developing countries. Although a bigger and carefully planned 
study is recommended to validate our observation.  
To prevent the continued emergence and spread of MDR many factors need to be employed 
primarily through antimicrobial stewardship and reducing the indiscriminate use of 
antibiotics in farming. Additional measure that encourage reference laboratories, referral 
hospital laboratories and regional health laboratories to establish a continuous and sustainable 
antimicrobial surveillance platform that has the potential to transform national and regional 
public health action on the burden of antimicrobial drug resistant bacteria.  
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Chapter 8: Whole Genome Sequencing of Selected EAEC strains 
from case and control study children 
 
8.1 Introduction 
Identification and characterization of microbial pathogens are pivotal for our understanding 
of host-pathogen interaction, diagnosis, drug target and drug development and safety of 
patients. Unfortunately, many available molecular tests are unable to detect emerging genetic 
features in rapidly evolving infectious agents that spread in humans, animals and the 
environment. Unrecognised pathogens can cause outbreaks that can put patients and 
healthcare providers at risk (Deurenberg, Bathoorn et al. 2017).  
During the last 20 years, molecular diagnostic methods have evolved tremendously and 
played important roles in medical microbiology laboratories. Sequence analyses can be used 
to answer different diagnostic questions, such as the genetic relationship of either bacteria or 
viruses, the detection of mutations that cause resistance against antivirals and or antibiotics in 
viral and bacterial genomes and identification of bacteria through sequence analyses of the 
16S rDNA (Bush 2013). Sanger sequencing (first generation sequencing) use the principle 
of amplifying single gene or genomic region using specific primers (Deurenberg, Bathoorn et 
al. 2017). This same sequencing approach is applied for the identification of pathogens in 
clinical samples. Unfortunately, the approach has poor specificity if use on non-invasive 
samples such as faeces which has normally multiple microbial species. In such cases, results 
obtained by Sanger sequencing are unreliable.  Also, the cost of Sanger sequencing required 
to achieve the investigational tasks needed is high and the turnaround time is long. The 
standard Sanger sequencing (traditional dideoxynucleotide chain termination) identifies linear 
sequences of nucleotides by electrophoretic separation of randomly terminated extension 
products (Rizzo and Buck 2012). The reactions can read DNA fragments of 500 bp to 1000 
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bp in length, and this method is still in used routinely for sequencing small amounts of DNA 
fragments and it is the gold standard for clinical cytogenetics (Kingsmore and Saunders 
2011). However, the challenge is the requirement for electrophoretic separation of DNA 
fragments for reading DNA sequence content in Sanger-based sequencing becomes a 
bottleneck for the throughput, increasing time and limiting the number of reactions that can 
be run in parallel (Rizzo and Buck 2012). 
Next-generation sequencing (NGS) refer to as high-throughput DNA sequencing 
technologies which are capable of sequencing large numbers of different DNA sequences in a 
single reaction for example in parallel. All NGS technologies monitor the sequential addition 
of nucleotides to immobilized and spatially arrayed DNA templates but differ substantially in 
how these templates are generated and how they are interrogated to reveal their sequences 
(Linnarsson 2010). NGS allows sequencing of the whole genome of numerous pathogens in 
one sequence run, either from bacterial isolates of different patients, or from multiple species 
present in patient material from one individual (metagenomics). Advantage of NGS to Sanger 
sequencing is that a single protocol can be used for all pathogens for both identification and 
typing applications. Thus, NGS has proven useful in medical microbiology laboratories and 
for infection prevention measures (Zhou, Lokate et al. 2016). There are three basic 
methodological steps of NGS which are; Template preparation (genomic DNA or cDNA, 
library preparation and library amplification), Sequencing and imaging (either Ion torrent 
PGM [personal Genome Machine] that uses pH change or MiSeq which uses fluorescence) 
and Data analysis (Grada and Weinbrecht 2013). However, different sequence platform 
vendors have devised different strategies to prepare the sequence libraries into suitable 
templates as well as to detect the signal and ultimately read the DNA sequence. So the 
different strategies to generate the sequence reads also lead to differences in the output 
capacity for the different platforms (Buermans and den Dunnen 2014).  
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NGS studies of microorganisms typically follow one of two general strategies: targeted 
amplicon sequencing (TAS) or whole genome sequencing (WGS) (figure 8.1). Target 
Amplicon sequencing approach uses target-specific primers for PCR-mediated amplification, 
so that the genomic regions of interest are enriched and selectively sequenced. This approach 
is often used to interrogate well-characterized genomic regions to identify known drug 
resistant mutant as well as disease-causing mutations for diagnosis of pathological conditions. 
Sequencing for de novo assembly of whole genome relies on non-targeted library preparation 
or fragmentation. This method is usually performed when microorganism are unknown and 
or when the aim is to determine the genomic content and functional potential of the organism 
under investigation (Lefterova, Suarez et al. 2015).  
 Whole genome sequencing (WGS) is a molecular method that determines the exact order of 
nucleotides present in a given DNA or RNA (Grada and Weinbrecht 2013). The method often 
applied to primary or complex polymicrobial specimens that include clinical, environmental 
and food specimens for the identification of culture-independent pathogen as well as 
characterization of the microbial population. In addition, WGS of bacterial genomes divulge 
the presence of antimicrobial resistance (AMR) genes, virulence genes or genes associated 
with virulence and pathogenicity and to discover new genetic mechanisms that dictate 
bacterial virulence (Rossen, Friedrich et al. 2018). It is on this bedrock we performed WGS 
on 51 EAEC in order to determine these isolates genetic content. The first complete genome 
sequence of EAEC, targeting strain 042, the prototypical member of EAEC-pathotype was 
achieved in 2009 by Chaudhuri and colleagues revealing major features of the E. coli 042 
genome (Chaudhuri, Sebaihia et al. 2010). Also, the study showed genomic and phylogenetic 
comparisons of E. coli 042 with other E. coli strains leading to the detection of previously 
uncharacterised virulence factors. 
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In this study, we aim to explore WGS to investigate the antimicrobial resistance genes 
contain in the EAEC isolates which phenotypic resistance assay has been conducted, and do a 
correlation between the data generated from both phenotypic (disk diffusion) and genotypic 
(WGS) characterisation to evaluate the concordance of resistance. Also, we will study the 
distribution of Multi-locus Sequence Types (MLST) circulating among the EAEC isolates in 
the rural Gambia. Additional investigation includes genetic relationship of the EAEC strains. 
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Figure 8.1: Sketch sequencing approaches for diagnosis and monitoring of infectious 
diseases. Adapted from (Lefterova, Suarez et al. 2015).  
Targeted amplicon sequencing uses target-specific primers for template (green bars) 
enrichment, followed by primers that are partially complementary to the target-specific 
primers (black bars) and contain sequencing adaptors and bar codes (blue bars). 
Whole-genome sequencing uses enzymatic or mechanical fragmentation, followed by end 
pair to allow ligation of primers that contain sequencing adaptors and bar codes (blue bars) 
Size selection allows only fragments of a predefined length to be used for sequencing. 
However, Bioinformatics removal of human sequences is required because the nucleic acids 
of the organism of interest often constitute <1% of the nucleic acid pool. Fragmentation 
libraries can also be made from PCR-enriched amplicon. 
The application of Whole-genome shotgun sequences (WGS) involves sampling the 
chromosomes that make up one genome, and the WGS assembly which is the reconstruction 
of sequence up to chromosome length done by computer software that generate the results 
shown in the tables and figures in the result section of this chapter. De novo assembly does 
not require reference genome  
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8.2 Results 
The application of next-generation sequencing (NGS) was used to conduct whole-genome 
sequencing using MiSeq-Illumina, we sequenced 51 EAEC isolates out of which 50 turned 
out to be genuine E. coli as one isolate resulted in Stenotrophomonas maltophilia. E. coli 
reference genome NC_011748 E. coli 55989 chromosome with 5,154,862 bp in size was 
included in the analysis as reference strain. The summary of the WGS result regarding 
genome content is shown in the table 8.1. The contig (contiguous consensus sequence derived 
from the assembly of many short, overlapping DNA fragments) readings for the DNA 
sequenced were of good quality for genome interogation. The percentage Guanine Cytosine 
(G+C) contents were optimal. Also, the isolates N50 (half of the total length of the collection 
of all contigs), protein-coding sequence (CDS) or coding region and percentage aligned bases 
were obtained. Overall, the averages of genome contents or parameters yielded useful 
information about the EAEC isolates genome. For example the average for contigs, reads, 
GC, bp, N50, CDS, aligned bases and %-aligned bases were 439.29, 689729, 51.16%, 
5120782, 64127.35, 4773.18, 4359349 and 84.57%  respectively (Table 8.1). None of the 
aligned base for each of the DNA isolates sequenced genome was more than 4743331bp 
whilst the reference aligned base was 5154862 well above each of the 50 DNA isolates.  The 
number of virulence genes per isolates ranged from 55 to 110, and number of resistance 
genes per isolates ranged from 1 to 15. However, the total number of genes observed in each 
of the study EAEC isolates ranges from 4,182 to 6,097.  
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Resistance genes 
This study revealed thirty-seven (37) different resistance genes. From WGS data we look at 
the distribution of the identified resistance genes in diarrhoeal and non-diarrhoeal children to 
ascertain association with diarrhoea but results obtained showed no association except for a 
Trimethoprim resistance gene dfrA14_1 which showed p-value 0.010. Also, there are three 
resistance genes that were only found in diarrhoeal children, and these are blaTEM-1C_, blaSHV-
1_18, and Sul1_1 although in small number. Also, three different resistance genes that include 
blaOXA-1_1, aac(3)-IIa and dfrA17_1 were detected only among the non-diarrhoeal children 
(Table 8.2) which are in small number too. 
Comparison of resistance between presence of resistance genes using whole genome 
sequencing and resistance using phenotypic (disk diffusion) assay showed significant 
correlations between phenotypic antimicrobial resistance and each antimicrobial resistance 
genes that were correspond to antibiotics tested. The correlation investigation showed 100%, 
100%, 76%, 97% and 95% concordance with Ampicillin, Gentamicin, Chloramphenicol, 
Sulphamethoxazole-trimethoprim and Tetracycline respectively (Table 8.3).   
 
Multi-locus Sequence Type (MLST) 
The MLST analysis of structural seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA 
and recA) revealed twenty-nine distinct sequence types (STs) and thirteen clonal complexes 
(ST-complex) from the 50 EAEC isolates sequenced. The most frequent ST was ST38 which 
was 16% (8/50) and distributed evenly among diarrhoeal and non-diarrhoeal children. The 
next common ST in the study was ST10 which account for 6% (3/50) two of which were 
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found in non-diarroeal children. Also there are 12 dual STs and 15 single STs, majority of 
these were unevenly distributed among cases and control (Table 8.4 & Table 8.5).   
 
Sequence type and Resistance genes 
Resistance gene Sul2_2 is found in all the ST38 while the Tet-D and blaTEM genes account 
for seven and six respectively in the ST38. Tet-B gene was found in the 3 ST10 but Tet-A was 
found in two of the three ST10. The two ST3032 has six resistance genes that include 
blaTEM, CatA1, Sul1_2, Sul2_2, dfrA12 and Tet-A. The two ST111 has four resistance genes 
that include blaTEM, CatA1, Sul2_3 and Tet-A. Also the two ST131 has blaTEM, Sul2_2, 
dfrA8_1 and Tet-B in common, while the two ST156 has blaTEM, Sul1_2, dfrA1_30 and Tet-
A in common. At least one resistance gene is found common to two ST349, ST394, ST678, 
ST1291 and ST3018 which are Tet-B, blaTEM, Sul2_2, dfrA1_1 and dfrA1_1 respectively 
(table 8.6).     
 
Pairwise core SNP distance is graphed in histogram format as well as in phylogeny as 
representation of the SNPs distances (figure 8.2 and figure 8.3).  The farthest SNP is at 
position 487 and contains 2% SNPs while the highest percentage of SNPs (20%) is at 
distance position 280 (figure 8.3). The core SNP density revealed 471951 SNPs across the 
5.2 million base pair (bp). The genome position of the highest SNPs density (3,948 SNPs) is 
at 2.34M-2.36M, while the lowest SNPs density (166 SNPs) is at genome location 3.42M 
(figure 8.4). 
Pan genome graph computed using Roary software showed 51 taxa and 22,045 clusters that 
include core and accessory genes (figure 8.5). The dark left side of the graph showed genes 
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common to all isolates, hence, the darker the blue colour to the left side the more common the 
genes so, this group of genes are regarded as core-genes. Also, the paler the blue colour to the 
right side the more differences are the genes and this group of genes are regarded as 
accessory genes. The highest number of genes registered was 6,097 contain in isolate 
SID100590 while the lowest gene recorded was 4,182 found in isolate SID100096. The pan 
genome phylogenetic tree was constructed using a distance matrix based on the presence or 
absence of genes in the isolates (figure 8.6).   
The annotated phylogenetic tree showed relatedness of the strains and their commonality 
details regarding year the strains isolated, sequence type, sequence type complex, number of 
antibiotic resistant to and resistance genes contained (figure 8.7a and 8.7b). The annotation 
was done using interactive tree of life (Letunic and Bork 2016) an online 
(https://itol.embl.de/personal_page.cgi) tool for the display and annotation of phylogenetic 
and other trees.  
 
Plasmid investigation 
Of the 50 EAEC isolates investigated to identify genetic components using whole genome 
sequencing (WGS), 47 harbours plasmid. Thirty-four of the 47 isolates harbours plasmid 
associated with resistance genes. However, 32 EAEC isolates have antibiotic resistance genes 
associated with the detected plasmids. Coincidentally, the 32 EAEC consist of 16 cases and 
16 controls and 10 distinct plasmid associated resistance genes were distributed among the 32 
EAEC isolates (table 8.7). The three EAEC isolates that had no plasmid are females of two 
controls and a case with age 6, 19 and 28 months respectively. 
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Table 8.1: Summary of genome content of the 50 Isolates Examined 
Sample
ID 
Year of 
Isolation 
Origin 
in 
Gambia 
ST 
C
o
n
ti
g
s 
Reads G+C 
Content 
bp N50 CDS Aligned 
Bases 
% 
Aligned 
Bases 
100020 2007 102 10 341 752558 51.7 5092123 41988 4790 4523874 87.76 
100096 2008 101 2162 135 809278 50.6 4632118 76820 4133 4226716 81.99 
100119 2008 103 14 349 1076290 50 5318912 46267 5026 4177708 81.04 
100125 2008 102 2707 1101 779624 51.8 4879617 8432 4426 4657004 90.34 
100127 2008 102 131 174 748868 50.8 5025243 114540 4722 4130745 80.13 
100138 2008 103 200 175 608330 50.8 5053235 109100 4812 4572848 88.71 
100182 2008 101 73 174 630814 50.8 5049330 118871 4655 4130142 80.12 
100191 2008 104 58 129 981712 51.3 4775355 131337 4406 4569449 88.64 
100342 2008 105 131 216 688330 51 5160817 145157 4877 4107319 79.68 
100382 2008 104 394 869 620850 51.9 4900370 10481 4403 4210767 81.69 
100404 2008 102 2622 236 1025872 49.1 4985608 107951 4579 4268305 82.8 
100415 2008 103 38 254 896092 50.7 5404046 110276 5038 4475169 86.81 
100427 2008 103 222 1460 872504 51.1 5729908 9144 5411 4743331 92.02 
100503 2008 103 2067 356 911726 51.1 5244148 49441 4976 4636867 89.95 
100569 2008 102 10 259 870236 50.8 5127539 72495 4843 4443136 86.19 
100590 2008 102 3444 1972 510362 49.5 6344745 6760 6054 4523394 87.75 
100715 2008 105 73 265 571534 50.3 5180187 49693 4799 4132871 80.17 
100722 2008 101 6907 140 946636 51.5 4655989 88452 4324 4245256 82.35 
100796 2008 105 3032 132 613194 50.7 5171336 124870 4724 4408160 85.51 
102031 2009 101 38 279 566012 50.6 5188333 43014 4818 4375354 84.88 
102098 2009 101 38 307 472684 50.9 5365437 57209 4996 4448305 86.29 
102106 2009 101 38 315 612080 50.8 5367356 48111 4990 4457968 86.48 
102191 2009 104 2704 502 488414 49.5 5179127 22265 4883 4135098 80.22 
102274 2009 101 517 123 959836 50.7 4825593 112857 4498 4518971 87.66 
102296 2009 102 38 846 481110 50.9 5291567 12763 4909 4447504 86.28 
102375 2009 104 394 2052 366674 50.6 5845401 5032 5522 4516037 87.61 
102425 2009 101 3018 233 567074 51.2 5055435 51977 4650 4422738 85.8 
102469 2009 102 3018 1123 275602 51.4 4936793 6989 4483 4363593 84.65 
102602 2009 103 222 1265 658718 51.4 4876817 7239 4456 4626879 89.76 
102705 2009 101 1312 367 351646 50.8 4888741 24553 4565 4406444 85.48 
102742 2009 102 111 316 484450 50.9 5008195 35975 4713 4533387 87.94 
102806 2009 101 3032 193 507192 51.1 5168696 65709 4724 4394450 85.25 
102820 2009 103 111 165 725744 51.5 5017709 117311 4732 4541878 88.11 
102871 2009 103 58 220 863704 50.8 5046801 76384 4724 4641815 90.05 
102906 2009 103 678 329 719200 51.1 5187229 44460 4880 4952539 96.08 
102951 2009 106 31 222 678740 51.1 5200279 75077 4838 4402428 85.4 
103016 2010 106 678 205 747746 50.1 5085193 78163 4773 4864334 94.36 
103047 2010 106 349 195 779672 51.5 5097266 91200 4798 4376479 84.9 
103069 2010 106 1291 313 739394 51.1 5139442 51283 4852 4557229 88.41 
103070 2010 106 1291 1521 488756 49.1 4989253 5034 4734 4523081 87.74 
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Continue 
   
 
       Sample
ID 
Year of 
Isolation 
Origin 
in 
Gambia 
ST 
C
o
n
ti
g
s Reads G+C 
Content 
bp N50 CDS Aligned 
Bases 
% 
Aligned 
Bases 
 
103076 2010 101 2141 288 827428 50.9 5400256 75086 5079 4344936 84.29 
103275 2010 101 156 305 487564 50.6 4991005 34622 4686 4551111 88.29 
103276 2010 104 156 159 731316 51.4 4991009 99209 4692 4560074 88.46 
103278 2010 104 10 193 836276 50.9 4910239 66617 4582 4452867 86.38 
103400 2010 101 38 197 548974 50.3 5234471 127805 4854 4421501 85.77 
103446 2010 101 196 94 1272482 50.5 4583263 126431 4245 4446534 86.26 
103530 2010 102 38 423 840518 50.2 5390647 37619 5014 4478512 86.88 
103691 2010 101 349 193 473444 51 5094603 85955 4785 4362597 84.63 
103693 2010 102 2178 316 410882 51.1 4914690 34201 4590 4552339 88.31 
103709 2010 103 38 275 622328 50.9 5335918 65014 4958 4434509 86.03 
AVERAGE 
 
439 689729 51.16%, 5120782 64127 4773 4359349 84.57% 
 
Origin in The Gambia 
Key: 
101 – Basse,  
102 – Gambisara,  
103 – Koina  
104 – Fatoto 
105 – Yorobawol  
106 – DamphaKunda  
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Table 8.2: Distribution of Antimicrobial resistance genes among diarrhoeal and non-diarrhoeal children 
Group of 
Antimicrobial 
agent 
Antimicrobial agent Resistance 
gene 
Case (n = 23) 
n (%) 
Control (n = 27) 
n (%) 
Total (n = 50) 
n (%) 
OR (95% CI) P-value 
 
Beta-lactams 
 
Ampicillin 
blaOXA-1_1 0 (00) 2 (7) 2 (4) -- 0.182 
blaTEM-1B_1 14 (61) 14 (52) 28 (56) 1.44(0.407-5.194) 0.522 
blaTEM-1C_5 1 (4.4) 0 (00) 1 (2) -- 0.273 
blaSHV-1_18 1 (4.4) 0 (0.00) 1 (2) -- 0.273 
 
Aminoglycoside 
Gentamicin aac(3)-IIa 0 (0.00) 1 (3.70) 1 (2) -- 0.351 
 
Streptomycin 
strA_1 4 (17.4) 4 (14.8) 8 (16) 1.21(0.196-7.418) 0.804 
strA_4 7 (30) 10 (37) 17 (34) 0.74(0.190-2.815) 0.623 
strB_1 13 (56.5) 13 (48.2) 26 (52) 1.40(0.398-4.956) 0.554 
Phenicol Chloramphenicol CatA1_1 8 (35) 9 (33) 17 (34) 1.07 (0.279-4.024) 0.914 
 
Sulfonamide 
 
Sulfonamide 
Sul1_1 1 (4.35) 0 (0.00) 1 (2) -- 0.273 
Sul1_2 7 (30) 7 (26) 14 (28) 1.25 (0.301-5.156) 0.723 
Sul2_2 14 (61) 11 (37) 25 (50) 2.64 (0.732-9.718) 0.092 
Sul2_3 3 (13) 3 (11) 6 (12) 1.20 (0.144-9.947) 0.834 
 
Trimethoprim 
 
Trimethoprim 
dfrA12_1 1 (4) 2 7) 3 (6) 0.57 (0.009-11.746) 0.649 
dfrA14_1 5 (22) 0 (00) 5 (10) -- 0.010 
dfrA17_1 0 (00) 2 (7) 2 (4) -- 0.182 
dfrA1_1 2 (9) 6 (22) 8 (16) 0.33 (0.030-2.191) 0.193 
dfrA1_30 4 (17) 2 (7) 6 (12) 2.63 (0.329-31.369) 0.278 
dfrA7_1 3 (13) 1 (4) 4 (8) 3.90 (0.281-
212.447) 
0.225 
dfrA8_1 3 (13) 4 (15) 7 (14) 0.86 (0.112-5.801) 0.857 
 
Tetracycline 
 
Tetracycline 
tet(A)_4 8 (35) 5 (18) 13 (26) 2.34 (0.540-10.855) 0.191 
tet(B)_4 7 (30) 6 (22) 13 (26) 1.53 (0.357-6.674) 0.509 
tet(D)_1 6 (26) 3 (11) 9 (18) 2.82 (0.504-19.501) 0.169 
Bonfire is 0.05/22 = 0.002 cut off 
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Table 8.3: Comparison between Genome (WGS) and Phenotypic (Disk diffusion) based 
predictive Antimicrobial Susceptibility Test (AST)  
Class of Antimicrobial 
agent 
Antimicrobial 
agent 
Resistance 
gene 
Frequency  
of 
Resistance 
gene 
Frequency 
Phenotypic 
resistance 
(Disk diffu) 
Rate of Concordance 
between phenotypic 
and genotypic 
detection of resistance 
Beta-lactams  
Ampicillin 
blaTEM-1B_1 28  28 100%      
100% blaTEM-1C_5 1  1 100% 
blaSHV-1_18 1  1 100% 
Aminoglycoside Gentamicin aac(3)-IIa 1  1 100% 100% 
Phenicol Chloramphenicol CatA1_1 17  13 76% 76% 
 
Sulphamethoxazol-
Trimethoprim 
Sulfonamide Sul1_1 1  1 100%  
 
 
 
97% 
 
 
 
Sul1_2 14  13 93% 
Sul2_2 25  25 100% 
Sul2_3 6  6 100% 
Trimethoprim dfrA12_1 3  3 100% 
dfrA14_1 5  5 100% 
dfrA17_1 2  2 100% 
dfrA1_1 8  7 88% 
dfrA1_30 6  5 84% 
dfrA7_1 4 4 100% 
dfrA8_1 7  7 100% 
Tetracycline Tetracycline tet(A)_4 13  13 100%  
95% tet(B)_4 13 11 85% 
tet(D)_1 9 9 100% 
 
To obtain concordance for each resistance gene we applied formular; 
Percentage concordance = Phenotypic resistance number/Genotypic-resistance genes number X 100 
For example, in the case of Sul1_2 resistance gene; 13/14 X100 = 92.86% = 93%      OR 
100/14 = 7, (100 – 7 = 93).  
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Table 8.4: showing MLST detail that results in STs and ST-complex 
sid *age gender ST adk fumC gyrB icd mdh purA recA ST Complex 
100020 6 F 10 10 11 4 8 8 8 2 10 
100096 
 
F 2162 31 58 54 10 11 35 47 none 
100119 7 M 14 14 14 10 14 17 7 10 14 
100125 5 M 2707 9 23 64 18 11 8 219 278 
100127 5 F 131 53 40 47 13 36 28 29 131 
100138 5 M 200 6 4 5 26 7 8 14 40 
100182 5 F 73 36 24 9 13 17 11 25 73 
100191 6 M 58 6 4 4 16 24 8 14 155 
100342 2 M 131 53 40 47 13 36 28 29 131 
100382 15 F 394 21 35 61 52 5 5 4 394 
100404 17 M 2622 13 363 10 97 17 94 93 None 
100415 9 F 38 4 26 2 25 5 5 19 38 
100427 15 F 222 9 6 15 56 11 8 6 None 
100503 21 F 2067 6 95 3 18 11 122 2 none 
100569 20 F 10 10 11 4 8 8 8 2 10 
100590 22 M 3444 76 24 9 13 17 28 25 73 
100715 9 M 73 36 24 9 13 17 11 25 73 
100722 19 F 6907 10 929 4 8 8 2 2 None 
100796 9 F 3032 54 22 211 342 40 16 4 None 
102031 2 F 38 4 26 2 25 5 5 19 38 
102098 8 F 38 4 26 2 25 5 5 19 38 
102106 6 M 38 4 26 2 25 5 5 19 38 
102191 6 M 2704 53 ~400 47 13 36 28 29 131 
102274 21 F 517 109 65 5 1 9 13 14 269 
102296 4 F 38 4 26 2 25 5 5 19 38 
102375 3 M 394 21 ~35 ~61 52 5 5 4 394 
102425 6 F 3018 12 58 54 344 1 2 47 None 
102469 22 F 3018 12 58 54 344 1 2 47 None 
102602 21 M 222 9 6 ~15 56 11 8 6 None 
102705 6 M 1312 6 11 4 8 8 78 2 None 
102742 8 F 111 6 29 14 16 24 8 2 None 
102806 18 F 3032 54 22 211 342 40 16 4 None 
102820 18 M 111 6 29 14 16 24 8 2 none 
102871 9 F 58 6 4 4 16 24 8 14 155 
102906 33 M 678 6 6 5 136 9 7 7 None 
102951 24 M 31 18 22 17 6 5 5 4 31 
103016 19 F 678 6 6 5 136 9 7 7 None 
103047 56 M 349 34 36 39 87 67 16 4 349 
103069 56 M 1291 10 11 4 8 8 5 2 None 
103070 58 M 1291 10 11 4 8 8 5 2 None 
103076 3 F 2141 101 88 ~262 281 59 215 196 None 
103275 5 M 156 6 29 32 16 11 8 44 156 
233 
 
Continue 
          
 
sid *age gender ST adk fumC gyrB icd mdh purA recA ST Complex 
103276 43 M 156 6 29 32 16 11 8 44 156 
103278 6 M 10 10 4 577 8 8 8 2 10 
103400 28 F 38 4 26 2 25 5 5 19 38 
103446 28 F 196 6 19 3 16 9 8 6 None 
103530 9 M 38 4 26 2 25 5 5 19 38 
103691 11 F 349 34 36 39 87 67 16 4 349 
103693 7 M 2178 9 6 15 56 11 26 6 None 
103709 16 F 38 4 26 2 25 5 5 19 38 
Key: *age in month,               gender: F – Female,    M – Male  
Following reanalysis of the whole genome sequencing data to obtain sequence types (STs), it 
became clear that allel fumC with ~400 and ~35 of SID 102191 and 102375 respectively, and 
allel gyrB with ~61 of SID 102375 were generated due to poor sequencing so they are 
sequencing artifacts. However, allel gyrB with ~15 and ~262 of SID 102602 and 103076 
respectively were generated as new allels.  
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Table 8.5: Distribution of ST among Cases and Controls 
ST (n = 29) Case (n = 23)  Control (n = 27)  Total (n = 50) (%) 
10 1 2 3 (6) 
14 1 0 1 (2) 
31 0 1 1 (2) 
38 4 4 8 (16) 
58 1 1 2 (4) 
73 0 2 2 (4) 
111 1 1 2 (4) 
131 0 2 2 (4) 
156 2 0 2 (4) 
196 1 0 1(2) 
200 0 1 1(2) 
222 1 1 2 (4) 
349 1 1 2 (4) 
394 1 1 2(4) 
517 0 1 1(2)  
678 1 1 2 (4) 
1291 0 2 2 (4) 
1312 0 1 1(2) 
2067 1 0 1 (2) 
2141 1 0 1 (2) 
2162 0 1 1 (2) 
2178 1 0 1(2) 
2622 0 1 1(2) 
2704 1 0 1 (2) 
2707 1 0 1(2) 
3018 1 1 2(4) 
3032 1 1 2 (4) 
3444 1 0 1 (2) 
6907 0 1 1(2)  
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Figure 8.2: Core SNP Phylogeny showing the evolutionary relationships of taxa. The evolutionary history was 
inferred using the Neighbour-joining method (Saitou and Nei 1987). The optimal tree with the sum of branch length = 
2.09214678 is shown. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary 
distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Maximum Composite 
Likelihood method (Tamura, Peterson et al. 2011) and are in the units of the number of base substitutions per site. The 
analysis involved 50 nucleotide sequences. All positions containing gaps and missing data were eliminated. These were 
a total of 1159 positions in the final dataset. Evolutionary analyses were conducted in (MEGA7) Molecular 
Evolutionary Genetic Analysis (Kumar, Stecher et al. 2016). 
 
236 
 
 
Figure 8.3: Showed distribution of SNPs according to their proximity to the nearest gene. Bars represent percentage of SNPs that have a gene 
within a certain distance from each other. The most distanced SNPs (2% SNPs) are at position 487. Similarly, 0 the closest distance interestingly 
has 2% SNPs are at this 0 position. The highest number of SNPs (20 SNPs) are at distance position 280 away from 0 distance. There are four 
wide gaps in the distances without SNPs and the wide gaps were observed at the distance position 365.5-383.5, 397.5-409.5, 420.5-437.5 and 
439.5-466.5 of A, B, C and D respectively with D been the widest.    
A B C D 
and nearest gene 
(%
) 
237 
 
 
 
 
Figure 8.4: Core SNP density revealed 471951 SNPs across the approximate 5.2 million base pair. Each bar represents 20 thousand base pair 
(20k bp) at their respective genomic position containing different number of single nucleotide polymorphism (SNPs). The first bar at genome 
position 0-20k has 1616 SNPs, whilst the last bar at genome position 5.14M-5.16M has 1173 SNPs. The bar at position 2.34M-2.36M has the 
highest number of SNPs which is 3948 whilst the bar at position 3.4m-3.42m has the lowest number of SNPs which is 166.
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Figure 8.5: Pan genome heat mapping showing the core genes (common to all isolates) and 
the accessory genes that are shared between isolates, determined by a pairwise comparison.  
 
 
 
 
 
  Sample ID                                                                                                                                                                                                                     No. of Gene 
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Figure 8.6: Molecular 
Phylogenetic analysis by 
Maximum Likelihood method  
The evolutionary history was 
inferred by using the Maximum 
Likelihood method based on the 
Tamura-Nei model (Tamura and 
Nei 1993). The tree with the 
highest log likelihood (-
13441.40) is shown. Initial 
tree(s) for the heuristic search 
were obtained automatically by 
applying Neighbour-Join and 
BioNJ algorithms to a matrix of 
pairwise distances estimated 
using the Maximum Composite 
Likelihood (MCL) approach, 
and then selecting the topology 
with superior log likelihood 
value. The tree is drawn to scale, 
with branch lengths measured in 
the number of substitutions per 
site. The analysis involved 51 
nucleotide sequences. All 
positions containing gaps and 
missing data were eliminated. 
There were a total of 1159 
positions in the final dataset. 
Evolutionary analyses were 
conducted in MEGA7 (Kumar, 
Stecher et al. 2016).  
Reference strain used was 
NC_011748 Escherichia coli 
55989 chromosome, complete 
genome of 5154862 bp 
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Table 8.6: Distribution of Resistance genes against the Sequence Types (STs) 
ST Case-
Control 
Ampicilli Chl
or 
Genta Sulfonamide Trimethoprim Tetracyline Drug 
Resis
-tant bla 
OXA 
bla 
TEM 
CatA
1 
aac(3)-
IIa 
Sul 
1_2 
Sul 
2_2 
Sul 
2_3 
dfrA12 dfrA14 dfrA17 dfrA 
1_1 
dfrA
1_30 
dfrA8_1 Tet-A Tet-B Tet-D 
10 Case 0 0 0 0 1 0 0 0 0 0 0 1 0 1 1 0 2 
10 Control 1 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 4 
10 Control 1 0 1 0 0 1 0 0 1 0 0 0 0 0 1 0   4 
14 Case 0 0 0 0 0 1 0 0 1 0 0 0 0 0 1 0 2 
31 Control 0 1 1 1 1 0 0 0 0 1 0 0 0 1 0 0 4 
38 Case 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 1 3 
38 Case 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 1 5 
38 Case 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 1 3 
38 Case 0 1 0 0 0 1 0 0 0 0 1 0 0 0 0 1 3 
38 Control 0 1 1 0 0 1 0 0 0 0 1 0 0 0 0 1 4 
38 Control 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 1 
38 Control 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 1 3 
38 Control 0 0 1 0 0 1 0 0 0 0 1 0 0 0 0 1 4 
58 Case 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 
58 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
73 Control 0 1 0 0 1 0 1 0 0 0 0 1 0 0 0 0 2 
73 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
111 Case 0 1 1 0 0 0 1 0 0 0 0 0 0 1 0 0 4 
111 Control 0 1 1 0 0 0 1 0 0 0 0 0 0 1 0 0 4 
131 Control 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 2 
131 Control 0 1 1 0 1 1 0 0 0 0 0 0 1 0 1 0 4 
156 Case 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 4 
156 Case 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 2 
196 Case 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
200 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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Continuation of Table 8.6  
ST CaseCo
n 
Ampicilli Chl
or 
Genta Sulfonamide Trimethoprim Tetracyline 
Drug 
Resis
-tant 
bla 
OX
A 
bla 
TEM 
Cat
A1 
aac(3)-
IIa 
Sul 
1_2 
Sul 
2_2 
Sul 
2_3 
dfrA1
2 
dfrA1
4 
dfrA17 dfrA 
1_1 
dfrA
1_30 
dfrA8_
1 
Tet-A Tet-
B 
Tet-D 
222 Control 0 1 0 0 1 0 0 0 0 1 0 0 0 0 0 0 2 
222 Case 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
349 Case 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 3 
349 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 2 
394 Control 0 1 0 0 1 0 1 0 0 0 0 1 0 0 0 0 3 
394 Case 0 1 1 0 0 1 0 0 0 0 0 0  0 1 1 3 
517 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
678 Control 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 3 
678 Case 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 1 
1291 Control 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
1291 Control 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
1312 Control 0 1 0 0 1 1 0 1 0 0 0 0 0 1 0 0 3 
2067 Case 0 0 0 0 1 1 0 0 1 0 0 1 0 0 0 1 3 
2141 Case 0 1 1 0 1 1 0 0 0 0 0 0 1 0 1 0 5 
2162 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2178 Case 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 3 
2622 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2704 Case 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 3 
2707 Case 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 2 
3018 Control 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 3 
3018 Case 0 0 0 0 0 1 0 0 0 0 1 0 0 1 0 0 2 
3032 Case 0 1 1 0 1 1 0 1 0 0 0 0 0 1 0 0 4 
3032 Control 0 1 1 0 1 1 0 1 0 0 0 0 0 1 0 0 5 
3444 Case 0 1 1 0 1 1 0 0 1 0 0 0 1 0 1 0 4 
6907 Control 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Key: 1 – Present; 0 – Absent  
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Table 8.7: Distribution of plasmid Associated Resistance Gene in EAEC isolates among cases and 
controls (n=32) 
Plasmid-Associated-
Resistance-Genes 
Cases (n=16) Controls (n=16) Total 
(n=32) 
P-value 
IncFIC(FII)_1 1 (6) 5 (31) 6 (19) 1.070 
ColRNAI_1 6 (38) 6 (38) 12 (38) 1.000 
IncQ1_1 2 (13) 3 (19) 5 (16) 0.626 
IncFIA_1 0 (0) 1 (6) 1 (3) 0.309 
IncFIB(AP001918)_1 1 (6) 5 (33) 6 (19) 0.056 
IncFIB(pB171)_1_pB171 7 (44) 3 (19) 10 (31) 0.127 
IncFII(pCoo)_1_pCoo 0 (0) 1 (6) 1 (3) 0.309 
IncI2_1 1 (6) 0 (0) 1 (3) 0.309 
IncFII(pRSB107)_1_pRSB107 1 (6) 2 (13) 3 (9) 0.544 
IncFII(pHN7A8)_1_pHN7A8 1 (6) 0 (0) 1 (3) 0.309 
 
None of the ten distinct plasmids resistance genes is significantly associated with diarrhoeal children. 
The most prevalent plasmid associated resistance gene detected were incompatibility types (Inc) 
account for 90% (9/10) while the only compatible type (ColRNAI_1) account for 10% (1/10). Among 
the plasmids incompatibility type, the IncF plasmids preponderate 78% (7/9). Of the 28 IncF; IncFII, 
IncFIA, IncFIB and IncFIC account for 18% (5/28), 4% (1/28), 57% (16/28) and 21% (6/28) 
respectively.  
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Figure 8.7a: Phylogenetic tree showing relatedness of EAEC                                                    
strains  
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Figure 8.7a: phylogenetic tree showed strong genomic divergence across the EAEC 
isolates genome as few of the isolates are closely related. For example, isolates of 
study ID 103275 and 103276 are very close share the same clone, same distance, 
possess similar resistance genes and having similar ST/ST-complex 156/156. 
Similarly, study ID 100415, 102106 and 103709 share the same clone, distance, 
ST/ST-complex 38/38 and resistance-genes in common. Other than the 8 isolates that 
have ST38 and share the same clone, the rest of the isolates are highly diverse.                          
Furthermore, 9 (82%) of the 11 isolates that had phenotypic zero (0) resistance to the 
eight antibiotics also had the corresponding resistance-genes absent in their genome 
following whole-genome-sequencing.   
Plasmid: Thirty-two of the 50 sequenced EAEC isolates harboured antibiotic resistance 
genes associated with the detected plasmids. The most common plasmid associated 
resistance gene detected were incompatibility types (Inc) account for 90% (9/10) while 
the only compatibility type (CoIRNAI_1) account for 10% (1/10). Also, the figure 
above showed strong association of ST38 with plasmid IncFIB and strongest with 
IncFIB(pB171)_1_pB171 which accounts for 75% (6/8).   
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Key: 
            Case 
            Control 
             Resistance gene absent 
             Resistance gene present 
*Plasmid Associated Resistance Genes; 
I - IncFIC(FII)_1     II - ColRNAI_1 
III - IncQ1_1          IV - IncFIA_1 
V - IncFIB(AP001918)_1     Nil – No PlasmidARG 
VI - IncFIB(pB171)_1_pB171 
VII - IncFII(pCoo)_1_pCoo      VIII - IncI2_1 
IX - IncFII(pRSB107)_1_pRSB107 
X - IncFII(pHN7A8)_1_pHN7A8      
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Figure 8.7b: Phylogenetic tree showing relatedness of EAEC strains in circular format 
 
 
 
 
 
 
 
 
Key: 
 
  
 
 
 
Case 
Control 
Resistance gane absent 
Resistance gene present 
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8.3 Discussion 
EAEC is globally recognised as a cause of paediatric persistent diarrhoea and travellers 
diarrhoea among adult arriving from EAEC endemic region (Knutton, Shaw et al. 2001; 
Cohen, Nataro et al. 2005; Kaur, Chakraborti et al. 2010; Estrada-Garcia, Perez-Martinez et 
al. 2014). We applied WGS to study EAEC in order to understand genetic factors that are 
likely responsiblefor the pathogen  heterogeneity characteristics. In the past, very few studies 
have adopted WGS to demonstrate genomic components and phylogenetic diversity of EAEC 
isolates particularly from West-Africa region. We have shown in our previous study the 
contribution of EAEC virulence genes in infant diarrhoea (Ikumapayi, Boisen et al. 2017). It 
is interesting to report that 238 virulence genes identified by WGS were mostly evenly 
distributed among the diarrhoeal and non-diarrhoeal children, and some virulence genes are 
found more in controls than in cases. Thus, the virulence genes result in this study 
corroborate reports from past studies regarding heterogeneous nature of EAEC.   
Following the discovery of the EAEC pathovar many clinical isolates of EAEC developed 
multiple antibiotic resistance (Bangar and Mamatha 2008), and high levels of resistance to 
tetracycline, Spectinomycin, Streptomycin, Sulphamethoxazole-trimethoprim and Ampicillin 
(Sang, Oundo et al. 1997; Vila, Vargas et al. 1999; Nguyen, Le et al. 2005; Mendez 
Arancibia, Pitart et al. 2009; Aslani, Alikhani et al. 2011; Ali, Ahmed et al. 2014). Similar, 
outcome is recorded in this study as our both clinical and environmental EAEC isolates 
showed over 80% resistance to Ampicillin, Sulphamethoxazol-Trimethoprim and 
Tetracycline, whilst resistant to Chlorampenicol was 23%. Although resistance to third 
generation antibiotics that include fluoroquinolone and cefolosporin were negligible even 
though variety of studies from geographically distinct areas have reported high rate of EAEC 
resistance to quinolone (Vila, Vargas et al. 2001; Khoshvaght, Haghi et al. 2014).  
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Also, it is amazing to discover that majority of the detected resistance genes in this study 
were found to be more evenly distributed among cases and control children, although 
resistant gene dfrA14_1 was exclusively found in diarrhoeal children alone with p-value 
0.010. A study in the past corroborates prevalence of the dfrA14_1 among bacterial infected 
individuals (Park 2018). Our study compared genetic (presence or absence of resistance 
genes) with resistant scores obtained from phenotypic disk diffusion technique that 
determined bacterial resistance and found that the concordance between the two methods was 
94% combined. In the resent time this is one of the few studies in West-Africa that have 
looked at the concordance of the presence of resistance genes and compared to phenotypic 
disk diffusion method.  Among the class of antibiotics that include bectalactams, 
aminoglycoside, phenicol, Sulphamethoxazol-Trimethoprim and tetracycline the concordance 
rate was 100%, 100%, 76%, 97% and 95% respectively (table 8.3). The possible explanation 
for the antibiotics that did not yield 100% concordance is that the organism did not express 
the resistance genes present thereby resulting in organism showing sensitivity in the 
phenotypic disk diffusion method. Also it was interesting to see nine isolates that showed 
zero resistance score to eight antibiotics in the disk diffusion method,also WGS showed 
absence of the corresponding resistance genes (table 8.6 and figure 8.7a). Limited studies 
have shown similar report among bacterial enterobacteriacae family and little is known of 
any such report regarding EAEC pathotype. However, the high concordance rate cannot be 
enough to justify use of whole genome sequence revealing presence of antibiotic resistance 
gene(s) to predict or determine bacterial isolates as resistant to an antibiotic until a multisite 
study is considered to conduct standard and thorough investigation. Moreover, in 2017, the 
outcome of European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
subcommittee scientific meeting on the role of WGS in antimicrobial susceptibility (AST) of 
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bacteria issued ten recommendations that should be considered prior adopting use of WGS-
inferred susceptibility to guide clinical decision making (Ellington, Ekelund et al. 2017).  
In order to determine the linkage between diarrhoeal and non-diarrhoeal EAEC strains we 
obtained ST result from MLST data generated by WGS. A total of 29 different Sequence 
types (STs) were identified among the 50 EAEC isolates sequenced, and these 29 STs were 
heterogeneously disseminated among 23 diarrhoeal and 27 non-diarrhoeal children. Fifteen of 
the EAEC isolates have distinct ST types, whilst twelve STs that include ST58, ST73, ST111, 
ST131, ST156, ST222, ST349, ST394, ST678, ST1291, ST3018 and 3032 contained in 2 
isolates, ST10 identified in 3 isolates and ST38 was identified in eight isolates. The 
commonest ST in the study was ST38 which constitute 16% of the STs and belongs to 
phylogroup A. All the ST38 produced ESBL blaTEM except one from healthy child, and 50% 
of the ST38 are linked with diarrhoea in children less than 10 month old. Two of the ST38 
linked with diarrhoea are from the same peri-urban community and were isolated the same 
month and year and resistant to at least 3 drugs which are Ampicillin, Chloramphenicol, 
Sulphamthoxazol-trimethoprim and Tetracycline (figure 8.7a). ST38 has previously been 
described in some studies. For example, a study investigating EAEC STs among Nigerian 
diarrhoeal and healthy children showed ST38 and other clonal complexes with predicted 
ancestors ST10, ST23 and ST31 possesses both pathogenic and non-pathogenic EAEC strains 
(Okeke, Wallace-Gadsden et al. 2010). Similarly report obtained from a study in China 
emphasised the heterogeneous distribution of ST10, ST38 and ST131 among clinical and 
environmental samples with EAEC isolates (Zhang, Gu et al. 2016). However, the majority 
of Nigeria isolates in the Okeke‟s study possessed ST10-complex EAEC that were associated 
with diarrhoea in children older than 1 year. The ST10 in our study belong to phylogenetic 
group-A, this finding corroborates findings from the Nigeria study. Futher analysis of cluster 
ST38 showed strong association of ST38 with plasmid incompatibility types, particularly 
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with plasmid IncFIB and strongest with IncFIB(pB171)_1_pB171 and were mostly link to 
diseased children. This is a clear demonstration of virulence clone of ST38. The only ST38 
(SID103530) lacking plasmid associated resistance gene was not link to disease. Although 
there are three ST38 that have IncFIB which were not link to disease during the study but the 
children with these three ST38 that harbours IncFIB were confirmed to have developed 
diarrhoea following 60 days followup.   
Following reanalysis of the WGS data using galaxy pipeline instead of nullabo pipeline we 
realised that two EAEC isolates of SID 102191 and 102375 generated allels that are artefact 
due to poor sequencing so because of this finding the ST2704 and ST394 is cancelled for the 
two SIDs respectively. However, the SID102602 and SID103076 yielded new allels that 
require futher confirmation by the custodian of MLST database.  
 
The production of extended-spectrum β-lactamases (ESBL) is one of the common causes of 
resistance to the oxyimino-cephalosporin such as ceftazidime, cefotaxime and ceftriaxone 
(Pitout and Laupland 2008). The predominant types of ESBLs in 1980s and early 1990s that 
belong to TEM and SHV families such as TEM-1, TEM-2, and SHV-1 β-lactamases, which 
are regarded as derivatives of non-ESBLs (Paterson and Bonomo 2005), are what we found 
in our investigation.  It is interesting to note that all of our EAEC isolates did not produce 
ESBL CTX-M complex or CTX-M15 or CTX-M-14 which is contrary to many studies that 
have shown prevalence of ESBL CTX-M-15 producing E. coli (Fam, Leflon-Guibout et al. 
2011; Aibinu, Odugbemi et al. 2012; Peirano, van der Bij et al. 2012; Imuta, Ooka et al. 
2016). The reason for this is unclear, it may be that ESBLs CTX-M clone is not in circulation 
in the Gambia rural regions although it should be noted that our samples are mainly from 
children under 5 years old who are probably not expose to ESBL CTX-M producing drugs 
either through their case contacts or animals. This may explain why the majority of the EAEC 
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strains are carriage as they lack CTX-M resistant clone. More studies may be required to 
resolve our speculation.   
 
8.4 Conclusion 
This study shows that EAEC strains are diversely distributed among diarrhoeal and non-
diarrhoeal children using variables such as phenotypic resistant score and genotypic typing 
that include sequence type and presence or absence of resistance-gene. Our study further 
showed that ESBL CTX-M clone associated with bacterial virulence and widespread in other 
geographic regions in the globe is not in circulation among children in the rural Gambia. 
Additionally, this is one of the few studies from sub-Sahara Africa that has shown higher rate 
of concordance of phenotypic resistant score with WGS resistant genes.  
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Chapter 9: Discussion of Hypotheses, Aims and Objectives  
 
The primary aim of this study was to explore molecular approaches in the diagnosis of 
diarrhoea caused by infectious EAEC among children from rural Gambia. This has been 
fulfilled following characterisation and evaluation of the putative virulent factors of EAEC 
strains from children under five year old in relation to diarrhoeal outcome, measure of 
bacterial load and screening for production of biofilm factor.  
 
9.1 Putative virulent factors such as pet, sepA and aggA influence disease outcome in 
The Gambia 
The association of EAEC virulent genes such as pet and aggA and diarrhoeal disease have 
been shown in some studies (Eslava, Navarro-Garcia et al. 1998; Lima, Boisen et al. 2013; 
Bafandeh, Haghi et al. 2015; Jensen 2017). However, many studies from different regions of 
the world have not detected a strong association of pet and aggA genes among diarrhoeal 
infants (Samie, Obi et al. 2007; Boisen, Scheutz et al. 2012) as this study indicated. Therefore 
this hypothesis was accepted in respect of pet and aggA genes causing diarrhoea among 
infants. Additionally, the hypothesis was accepted for sepA, astA and capU that were 
associated to diarrhoeal among children less than five years old.  
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9.2 Measure of Bacterial load assay to ascertain the relevance of TaqMan-qPCR to 
diagnose EAEC 
Globally, limited studies have utilised TaqMan-qPCR that target aatA gene to diagnose 
EAEC (Chattaway, Harris et al. 2013; Lima, Quetz Jda et al. 2013). This was the first study 
in sub-Sahara Africa to explore TaqMan-qPCR diagnostic tool to investigate infectious 
EAEC. This diagnostic tool is highly discriminatory, although the result obtained showed that 
EAEC was not associated with diarrhoea. However, presence of pet gene in the EAEC with 
higher bacterial load showed association with diarrhoeal illness among children.   
 
 
9.3 Screening for biofilm production among EAEC strains to diagnose infectious EAEC 
diarrhoea  
Many studies have used production of biofilm to detect infectious EAEC strains (Wakimoto, 
Nishi et al. 2004; Bangar and Mamatha 2007; Dadawala 2010). In this study, three biofilm 
screening methods were adopted (TT, CRA and TCP) of which TCP method found to be 
more reliable and specific and was used in the data analysis. Despite TCP reliability, result 
showed that its specificity and sensitivity will increase if the test is done on EAEC isolates 
known to have harboured aatA and aggR genes as well as other genes under the regulatory of 
aggR.  
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9.4 Investigating the prevalence of multidrug resistant EAEC 
The treatment of EAEC and its eradication continue to be a challenge majorly in low income 
countries despite been sensitive to many antibiotics particularly third generation antibiotics 
(Nguyen, Le et al. 2005; Aslani, Alikhani et al. 2011). The problem associated with the 
eradication of EAEC includes increase in resistance to commonly use antibiotic likely due 
largely to indiscriminate use of antibiotics in human and animal. Several studies have 
reported EAEC strains to be resistant to multiple antibiotics (Nguyen, Le et al. 2005; 
Hebbelstrup Jensen, Stensvold et al. 2016) but majority of these studies have not shown 
multi-resistant strains been associated to a particular age stratum as shown in this study  
 
 
 
9.5 Employ WGS to investigate Association of EAEC with diarrhoeal disease 
Whole Genome Sequencing was employed to identify EAEC strains that caused diarrhoeal 
outbreak in developed countries (Scavia, Staffolani et al. 2008). In this study, WGS unveiled 
the resistant gene associated with diarrhoea in children. Also, the method has emphasised the 
concordance of phenotypic resistance with genotypic presence of resistance genes. WGS 
further displayed the divergence of EAEC which make it more difficult to attribute a 
particular sequence type (ST) and other genetic components to infectious EAEC.  
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Chapter 10: Concluding remarks 
 
10. 1 Limitations of the study  
10.1.1 Inability to perform adherence assay 
Adherence assay is regarded as gold standard for diagnosing EAEC, the assay should have 
been considered in this study in order to classically measure the strength of the three 
diagnostic approaches used. Although an attempt was made to perform the adherence assay in 
the collaborator‟s laboratory in the USA but due to gross contamination of the EAEC isolates 
during shipment thus it became impossible to perform the assay.  
 
10.1.2 Unable to conduct conventional serotyping on the study strains  
I was unable to do serotyping on the EAEC isolates due to cost. If the serotyping was done, 
the study would have been strengthened by linking distinct serotypes to the cluster of 
virulence genes and possibly bacterial load and biofilm production. However, I was able to 
utilise whole genome sequencing to do MLST and obtained sequence type (ST). WGS also 
revealed resistance genes associated with the EAEC used in this study. Thus, WGS is 
considered to be more discriminatory compared to the conventional serotyping.  
 
10.1.3 Inability to perform pathogenicity assay 
Again, I was unable to perform pathogenicity assay using animal (mouse) model to 
investigate virulence activities of the identified EAEC virulent genes such as pet, aggA and 
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capU due to lack of facility and skill. Although, this aspect is among the investigations 
planned for future study. 
 
10.1.4 Data 
The EAEC isolates used in this study were obtained from among the children living in the 
rural Gambia. It was recommended to have considered sampling adult particularly, mothers 
of children or adult case-contacts in order to extend possible source of infection. Animals in 
the compound where the children reside were recorded but samples were not taken. 
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10.2 Future studies 
10.2.1 Adherence and pathogenicity assay 
Given the fact that adherence (HEp-2 cell) assay is the gold standard for the identification of 
EAEC, it is important to factor it into the future studies relating to diagnosis of diarrhoea 
even though the technique is unable to differentiate typical-EAEC (presence of aggR gene) 
from atypical-EAEC (absence of aggR gene). Also, pathogenicity assay is an important 
experiment to consider as it can demonstrate causality and clear doubt on the importance of 
EAEC in diarrhoeal disease. 
 
10.2.2 Conduct bacterial load that target aggR, pet, sepA, orf3 and capU 
Measure of bacterial load that target true and essential genes listed above must be considered 
in the future study, so that, EAEC genes that were found to be associated with diarrhoea can 
be well established.  
 
10.2.3 Perform Whole Genome Sequence on identified EAEC isolates from human and 
animal to establish transmission route 
Whole genome sequencing of EAEC that were concurrently isolated from human and animal 
will be ideal future investigation to identify source of transmission. This will unmask 
relatedness of the strains as well as reveal several virulence factors that include resistance 
genes and biofilm producing genes that are contributory to EAEC infectivity.   
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10.2.4 Investigate how pet may allow successful competition with commensal members of 
the gut microbiome 
The mechanisms that regulate the ability of microbiota to restrain pathogen growth are 
complex and include competitive metabolic interactions, localization to intestinal niches, 
induction of host immune responses. Pathogens such as EAEC having pet virulent factor 
might, in turn, have evolved strategies to escape from commensal-mediated colonisation 
resistance. Investigating into these strategies will broaden our understanding of pathogen-
commensal interactions which may lead to new therapeutic approaches that are critical for 
controlling infection and disease 
 
 
10.2.5 Investigate into how EAEC infection predisposes children to malnutrition Vis 
versa  
Many studies outside West-Africa have incriminated EAEC infection as a cause of 
malnutrition in children but no such studies have been demonstrated in the region where 
malnutrition is endemic particularly in the rural Gambia. Therefore, this type of study will be 
considered as an area of future investigation.  
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10.3 Closing remarks  
Despite all the limitations, this study provides detailed initial description of EAEC virulence 
factors circulating among children in the rural Gambia and it is directly related to a 
geographically defined West-African population setting.  
Moreover, the study unmasked the magnitude of multi-drug resistant EAEC strains among 
children and this was never done in the West-Africa before now.  
This study has at least answered some relevant questions relating to characteristics of EAC in 
association to diarrhoea among younger children from Gambia. Although, more 
investigations are required in order to explain why many children in the rural Gambia are 
carrier of EAEC and did not fall ill of the infection to result to diarrhoea. However, this study 
has hinted that EAEC infection makes Gambian children susceptible to malnutrition.  
Also, it gladdens me that all of the laboratory investigations and laboratory procedures were 
performed at MRCG@LSHTM The Gambia, providing basis for future studies into areas 
requiring exploring more in great detail in the sub-regions in future.  
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Chapter 12: Appendix  
 
Appendix A – Study approvals 
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Appendix B – Good Clinical Practice / Good Clinical Laboratory Practice training & Certificates 
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Appendix C – Creating standard curves with genomic DNA 
                                         (Adapted from Applied Biosystem 2003) 
1. Extract total DNA from sample (stool) using appropriate extraction kit 
2. Measure/Quantify the concentration of the total DNA (EAEC 042 – 55ng) 
3. Identify the genome size of the organism (EAEC 042 – 5,355323bp) 
4. Identify the mass of the genome by inserting the bacterial genome size value in the 
following formula  
 
 
 
 
 
 
 
 
 
5. The mass of the EAEC 042 genome is calculated and convert to picogram units 
 
M = [5.0e6 bp][1.096e-21g/bp] = 5.5e-15g 
 
 
6. Convert the mass to picogram as below 
 
[5.5e-15g][1e12pg/g] = 0.0055pg 
 
 
7. Divide the mass of the genome by the copy number of the gene of interest (aaiC & 
aatA) per haploid genome 
 
0.0055 pg/genome ÷ 1 copy gene T /genome = [0.0055pg/genome][genome/1 copy]                 
= 0.0055p/1 copy gene T 
 
          Therefore, 0.0055 pg of EAEC 42 genome contains one of the aatA gene and aaiC gene 
 
 
M = [n][1.096e-21 g/bp] 
Where: n = genome size (bp),  
               m = mass,  
               e-21 = x10
21
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8. Calculate the mass of gDNA containing the copy number of interest, that is 5,000000 
to 5 copies (5 x 10
6
 to 5 x 10
-1
) 
 
 
Copy #  
 
 
 
 X 0.0055pg 
Mass of gDNA needed (pg) 
5000000 27500 
500000 2750 
50000 275 
5000 27.5 
500 2.75 
50 0.275 
5 0.0275 
0.5 0.00275 
 
9. Calculate the concentrations of the gDNA needed to achieve the copy numbers of 
interest Divide the mass required (step 4) by the volume to pipette into each reaction  
 
10. 2 µL or 5uL of gDNA solution is pipetted into each PCR reaction 
 
11. Calculate the concentration of gDNA needed to achieve the required masses of gDNA 
 
12. Prepare a serial dilution of the gDNA using the formula C1V1 = C2V2 
13. Determine the stock concentration using spectrophotometric analysis (picogreen) 
given 55ng or 0.055 µg/µL  (55000pg/µL) as C1. Each dilution has a final volume 
(V2) of 100µL 
14.   [55000 pg/ µL][V1] = [13750 pg/µL][100 µL] = 25 µL 
15. V1 = 25 µL 
16. Volume of diluents  = 100 µL – 25 µL = 75 µL 
Copy # Mass of gDNA needed (pg)  
 
 
 
÷ 2µL  
 
Final Conc. (pg/µl) of gDNA 
5000000 27500 13750 
500000 2750 1375 
50000 27.5 137.5 
5000 2.75 13.75 
500 0.275 1.375 
50 0.0275 0.1375 
5 0.00275 0.01375 
0.5  0.001375 
Copy # of interest x mass of genome = mass of gDNA required 
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17. To achieve the final volume of 100 µL, add 25  µL of stock gDNA to 75 µL of 
diluents (Nuclease free water) 
Table below is representation of the calculated volumes of gDNA and diluent for all the 7 
dilutions 
Dilution Source 
gDNA 
diluents 
Initial 
Conc (pg/ 
µL) 
Vol of 
gDNA 
(µL) 
Vol of 
Diluent 
(µL) 
Final 
Vol. 
(µL) 
Final conc. Of 
dilution (pg/ 
µL) 
Resulting copy 
DNAse aaiC/aatA 
gene / 1 µL 
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Appendix D – Media preparations and reagents 
 
Congo red agar (CRA) 
 Weigh 37g of Brain Heart Infusion (BHI) broth  
 Weigh 50g of Sucrose  
 Weigh 10g of Nutrient agar or Agar No.1 + optional 0.1g glucose 
 Dissolve in 1 L Distilled/H2O and sterilise at 121
o
C for 15 minutes 
 Separately, weigh 0.8g/L Congo-red and dissolve in d/H2O, sterilise appropriately 
 Add the sterilised Congo-red to the other agar medium constituents after cooling to 
55
o
C 
 Set up QC using appropriate control strains 
 
MacConkey agar – Oxoid CM0007 
 Suspend 52g in 1 litre of distilled-water and bring to boil to dissolve completely 
 Sterilise by autoclaving at 121oC for 15 minutes   
 Allow to cool to 55oC in cooling water bath  
 Distribute in 20mls in 30mm Petri dishes  
 Flame the agar surface and allow to solidify  
 Dry the gel surface before use 
 Perform quality control (QC) 
 Label and store in plastic bag at  +4oC to +8oC 
 
Muller-Hinton agar – Oxoid CM337 
 Suspend 38g in 1 litre of distilled-water and bring to boil to dissolve completely 
 Sterilise by autoclaving at 121oC for 15 minutes   
 Allow to cool to 55oC 
 Distribute in 20mls in 30mm petri dishes  
 Flame the agar surface and allow to solidify  
 Dry the gel surface before use 
281 
 
 Perform quality control (QC) 
 Label and store in plastic bag at  +4oC to +8oC 
 
Nutrient agar – Oxoid CM0003 
 Suspend 28g in 1 litre of distilled-water and bring to boil to dissolve completely 
 Sterilise by autoclaving at 121oC for 15 minutes   
 Allow to cool to 55oC 
 Distribute in 20mls in 30mm petri dishes  
 Flame the agar surface and allow to solidify  
 Dry the gel surface before use 
 Perform quality control (QC) 
 Label and store in plastic bag at  +4oC to +8oC 
 
Preparation of Tryptic soy broth – (SIGMA-ALDRICH T8907) for Slime production 
 Weigh 30g of Tryptic soy broth 
 Add 10g of glucose  
 Mix to dissolve in 1 litre of distilled-water 
 Distribute in bijou bottles or borosilicate tubes 
 Sterilise by autoclaving at 121oC for 15 minutes   
 Perform quality control (QC) 
 Label and store in plastic bag at  +4oC to +8oC 
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Appendix E: Peer-reviewed journal from the thesis 
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